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Abstract
Protein misfolding and aggregation are associated with the pathogenesis of a wide range of
neurodegenerative and systemic diseases, including Alzheimer’s disease, Parkinson’s disease and
cataracts. Consequently, cells have evolved a vast network of molecular chaperones, which include
the intracellular heat-shock proteins (Hsp), that act to prevent protein misfolding and aggregation as
part of protein homeostasis (proteostasis). However, the precise molecular mechanisms by which
these chaperones prevent protein aggregation are unclear, mostly due to the significant heterogeneity
and transient nature by which they interact with client proteins and co-chaperones. This heterogeneity
has made these proteins difficult to study using conventional ensemble-averaging approaches, as rare
and transient interactions between individual species cannot be observed. Recently, single-molecule
approaches have emerged as a useful tool to study chaperone function since individual protein
trajectories can be monitored in real time, enabling the characterization of events typically masked in
ensemble measurements. The work described in this thesis aimed to utilize and further develop singlemolecule approaches for the study of protein misfolding, aggregation and molecular chaperone
function.

A critical aspect of chaperone function is how they modify the conformation of their client proteins
to promote folding and prevent misfolding. To address this, two well-established client proteins,
firefly luciferase and rhodanese, were developed into protein-folding sensors that could be used to
monitor chaperone-induced conformational changes in real time using single-molecule fluorescence
resonance energy transfer (smFRET). To do so, both luciferase and rhodanese were modified such
that they could be specifically immobilized to a functionalized coverslip surface to monitor structural
changes in a temporally-resolved manner and over extended periods via total internal reflection
fluorescence (TIRF) microscopy. For the first time, the conformation of a client protein as it was
being folded by the bacterial or human Hsp70 chaperone machinery (i.e., Hsp40, Hsp70 and a
nucleotide-exchange factor) was monitored in real time. From these data, it was demonstrated that
iv

the Hsp40 chaperone binds to and conformationally remodels misfolded client proteins for delivery
to Hsp70. Following binding by Hsp70, the conformation of the client becomes significantly
expanded but remains conformationally dynamic, thereby resolving misfolded states. Release of the
client protein by Hsp70 enables an opportunity for spontaneous refolding of the client to the native
state or collapse to a misfolded conformer. The latter can undergo additional rounds of chaperone
action until the native state is acquired. Thus, the luciferase and rhodanese protein-folding sensors
developed in this work were used to elucidate key aspects of chaperone function and represent ideal
tools for the continued study of other chaperone systems.

This work also describes the characterization of a novel client protein, the chloride intracellular
channel protein (CLIC1), for the study of small Hsp (sHsp) molecular chaperone function. Using a
combination of ensemble-based approaches, this work demonstrated that the sHsp 𝛼B-crystallin
could inhibit the heat-induced aggregation of CLIC1 by sequestering aggregation-prone clients into
a soluble high-molecular mass complex. Additionally, the fluorescence self-quenching phenomenon
of tetramethylrhodamine (TMR) dyes was utilized to develop CLIC1 into a single-color proteinfolding sensor. While the TMR-labelled CLIC1 sensor exhibited complex fluorescence dynamics and
could not reliably report on the folded state of CLIC1, this work demonstrated the use of CLIC1 as a
reliable model client for future studies of sHsp function.

Finally, work in this thesis also describes the characterization of a novel dye, ASCP, that can be used
as an alternative to Thioflavin T (ThT) to monitor protein aggregation in ensemble and singlemolecule studies. ThT is the most used dye for the study of amyloid fibrils; however, it has a poor
ability to report on the soluble oligomeric species formed early during aggregation. Using light
scattering and fluorescence-based assays, ASCP was found to be capable of monitoring the
amorphous and fibrillar aggregation of a range of model proteins in situ and ex situ and, in some
cases, could report on the formation of early oligomeric species not detected by ThT. Notably, it was
found that ASCP had a higher binding affinity to 𝛼-synuclein fibrils compared to ThT and
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competitively displaced ThT bound to fibrillar species, suggesting that ASCP shares similar binding
sites to amyloid fibrils as ThT. ASCP also exhibited a significant Stokes shift (145 nm) when bound
to fibrillar 𝛼-synuclein that was much larger than that observed for ThT (68 nm). This work describes
single-laser two-color TIRF microscopy experiments to make use of this Stokes shift and
simultaneously observe the binding of the sHsp 𝛼B-crystallin to ASCP-stained 𝛼-synuclein fibrils.
Thus, this work describes a simple single-molecule imaging setup that can be utilized to answer some
fundamental questions on the role of molecular chaperones in the prevention or disassembly of
aggregated species.

Collectively, the results presented in this thesis demonstrate the utility of single-molecule
fluorescence approaches to study the mechanistic details by which molecular chaperones fold proteins
and prevent their misfolding and aggregation. The continued investigation of chaperone function
using such approaches is critical to gain a more holistic understanding regarding the mechanisms by
which molecular chaperones ameliorate the pathogenesis of debilitating aggregation-associated
diseases.
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Chapter 1- Introduction
Protein misfolding and aggregation is associated with the progression of a range of debilitating
neuropathies and systemic diseases, such as Parkinson’s disease, Alzheimer’s disease and cataracts
(Dauer et al., 2003; Truscott, 2005; Thal et al., 2015). Consequently, cells have evolved a complex
network of molecular chaperones that act to prevent protein aggregation and maintain protein
homeostasis (proteostasis) (Taylor et al., 2005; Hartl et al., 2011; Chiti et al., 2017). However, the
dynamic and heterogeneous manner by which these molecular chaperones perform their multi-faceted
roles have made them difficult to study using traditional solution-phase ensemble-based techniques,
which tend to mask rare and transient events. Conversely, single-molecule approaches overcome the
inherent limitations of ensemble-averaging methodologies by facilitating the observation of
individual molecules in real time. As such, these techniques are particularly suited for the study of
molecular chaperones owing to the heterogeneous manner in which they interact with clients and cochaperones (Mashaghi et al., 2014). The first part of this review provides an overview of the proteinfolding problem and discusses the role of key molecular chaperones that assist in maintaining a
healthy proteome. A brief overview of common single-molecule methodologies is then provided with
a particular focus on their application for the study of molecular chaperones.

1.1
1.1.1

Protein misfolding and aggregation
The protein-folding problem

Most proteins need to fold into a specific, three-dimensional conformation to carry out their biological
function (Dobson, 2003). However, folding represents a challenging problem for a protein due to the
large number of conformations that a polypeptide can adopt. For example, each peptide bond in the
polypeptide chain can exist in one of three possible conformations, hence a 101-amino acid protein
could theoretically exist in ~ 5 x 1047 configurations (Zwanzig et al., 1992). As such, it seems
remarkable that the self-assembly of individual and multi-protein complexes occurs at all, let alone
on a biologically relevant timescale. It is now known that proteins fold by exploring an ensemble of
structures driven by residues within the polypeptide chain randomly diffusing and interacting with
each other. These interactions of side chain groups form native contacts that guide the protein down
2
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a rugged ‘folding energy landscape’ towards a small ensemble of thermodynamically stable
conformations, biased towards the native fold (Onuchic et al., 1997) (Figure 1.1). The reduction in
free energy during folding is strongly favored due to burial of surface exposed hydrophobic residues,
which results in the formation of a compact globular state that can act as an intermediate to enhance
folding efficiency (Dobson, 2003; Neuweiler et al., 2005; Bartlett et al., 2009). However, the
presence of unfolded state ensembles results in a plethora of possible ‘routes’ down the folding
landscape, some of which may involve significant barriers or kinetic traps that can cause the
formation of misfolded or partially-folded species. Breaking of native-state bonds, which requires
substantial amounts of energy, is needed to push the protein over an energy barrier to an ensemble of
folding intermediate states, from which refolding can occur down a different trajectory (Dill et al.,
1997). While relatively simple in the context of describing protein folding in isolation, relating the
folding energy landscape to in vivo situations is significantly more complex due to competing
reactions between macromolecules in the crowded environment of the cell.

During the vectorial synthesis on the ribosome, nascent polypeptides have limited opportunity for
folding. The structural constraints of the ribosome limit folding to the formation of α-helices
(Woolhead et al., 2004), while efficient folding between distal residues separated in sequence cannot
occur productively until a substantial amount of the protein (~ 50 - 300 amino acids) has been
synthesized (Hartl et al., 2009). Furthermore, the relatively slow translation speed (5 - 9 amino acids
per second) in eukaryotes (Kramer et al., 2009) means there is a significant period of time where the
nascent polypeptide can erroneously interact with itself or other proteins within the cell. This is
particularly the case for larger proteins with many domains (> 100 amino acids), as unassisted protein
folding is slower than the rate of translation (Frydman, 2001), thereby increasing the probability of
undesirable interdomain interactions. While this is partially minimized by the pseudo-helical
arrangement of polysomes, which position emerging polypeptides distally (Brandt et al., 2009), the
concentration of non-native species remains high, encouraging the formation of misfolded or
kinetically trapped proteins. Upon release of the polypeptide from the ribosome, folding can be
3
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further hindered in the crowded environment of the cell (van den Berg et al., 1999), with many nonnative conformations explored before the protein acquires its native state. Consequently, without
folding assistance in vivo, proteins often travel down an extremely rugged energy landscape that is
highly populated with kinetic traps and misfolded species, which can cause them to aggregate into
toxic species (Figure 1.1).

Figure 1.1: The funnel-shaped energy landscape of protein folding. Unfolded or nascent polypeptides with
high conformational entropy can explore multiple pathways down the folding energy landscape en-route to
acquiring a native state, which is characterized by low free energy and conformational entropy (blue). The
ruggedness of the folding landscape results in the accumulation of folding intermediates within kinetic traps,
which must overcome a significant free energy barrier to proceed down ideal folding pathways to the native
state. Alternatively, proteins that are unable to fold to the native state may adopt misfolded conformations.
These misfolded intermediates are prone to erroneous intermolecular interactions with other misfolded species
that can result in the formation of extremely stable, low free energy aggregated species (red). Figure adapted
from Hartl et al., (2011).
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1.1.2

Protein folding, aggregation and disease

Proteins have evolved relatively smooth folding landscapes to minimize the formation of intermediate
and misfolded states, and to allow folding to proceed on a biologically relevant time scale (Bartlett et
al., 2009). While more common for larger multi-domain proteins, it has been shown that even small
proteins that fold in microseconds can populate an ensemble of folding intermediates that constitute
an obligatory step in the pathway to the native state (Mayor et al., 2003; Brockwell et al., 2007; Friel
et al., 2009). This highlights that most (if not all) proteins are subject to kinetic partitioning between
unfolded, partially folded, and native ensembles (Figure 1.2). The equilibrium of a protein between
these different states can be affected by genetic factors (e.g., mutations that affect the primary
structure and thus the folding landscape of a protein) or cellular conditions. For example, during
periods of cellular stress (e.g., changes in temperature, pH or redox state) the native state is perturbed
and pathways to the native state are disfavored; under such conditions the formation of denatured or
intermediate molten globule states becomes favored (Dobson et al., 1998). As folding intermediate
states expose hydrophobic regions that are normally buried within the native fold (Eichner et al.,
2011), they have a high propensity to interact with each other, resulting in the protein leaving ‘onpathway’ folding trajectories and progressing towards ‘off-pathway’ routes that result in aggregation
(Figure 1.2). Like folding, aggregation is driven by hydrophobic interactions, and this can result in
amorphous or fibrillar structures, which represent significant kinetic traps with extremely low free
energy (Dobson, 1999). Protein aggregation typically consists of three distinct stages: (i) nucleation,
(ii) growth, and (iii) the stationary phase. During the nucleation stage, misfolded monomers selfassemble into an aggregation-competent nuclei in a process that is generally rate limiting for
aggregation (Wetzel, 2006; Arosio et al., 2015). During the growth stage, monomers of misfolded
protein are rapidly added to the nuclei, which results in aggregate assembly, until all misfolded
proteins have been depleted from solution and the system reaches equilibrium (i.e., the stationary
phase).
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Figure 1.2: Kinetic partitioning between competing pathways during protein folding and aggregation.
Nascent proteins fold ‘on pathway’ to the native state via folding intermediate states. During periods of cellular
stress, or if the folding of the protein is somehow comprised (e.g., by genetic mutations), the equilibrium
between these different states is disturbed such that the protein can transition to misfolded states that are ‘offpathway’. The accumulation of non-native species can then partition the misfolded protein towards the
formation of amorphous or fibrillar aggregates that contribute to the pathogenesis of various neuropathies and
systemic diseases. Molecular chaperones partition proteins towards ‘on-pathway’ folding by refolding
misfolded or aggregated proteins (blue arrows) or by inhibiting protein aggregation (orange).

During amorphous aggregation, the rapid addition of misfolded monomers to hydrophobic regions
on the nuclei occurs in a three-dimensional manner, which consequently leads to increased
aggregation propensity due to a growing hydrophobic surface area for interaction between the
aggregate and misfolded monomer (Stranks et al., 2009). Consequently, amorphous aggregates are
generally disorganized and, unlike amyloid fibrils, lack a defined structural motif. While amorphous
aggregates have been associated with the pathogenesis of several diseases, such as cataracts
(Sandilands et al., 2002), much of the research in the last few decades has focused on fibrillogenesis
6
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due to its implication in numerous neurodegenerative diseases (Chiti et al., 2017). In contrast to
amorphous aggregates, the early stages of amyloid fibril formation are characterized by the addition
of misfolded monomers to the soluble oligomer or pre-fibrillar nuclei in an ordered two-dimensional
process to form a mature fibril. Secondary nucleation of amyloid fibrils can also occur via two major
mechanisms; (i) fibril fragmentation, which results in the generation of smaller nuclei or ‘seeds’ from
which fibrils can propagate (Lomakin et al., 1997; Knowles et al., 2009) or, (ii) surface-nucleation,
whereby the addition of misfolded monomers to an existing fibril creates a secondary nucleus from
which elongation can occur (Cohen et al., 2013; Linse, 2017, 2019). Amyloid fibrils are characterized
by a well-defined cross β-sheet structure that runs perpendicular to the long axis of the fibrils (Makin
et al., 2005); however, fibrils from the same and different aggregation-associated proteins (e.g., 𝛼synuclein, tau and amyloid-β [Aβ]) have been shown to be structurally diverse and polymorphic
(Fitzpatrick et al., 2013, 2017; Guerrero-Ferreira et al., 2019; Ni et al., 2019; Cendrowska et al.,
2020; Gallardo et al., 2020). Whilst the toxicity of amyloid fibril formation has been recognized for
some time, there remains considerable debate regarding which species is responsible for the observed
cytotoxicity of amyloid fibrils. Increasing evidence suggests that the soluble oligomeric species,
rather than the mature fibrils themselves, are the most cytotoxic species and may be responsible for
disease pathogenesis (Kayed et al., 2003; Glabe, 2006; Xue et al., 2009; Chen et al., 2015; Cohen et
al., 2015; Fusco et al., 2017). To avert the deleterious effects of protein aggregation, cells have
evolved a complex network of molecular chaperones to help prevent the formation and accumulation
of misfolded, oligomeric, and aggregated forms of proteins.

1.2

The molecular chaperone network – an important component of proteostasis

The maintenance and regulation of the cellular proteome is heavily dependent on a network of
molecular chaperones, which predominantly include the intracellular heat-shock proteins (Hsps),
however extracellular chaperones have also been identified (Wilson, 2000; Wyatt et al., 2013). The
importance of chaperone function is exemplified during periods of cellular stress (particularly in
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response to high temperatures), when the expression of Hsps is dramatically upregulated to prevent
the formation of misfolded or aggregated proteins (Gething et al., 1992). Proteome maintenance is
achieved by a diverse spectrum of Hsp chaperone families, traditionally named in accordance with
their molecular weight and includes the small Hsps (sHsps), Hsp40, Hsp60, Hsp70, Hsp90 and
Hsp100 families. This network of chaperones performs a plethora of independent and co-operative
roles, which include (i) assisting de novo folding, (ii) refolding kinetically trapped proteins, (iii)
preventing aggregate formation and (iv) the disassembly of aggregates. Of critical importance is that
chaperone function relies on a complex interactive network between different chaperone and cochaperone families. Relevant to this thesis are the functional mechanisms by which the sHsps, Hsp40
and Hsp70 molecular chaperones act to maintain proteostasis, which are discussed below. For details
regarding the other chaperone systems, such as Hsp60 and Hsp90, the reader is referred to the
following excellent reviews (Li et al., 2012; Balchin et al., 2016; Hayer-Hartl et al., 2016).

1.2.1

The Hsp40 and Hsp70 system – a hub of chaperone-mediated proteostasis

1.2.1.1 Structure and function of Hsp70
The Hsp70s (DnaK in Escherichia coli [E. coli]) are a family of ubiquitous intracellular ATPdependent chaperones, of which there are 13 genes in humans (Kabani et al., 2008; Kampinga et al.,
2009). The Hsp70 family is a central hub of the chaperone network, whereby it performs a plethora
of cellular roles including de novo protein folding and refolding, protein disaggregation, facilitation
of client handover to other proteostasis quality control systems (e.g., autophagy, proteasome, etc.),
the assembly and disassembly of protein complexes and protein translocation (Calloni et al., 2012;
Goloubinoff, 2017). The cellular roles and functions of the major Hsp70 isoforms are described in
Table 1.1. The functional diversity of Hsp70 members is surprising considering that this protein
family remains one of the most evolutionary conserved across all protein families in humans
(Rebeaud et al., 2021). Structurally, most Hsp70 proteins consist of the same core motifs; an Nterminal nucleotide-binding domain (NBD), a flexible linker that connects to the client-binding
domain (CBD), which itself is composed of a β-sandwich peptide-binding subdomain (CBDβ) and a
8
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α-helical lid (CBD𝛼), and an unstructured C-terminal tail (Mayer, 2013) (Figure 1.3). A leucine rich
EEVD motif is located at the extreme C-terminus and plays a critical role in regulating the various
interactions and functions with co-chaperones (Freeman et al., 1995; Assimon et al., 2015; Yu et al.,
2015; Serlidaki et al., 2020). The mechanisms by which Hsp70 folds client proteins is highly
regulated by its co-chaperones Hsp40 and nucleotide-exchange factors (NEFs) and is discussed in
more detail below (sections 1.2.1.2 and 1.2.1.3).

Figure 1.3: Structure and domain organization of Hsp70. The structure of the bacterial (E. coli) archetype
Hsp70 homolog, DnaK (PDB 2KHO, Bertelsen et al., 2009) in the ADP-bound ‘closed conformation’. The Nterminal nucleotide-binding domain (NBD, grey) is connected to the client-binding domain (CBD) by a short
linker region (green). The CBD comprises a β-sandwich peptide-binding subdomain (CBDβ, purple) and an
𝛼-helical lid subdomain (CBD𝛼, blue).
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Table 1.1: Summary of the most studied Hsp70 isoforms and their reported stress inducibility, subcellular location and functions

Name

Synonyms Stress
Subcellular
inducible localization

Cellular functions

References

DnaK

None

Yes

Cytosol

DnaK is the archetype Hsp70 and is constitutively expressed in E. coli.
Consequently, it is heavily involved in de novo protein folding and acts
as a central regulator of proteostasis, either binding to misfolded proteins
and preventing their aggregation, directing proteins to other chaperone
systems (e.g., GroEL/ES, the E. coli Hsp60 homolog) or shuttling
misfolded proteins to degradation pathways. The expression of DnaK is
essential at elevated temperatures for cell survival. Much of the current
understanding regarding the mechanistic details of Hsp70 function is
derived from work performed with recombinantly purified DnaK. Using
reconstituted chaperone systems in vitro, DnaK has been shown to
efficiently refold chemically denatured luciferase and prevent its
aggregation. Under conditions when folding is not possible, DnaK has
also been shown to shuttle misfolded proteins (e.g., luciferase and
rhodanese) to downstream chaperone systems for efficient refolding.
DnaK is also an important component for the ClpB-mediated
disaggregation of luciferase or malate dehydrogenase aggregates.

(Langer et al., 1992;
Schröder et al., 1993;
Szabo et al., 1994, 1996;
Thomas et al., 1996;
Mogk et al., 2003;
Kellner et al., 2014;
Luengo et al., 2018;
Imamoglu et al., 2020)

Hsp70

Yes

Cytosol,
HspA1 is the most studied human Hsp70 isoform and is dramatically
nucleus, cell upregulated during periods of cellular stress to prevent protein
membranes
misfolding and aggregation and to refold denatured proteins. Notably,
HspA1 has been shown to inhibit the aggregation of a range of model and
disease-associated proteins in cells, such as superoxide dismutase 1
(SOD1), luciferase and green fluorescent protein (GFP). Also protects
cells from heat-induced death and promotes the efficient folding of
luciferase. HspA1 can direct misfolded proteins to other protein quality
control systems (e.g., proteasome, autophagy, etc.) with assistance from
co-chaperones. Sub-stoichiometrically inhibits the aggregation of a range
of proteins in vitro, including the Alzheimer’s-associated proteins Aβ
and tau as well as citrate synthase. Co-operates with a range of Hsp40s

(Freeman et al., 1996;
Takeuchi et al., 2002;
Evans et al., 2006;
Tzankov et al., 2008;
Hageman et al., 2011;
Baaklini et al., 2012; Yu
et al., 2015; FernándezFernández et al., 2017;
Kundel et al., 2018;
Serlidaki et al., 2020)

(E. coli)

HspA1

Hsp72
Hsp70-1
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(and NEFs) to refold chemically- and heat-denatured luciferase or βgalactosidase independently or in tandem with other chaperone systems
in vitro.
HspA5

BiP

No

Endoplasmic HspA5 is the resident housekeeping Hsp70 isoform in the endoplasmic
reticulum
reticulum (ER). It is crucially involved in the translocation of proteins
into the ER lumen and assisting in their correct folding. Furthermore,
HspA5 is a critical protein quality control sensor and is involved in the
transmission of stress signals, inducing the unfolded protein response
(UPR) and can direct misfolded proteins to the cytosol for degradation as
part of the ER-assisted degradation (ERAD) response.

(Bertolotti et al., 2000;
Molinari et al., 2000;
Nakatsukasa et al., 2008;
Otero et al., 2010; Hetz et
al., 2020)

No

Cytosol,
HspA8 is the constitutively expressed Hsp70 isoform and is involved in
nucleus, cell a wide range of cellular functions, including de novo protein folding,
membranes
protein translocation, protein disaggregation, regulation of protein
degradation and the disassembly and recycling of clathrin cages.
Evidence of these functions have been demonstrated by HspA8
mediating luciferase folding and preventing the toxic aggregation of
Huntingtin (Htt) fragments in vivo. HspA8 has also been shown to be an
important component of the disaggregation machinery, as evidenced by
the solubilization of luciferase and GFP aggregates. HspA8 can direct
disease-associated proteins to the ubiquitin-proteasome degradation
pathways. HspA8 can prevent the aggregation of and facilitate the
solubilization of aggregates from a range of reconstituted in vitro
systems, including 𝛼-synuclein, tau and polyglutamate (polyQ) Htt.
Recombinantly purified HspA8 has also been demonstrated to efficiently
refold chemically- and heat-denatured luciferase or β-galactosidase
independently or in tandem with other chaperone systems.

(Freeman et al., 1996;
Terada et al., 1997;
Minami et al., 1999;
Muchowski et al., 2000;
Meacham et al., 2001;
Tzankov et al., 2008;
Hageman et al., 2011;
Pemberton et al., 2011;
Shorter, 2011; Baaklini et
al., 2012; Sousa et al.,
2015; Yu et al., 2015;
Mok et al., 2018; Scior et
al., 2018)

Grp78

HspA8

Hsc70
Hsp73
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1.2.1.2 Structure and function of Hsp40
The multi-faceted functions of Hsp70s are underpinned by their interactions with and regulation by
Hsp40 chaperones (also known as J-domain proteins), which are the most evolutionarily and
structurally diverse family of molecular chaperones (Cheetham et al., 1998) (Table 1.2). Hsp40
chaperones achieve this regulation by (i) binding to and delivering clients to Hsp70 and, (ii)
promoting the capture of client proteins by Hsp70 through stimulating Hsp70 ATPase rates. The
sequence and structural diversity of Hsp40 chaperones is crucial for directing the functional and client
specificity of Hsp70 chaperones, enabling a relatively conserved ATP-dependent molecular machine
(i.e., Hsp70) to perform a plethora of unique cellular roles (Kampinga et al., 2010). All Hsp40
isoforms are characterized by the presence of a highly conserved J-domain, which contains the
histidine-proline-aspartate (HPD) motif that interacts with Hsp70 and stimulates ATP hydrolysis
(Tsai et al., 1996; Kityk et al., 2018). Hsp40 chaperones are separated into three distinct structural
classes (class I, class II and class III) based on their homology to the archetypal J-protein, E. coli
DnaJ.

The class I (DnaJAs) family of Hsp40 chaperones are most similar to DnaJ and consist of an Nterminal J-domain, a glycine-phenylalanine (G/F)-rich region, two C-terminal β-sandwich domains
(CTD-I, CTD-II) and a C-terminal dimerization domain (Figure 1.4A-B). Characteristic to the class
I Hsp40s, a cysteine-rich zinc finger-like region (ZFLR) is encompassed within CTD-I and has been
shown to be important in the recognition and binding of clients and their subsequent transfer to Hsp70
(Lu et al., 1998b; Fan et al., 2005; Summers et al., 2009; Jiang et al., 2019). The class II (DnaJBs)
family of Hsp40 isoforms have a similar overall structural topology as class I isoforms, with the
exception that class II Hsp40s do not possess the ZFLR that is characteristic of class I Hsp40s (Figure
1.4B). Some class II Hsp40 isoforms have also been reported to possess diverse subdomain regions
and/or lack the C-terminal dimerization domain (Kampinga et al., 2010). The G/F-rich region, CTDI and CTD-II subdomains have all been implicated in client binding and recognition (Lee et al., 2002;
Jiang et al., 2019). The class II Hsp40s contains one of the most ubiquitously expressed and up-
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regulated isoforms during heat-stress, DnaJB1 (Hageman et al., 2011), and have received a significant
amount of attention due to their reported ability to prevent the aggregation of a range of different
client proteins in vivo (Takeuchi et al., 2002; Evans et al., 2006; Hageman et al., 2010, 2011; Gillis
et al., 2013; Ormsby et al., 2013; Månsson, Arosio, et al., 2014; Månsson, Kakkar, et al., 2014;
Serlidaki et al., 2020; McMahon et al., 2021).

Lastly, the class III (DnaJCs) Hsp40 isoforms share only the J-domain architecture with the
archetypal DnaJ and are otherwise structurally diverse, exhibiting massive variations in length (100
- 4600 amino acids) and structural motifs (e.g., SANT, protein-kinase and GTP-binding domains)
(Kampinga et al., 2010) (Figure 1.4B). Notably, the J-domain is not restricted to the N-terminus of
class III Hsp40 chaperones but can be sandwiched between flanking domains. The molecular
interaction of Class III Hsp40 chaperones with clients is poorly described, however they tend to have
specific clienteles and functions that are often outside of protein folding (e.g., DnaJC6 mediates the
disassembly of clathrin cages) (Böcking et al., 2011; Rothnie et al., 2011); as such, class III Hsp40
chaperones will not be discussed further in this review.
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Figure 1.4: Structure and domain organization of Hsp40. (A) The structure of the bacterial (Thermus
thermophilus) archetype Hsp40 homolog, DnaJ (PDB 4J80, Barends et al., 2013). The N-terminal J-domain
(purple), with the histidine-proline-aspartate (HPD) motif, is connected to the C-terminal domain (blue) by a
short G/F-rich linker region (grey). The C-terminal domain comprises two subdomains, designated CTD-I and
CTD-II and is implicated in client binding. A zinc finger-like region (ZFLR) is present within CTD-I for class
I Hsp40 isoforms. Dimerization of Hsp40 monomers is enabled by a C-terminal dimerization domain (green).
(B) General domain architecture of the class I (top), class II (middle) and class III (bottom) Hsp40 chaperone
families.
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Table 1.2: Summary of common Hsp40 isoforms and their reported stress inducibility, subcellular location and functions

Name

Synonyms Stress
Subcellular
inducible localization

Cellular functions

References

DnaJ

None

Yes

Cytosol

DnaJ is the archetype Hsp40 from E. coli and performs a plethora of
functions in conjunction with DnaK (the E. coli Hsp70 homolog),
which includes the capture and delivery of misfolded clients to
DnaK, assisting in protein folding and refolding, assembly of protein
complexes and the prevention of aggregation. Furthermore, DnaJ is
involved in directing the proteolysis and degradation of certain
clients. DnaJ is also essential for the secretion and translocation of
proteins across the cytoplasmic membrane. As with DnaK, much of
the current understanding regarding the function of Hsp40
chaperones is derived from work performed with recombinantly
purified DnaJ. Recombinant DnaJ participates with DnaK and GrpE
(the major E. coli NEF) to efficiently refold chemically- or heatdenatured luciferase. Prevents the aggregation of luciferase and
rhodanese in vitro, which in the case of the latter will stably bind for
eventual delivery to DnaK and GroEL/ES for refolding.

(Wild et al., 1992;
Langer et al., 1992;
Sherman MYu et al.,
1992; Bukau, 1993;
Schröder et al., 1993;
Packschies et al.,
1997; Cheetham et al.,
1998;
Zolkiewski,
1999; Huang et al.,
2001; Kellner et al.,
2014; Luengo et al.,
2018; Imamoglu et
al., 2020)

DnaJA1 Hdj2

Yes

Cytosol,
nucleus,
mitochondria,
ER

DnaJA1 is a constitutively expressed Hsp40 isoform and is the
primary partner of HspA8. DnaJA1 can assist in the folding of
proteins (e.g., cystic fibrosis transmembrane conductance regulator
[CFTR]) and prevent the aggregation of and facilitate the clearance
and degradation (via the ubiquitin-proteasome system) of a range of
misfolded proteins, including the disease-associated proteins tau and
ataxin-1. DnaJA1 co-operates with HspA8 to recognize and
ubiquitinate non-native plasma membrane proteins for subsequent
degradation by the proteasome. Furthermore, DnaJA1 has a role in
androgen receptor signaling and spermatogenesis as well as
facilitating protein import into the mitochondria. Recombinantly
purified DnaJA1 can inhibit the chemically-induced aggregation of

(Terada et al., 1997;
Kanazawa et al.,
1997; Cummings et
al., 1998; Minami et
al., 1999; Terada et
al.,
2000,
2005;
Bhangoo et al., 2007;
Tzankov et al., 2008;
Okiyoneda et al.,
2010; Abisambra et
al., 2012; Baaklini et

(E. coli)

DjA1
HSDJ
DJ-2
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rhodanese in vitro; however, DnaJA1 has a limited capacity to refold al., 2012; Rauch et al.,
chemically-denatured luciferase.
2014; Yu et al., 2015)
DnaJA2 Dj3
DjA2

Yes

Cytosol,
nucleus,
mitochondria,
ER

DnaJA2 has varied roles within the cell. DnaJA2 is a potent inhibitor
of tau aggregation. As with most Hsp40 isoforms, DnaJA2 assists in
the folding and maturation of various proteins. Notably, DnaJA2 has
a well reported role in the context of CFTR folding and cellular
trafficking and can stabilize and/or refold misfolded conformers at
the surface of lipid bilayers and the plasma membrane. However, it
is also important in the ubiquitination and degradation of CFTR (in
conjunction with HspA1/HspA8 and the co-chaperone CHIP).
Furthermore, DnaJA2 assists in protein import into the mitochondria,
is a mediator in human ether-à-go-go-related gene protein trafficking
and binds to and regulates G-protein mediated signal transductions.
Recombinantly purified DnaJA2 co-operates with either HspA1 or
HspA8 to efficiently refold chemically denatured luciferase in vitro.
Also co-operates with HspA8 and DnaJB1 to assist in the
solubilization of luciferase aggregates and is a potent substoichiometric inhibitor of tau aggrgation.

(Terada et al., 2000;
Bhangoo et al., 2007;
Tzankov et al., 2008;
Rosales-Hernandez et
al., 2009; Baaklini et
al., 2012, 2020; Rauch
et al., 2014; Yu et al.,
2015;
Nillegoda,
Kirstein, et al., 2015;
Bagdany et al., 2017;
Chiaw et al., 2019;
Irwin et al., 2021)

Cytosol

DnaJB1 can bind to monomers and suppress the formation of
inclusions formed by the Htt protein, however, is unable to prevent
its toxicity. Potent suppressor of Htt polyQ fibrillation. Also assists
in the suppression of SOD1 aggregation by stimulating ATP
hydrolysis in HspA1 and in doing so can restore functional
deficiencies within the cell and support neuronal outgrowth. Is an
important component of the disaggregation machinery, in
combination with HspA8 and NEFs, which has been demonstrated in
vivo by the solubilization of luciferase and GFP aggregates.
Cooperates with HspA8 to mediate the degradation of proteins by
chaperone-assisted autophagy. DnaJB1 has also been extensively
studied in vitro using purified components. Notably, it has been
shown to inhibit the aggregation of a wide range of model and
disease-associated proteins, often in combination with members of

(Minami et al., 1996;
Muchowski et al.,
2000; Agarraberes et
al., 2001; Takeuchi et
al., 2002; Evans et al.,
2006; Shorter, 2011;
Hageman et al., 2011;
Ormsby et al., 2013;
Gao et al., 2015;
Nillegoda, Kirstein, et
al., 2015; Kaushik et
al., 2018; Scior et al.,
2018; Serlidaki et al.,

DnJ3

DnaJB1 Hsp40
Hdj1
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the Hsp70 family, which include Aβ, Htt, citrate synthase and 2020; Wentink et al.,
rhodanese. Also participates in the refolding of client proteins such 2020)
as luciferase and β-galactosidase. Has recently been revealed to be a
crucial component in the disaggregation machinery required for
solubilization of 𝛼-synuclein fibrils and luciferase aggregates.
DnaJB6 Hsj2a
Mrja
Mrjb

Cytosol,
nucleus

DnaJB6 has recently received significant attention following its
discovery that it can potently suppress the aggregation of polyQ
aggregates in vivo independently (i.e., it does not require Hsp70
isoforms to do so) and that DnaJB6 mutations are linked to several
myopathies. Human DnaJB6 also prevents the aggregation of other
polyQ proteins in a yeast model and its over-expression in transgenic
polyQ-mice reduces aggregation within the brain and extends
lifespan. Also inhibits the cellular aggregation of luciferase and 𝛼synuclein. Purified DnaJB6 is known to prevent polyQ aggregation
in vitro at sub-stoichiometric levels.

(Hageman et al.,
2011; Gillis et al.,
2013; Kakkar et al.,
2016; Reidy et al.,
2016; Ruggieri et al.,
2016; Deshayes et al.,
2019)
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1.2.1.3 The Hsp70 folding cycle
The Hsp70 cycle is initiated upon binding of a misfolded or unfolded client protein by Hsp40 and its
subsequent delivery to ATP-bound Hsp70 (Figure 1.5). The process by which Hsp70 then binds to
and refolds its client proteins is intricately regulated by an allosteric mechanism that couples ATP
binding in the NBD to client capture by the CBD. In the ATP-bound state, the CBD𝛼, CBDβ and the
flexible linker are docked onto the NBD, resulting in an ‘open conformation’ characterized by high
association/dissociation rates and low client affinity. In this state, the catalytic residues are positioned
in a conformation that is unsuitable for ATP hydrolysis, which results in a low basal rate of ATPhydrolysis (~ 1 ATP molecule per 5 – 30 min) and the requirement for Hsp40 (Laufen et al., 1999;
Kityk et al., 2012, 2015; Papsdorf et al., 2019). Upon Hsp40-mediated delivery of the client, the Jdomain (and HPD motif) of Hsp40 makes extensive contacts at the NBD-CBDβ and linker-CBDβ
interface, which interferes with the auto-inhibitory interactions between the NBD and CBDβ of
Hsp70 (Kityk et al., 2018). Concurrently, interactions between hydrophobic sequences from the client
protein and the CBDβ of Hsp70 are transiently established (Langer et al., 1992; Kudlicki et al., 1996;
Rüdiger et al., 1997; Clerico et al., 2015). The simultaneous interaction of Hsp70 with Hsp40 and the
client stimulates the rate of hydrolysis of ATP to ADP by more than 1,000 fold (Laufen et al., 1999;
Russell et al., 1999), which results in release of the linker and closing of the CBD𝛼 lid over the CBDβ
to trap the bound client (resulting in a ‘closed conformation’ characterized by low
association/dissociation rates and high client affinity). At this stage, Hsp40 dissociates from the
complex. Typically, Hsp70-bound clients have been shown to populate a conformationally expanded
ensemble, indicative of Hsp70-mediated unfolding of the client (Kellner et al., 2014; Imamoglu et
al., 2020). Dissociation of ADP from the NBD, which is accelerated by the binding of a NEF to ADPbound Hsp70 (e.g., GrpE in prokaryotes, Bag1 and others in eukaryotes), and concomitant rebinding
of ATP returns Hsp70 to the low-affinity ‘open conformation’. Consequently, the client protein
dissociates from Hsp70 and can either spontaneously refold to the native state or become misfolded,
whereby it can be subjected to additional rounds of chaperone binding and release.
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Figure 1.5: The Hsp70 folding cycle. (1) Binding of misfolded (or unfolded) protein by Hsp40 occurs and
the Hsp40-client complex is then (2) delivered to Hsp70. The Hsp40-client complex is orientated such that the
J-domain of Hsp40 makes contacts with the nucleotide-binding domain (NBD) of ATP-bound Hsp70 and the
client protein makes contacts with the client-binding domain (CBD) in the ‘open conformation’. (3) Hydrolysis
of ATP by Hsp70 is accelerated by Hsp40, which results in transfer and capture of the client protein by Hsp70
(which is now in the ADP-bound ‘closed conformation’). Hsp40 dissociates from the Hsp70-client complex
and is recycled for subsequent refolding cycles. (4) While bound to Hsp70, the client protein can form regions
of secondary structure distinct from the binding site. Association of a nucleotide-exchange factor (NEF) to
ADP-bound Hsp70 also occurs. (5) The NEF induces dissociation of ADP from Hsp70, which allows rebinding
of ATP to the NBD and returns Hsp70 to the initial ‘open conformation’. (6) Opening of the CBD of Hsp70
results in release of the client protein folding intermediate, which can then either (7a) refold to the native state
or (7b) spontaneously misfold and be subject to additional rounds of chaperone processing. Dissociation of
the NEF from ATP-bound Hsp70 also occurs during step 6 and both proteins can be reused for additional
chaperone cycles.
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1.2.2

Small heat-shock proteins (sHsps) are ATP-independent molecular chaperones

sHsps are a family of ubiquitous intracellular ATP-independent chaperones. There are 10 sHsp genes
in humans (HSPB1-10) (Kappé et al., 2003); these show tissue-specific expression with some being
widely expressed (e.g., Hsp27 [HSPB1]), and others showing very restricted tissue expression (e.g.,
HSPB9). Additionally, the levels of some (but not all) sHsps in cells are dramatically increased under
stress conditions. The sHsps are characterized by the presence of a highly conserved central αcrystallin domain, which is approximately 80 amino acids in length, and is flanked by less conserved
N- and C-terminal regions that are of variable length between sHsp members (Kriehuber et al., 2010).
While individual subunits of sHsps are quite small (~ 15 - 40 kDa), they are relatively unique among
the chaperone classes in that the majority of mammalian sHsps exist predominantly as large
polydisperse oligomeric complexes (Haley et al., 1998; Haslbeck, 2002; Haslbeck et al., 2015). Such
sHsp complexes undergo rapid and dynamic subunit exchange, the rate of which varies in response
to cellular conditions (e.g., temperature or redox state) and post-translational modifications (e.g.,
phosphorylation) (Spinozzi et al., 2006; Ecroyd et al., 2007; Delbecq et al., 2013; Jovcevski et al.,
2015). The characteristic subunit exchange dynamics of sHsps are thought to mediate their molecular
chaperone action via the formation of smaller (i.e., monomeric and/or dimeric) dissociated species
with enhanced chaperone function (Haslbeck et al., 1999; Montfort et al., 2002; Benesch et al., 2008).

A recent consensus model of sHsp chaperone action describes their interactions with client proteins
occurring through either (i) weak, transient interactions between sHsps and partially misfolded
proteins that result in the aggregation-prone protein being stabilized such that it can re-enter the
protein ‘folding’ pathway and thus refold to the native state, or through (ii) high-affinity stable
interactions, which result in the formation of stable high-molecular mass complexes with destabilized
protein intermediates at risk of hydrophobic collapse and aggregation (Figure 1.6) (Treweek et al.,
2015). Both types of interactions can occur with the same client protein, as demonstrated by the ability
of αB-crystallin and αA-crystallin to undergo both transient and stable interactions with the proteins
citrate synthase (Rajaraman et al., 2001) or α-lactalbumin (Lindner et al., 1997; Kulig et al., 2012).
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The factor that appears to govern the mode of binding is the extent of exposed hydrophobicity on the
partially folded protein (and hence the rate of aggregation). Thus, it has been postulated that sHsps
generally act through weak, transient interactions under normal cellular conditions and rely on higheraffinity client interactions (i.e., formation of sHsp-client complexes) during periods of cellular stress
when proteins are more destabilized (Kulig et al., 2012; Ecroyd, 2015).

The consensus model of sHsp chaperone action postulates that un-complexed, dissociated sHsps,
generally depicted as a dimer, are the chaperone-active species that bind to aggregation-prone
proteins to perform the initial ‘holdase’ chaperone function (Figure 1.6). Based on this model, the
larger oligomeric species act as reservoirs of these smaller chaperone-active forms, the latter having
increased exposure of hydrophobic regions and therefore higher affinity for misfolded proteins. Once
the dissociated species binds to a client protein, the sHsp-client protein complex can be sequestered
into a high-molecular mass sHsp-client complex. From this complex, aggregation-prone client
proteins can be either shuttled for degradation or held in a folding-competent state for subsequent
refolding by ATP-dependent chaperones (e.g., the Hsp70 system) (Treweek et al., 2015).
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Figure 1.6: A consensus model for the chaperone mechanism of sHsps. The sHsps are in a dynamic
equilibrium between large and small oligomers. They can form weak interactions with relatively stable protein
intermediates that have left the protein-folding pathway, enabling them to re-enter the folding pathway and
therefore refold to their native conformation. If a partially folded hydrophobic intermediate leaves the folding
pathway and is in a destabilized state, it can be recognized by dissociated sHsps, which bind to it and therefore
stabilize the protein. This high affinity interaction results in the formation of a sHsp-client complex that can
re-associate with large sHsp oligomers to form a high-molecular mass complex. Bound client proteins can then
be either shuttled for degradation or held until they can be refolded back to their native conformation via the
action of ATP-dependent chaperones. Diagram adapted from Treweek et al., (2015).

1.2.3

Outstanding questions in the field

While significant progress has been made to better understand the role chaperones play in maintaining
proteostasis, the precise molecular mechanisms by which chaperones act to refold proteins and
prevent their aggregation remains elusive. For instance, it is known that client proteins can undergo
multiple cycles of binding and release from ATP-dependent chaperones (Szabo et al., 1994; McCarty
et al., 1995; Laufen et al., 1999); however, it is not clear whether a single chaperone is involved
throughout the entirety of this process or if there is dynamic exchange between multiple chaperone
molecules that are within proximity of the client. Additionally, there is conjecture regarding whether
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chaperones utilize ATP hydrolysis to selectively bind a subset of client conformations (Sekhar et al.,
2018) or to directly alter the conformational state of the client to generate productive folding
intermediates (Sharma et al., 2010). One key question within the field is whether chaperones promote
protein folding by introducing structural and entropic constraints on the polypeptide that minimize
non-native interactions or smooth folding landscapes. Specifically, it is not known how chaperone
binding affects the free energy of the polypeptide in order to guide it towards a specific protein
topology (e.g., proteins that contain a TIM-barrel fold often require folding assistance by Hsp60).
Notably, the mechanisms by which chaperones can transition between different functions is still
unclear; for instance, how does Hsp70 transition from assisting the folding of nascent polypeptides
to its role as a component of the disaggregation machinery?

There are several critical aspects of sHsp function where definitive data is lacking to support the
consensus model. This gap in our understanding is predominantly due to the significant polydispersity
and inherent heterogeneity that arises from rapid and dynamic exchange of sHsp subunits. The exact
role that sHsp subunit exchange, and the resulting changes in oligomeric size, has on the chaperone
activity of sHsps remains enigmatic. While sHsps are known to be capable of transiently stabilizing
aggregation-prone proteins to facilitate their refolding, they can also prevent aggregation by
formation of stable, high-affinity complexes; the underlying mechanism by which sHsps mediate
these different roles is poorly understood. Likewise, the precise mechanistic details by which sHspbound clients are passed over to ATP-dependent Hsps for refolding (Veinger et al., 1998; Haslbeck,
2002; Narberhaus, 2002) remains elusive.

Owing to the heterogeneous, transient, and dynamic nature by which molecular chaperones interact
with their clients and co-chaperones, it has been traditionally difficult to study these fundamental
aspects of chaperone function using ensemble-averaging approaches. However, single-molecule
approaches are emerging as a promising tool to study the precise molecular mechanisms by which
these chaperones act to prevent protein aggregation and facilitate protein folding.
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1.3

Why use single-molecule approaches for the study of chaperone function?

Traditionally, the structure and chaperone function of Hsps have been studied using ensemble-based
techniques, which mask rare and transient species that may be present due to the averaging across
billions of asynchronous molecules. The established model of protein folding, whereby an ensemble
of dynamic non-native structures is guided towards the most thermodynamically stable state,
inherently implies that transient populations of rare folding intermediates are present during folding
and there is significant heterogeneity in these species (Dill et al., 1997; Onuchic et al., 1997). The
complexity of this system is further enhanced by the involvement of chaperones, such as the Hsps,
due to the multiplicity of potential chaperone interactions with co-chaperones and/or clients
(Mashaghi et al., 2014). Consequently, the ability to decipher the molecular mechanisms by which
chaperones assist protein folding and prevent aggregation is limited in ensemble-based measurement
techniques. Recently, there has been significant interest in employing single-molecule approaches to
study the mechanisms of chaperone function since they eliminate ensemble averaging through direct
observation of single proteins, allowing detection of kinetic features and states that are normally
hidden (van Oijen, 2008). Moreover, single-molecule experiments do not rely on the synchronization
of an ensemble of molecules, meaning rare, transient, and intermediate events of a single molecule
can be viewed and measured, and its dynamics analyzed. For instance, by fluorescently labelling the
light chain of myosin V and correlating the nanometer movements of fluorescence, the length of the
transient intermediate ‘steps’ have been determined to confirm the hand-over-hand mechanism
utilized by myosin V to travel along actin filaments (Yildiz, 2003). Furthermore, single-molecule
experiments are especially amenable for characterizing the association and dissociation kinetics of
bimolecular reactions (van Oijen, 2011); to the degree that the effect an individual parameter (e.g.,
on/off rates) has on the overall kinetics of a reaction can be determined (Wang et al., 2009).

Single-molecule techniques are particularly powerful for the study of chaperones, due to their
capacity to follow the dynamic cycling between high and low client-affinity states in response to the
presence of co-chaperones, nucleotides, temperature, client concentration and client conformation.
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While many force spectroscopy techniques have been developed and applied to study protein folding
and chaperone function at single-molecule resolution (Engel et al., 2000; Bechtluft et al., 2007;
Moffitt et al., 2008; Thoma et al., 2015), fluorescence-based experiments are gaining popularity as
they are more amenable for direct observation of chaperone-client interactions, changes in
conformation as a client folds, and measuring the kinetic rates and binding affinities of chaperones to
clients without applying any external forces (Ueno et al., 2004; Sharma et al., 2008; Sikor et al.,
2013; Kellner et al., 2014). A brief description of the most utilized single-molecule fluorescence
approaches to study chaperone function are outlined below.

1.4

Single-molecule fluorescence techniques

A significant hurdle that faces all single-molecule fluorescence studies is that to observe the
fluorescence signal from a single molecule, the background fluorescence originating from
surrounding molecules in solution must be effectively eliminated. With the diffraction limit posing
lower limits on the size of optically accessible sample volumes, the maximum effective concentration
of labelled species is limited to a few tens of nanomolar, which is often below the equilibrium
dissociation constant (KD) of most biochemical associations (van Oijen, 2011). There is therefore a
need to compromise between the low concentrations needed for visualization of single molecules and
maintaining the high concentrations needed to accurately reconstitute physiologically relevant
protein-protein interactions. This trade-off is particularly important in the context of Hsps as the
concentrations of these chaperones is variable across cell types and drastically up-regulated during
periods of cellular stress (Horwitz, 2003; Finka et al., 2013). This ‘concentration problem’ has
traditionally been addressed by employing optical techniques such as confocal or total internal
reflection fluorescence (TIRF) microscopy (Schneckenburger, 2005), which reduces the excitable
volume of the sample in order to significantly reduce background fluorescence and improve the
signal-to-noise ratio. Both confocal and TIRF microscopy have advantages and disadvantages when
it comes to sample analysis and set-up; the decision regarding which approach to use is non-trivial
and dependent on the experimental question to be addressed.
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For single-molecule confocal microscopy, the excitation beam is projected into the sample and
focused to a small, diffraction-limited volume only a femtolitre in size (Földes-Papp et al., 2001)
(Figure 1.7A). As labelled molecules diffuse through this confocal volume, they are excited, and the
emitted fluorescence is passed through a pinhole aperture that selectively filters for signal originating
from the focal volume by removing signal from out-of-focus areas (Jerome et al., 2018). At extremely
low concentrations of labelled-molecules (i.e., picomolar range), the probability of multiple
molecules passing through the confocal volume simultaneously is minimized and thus the detection
of fluorescence that originates from a single labelled species can be monitored (Rigler et al., 1993;
Nie et al., 1995) (Figure 1.7B). Additionally, since the focal point (or confocal volume) is positioned
well above the coverslip surface, the fluorescent molecule of interest does not need to be specifically
immobilized to a coverslip surface for detection. One significant disadvantage of confocal approaches
is that the observation period for a single molecule is limited by its diffusion time through the
diffraction-limited confocal volume (~ 1 ms) (Hou et al., 2019; Jazani et al., 2019). Thus, the effect
that a particular biological process has on a single molecule is unable to be monitored temporally,
which means that key kinetic parameters (e.g., conformational transitions and on/off times of single
molecules) become extremely difficult to determine.

Alternatively, the dynamics and kinetics of individual molecules can be temporally monitored using
objective-based single-molecule TIRF microscopy (Figure 1.7C). In these experiments, the laser
beam is passed through a high numerical aperture oil-immersion objective lens that approaches a
glass-medium interface at an angle that is greater than the critical angle such that the laser is totally
internally reflected (Fish, 2009). An exponentially decaying evanescent field is produced that
penetrates the sample to a depth of ~ 100 nm, which results in the selective excitation of labelled
molecules that are specifically immobilized to the glass (coverslip) surface. Consequently, the signal
from non-immobilized labelled molecules in solution are effectively eliminated, significantly
enhancing the signal-to-noise ratio required for the temporal detection of single molecules
(Schermelleh et al., 2010) (Figure 1.7D). One limitation is that molecules of interest must be
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specifically immobilized to the coverslip surface, which may necessitate modifications to the
molecule of interest (e.g., the addition of immobilization tags) and control experiments to ensure that
biological function is not affected following immobilization (Choi et al., 2012). However, TIRF
microscopy remains ideally suited to the temporal observation of many individual molecules and
biological processes.

The amount of information that can be obtained from single-molecule experiments can be increased
by coupling confocal and/or TIRF microscopy with other fluorescence-based approaches, such as
fluorescence resonance energy transfer (FRET) (Figure 1.7), photo-induced electron transfer (PET)
or fluorescence recovery after photobleaching (FRAP) methodologies (Choi et al., 2011; Haenni et
al., 2013; Schuler et al., 2013; Shashkova et al., 2017). Notably, single-molecule FRET (smFRET)
is particularly amenable for the study of complex and dynamic biological systems (i.e., molecular
chaperones) due to its ability to exquisitely report on conformational changes of a molecule via
changes in the energy transfer efficiency between a donor and acceptor fluorophore within the
distance of 1 – 10 nm (Ha et al., 1996). Studies that have used single-molecule fluorescence
techniques to provide new insights into the function and dynamics of Hsps are discussed below.
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Figure 1.7: Comparison of single-molecule fluorescence approaches. (A) Schematic of a confocal
microscopy beam for visualization of single molecules. The confocal beam is focused to the sample by an
objective (not shown) and the fluorescence of the labelled molecule is measured as it transiently diffuses
through the confocal volume. Molecules outside the confocal volume are not detected. The observation time
of a single molecule is limited by its diffusion through the confocal volume, which is typically ~ 1 ms. (B)
Example of single-molecule FRET (smFRET) data collected using a confocal microscope. Each fluorescence
peak measured from the donor (green) or acceptor (purple) emission channels corresponds to the measurement
of a single molecule. (C) Schematic of an objective-type total internal reflection fluorescence (TIRF)
microscopy setup. The incident laser passes through the objective lens and approaches the glass-water interface
at greater than the incident angle. The laser is totally internally reflected and an exponentially decaying
evanescent field is propagated into the sample to a depth of ~ 100 nm. Only molecules that are specifically
immobilized to the coverslip surface are excited by the evanescent field and the fluorescence measured. Single
molecules can be visualized until fluorophore photobleaching occurs (minute timescales). (D) Example of
smFRET data from an individual immobilized molecule collected using TIRF microscopy. The donor and
acceptor fluorescence intensity are measured (top) and the FRET efficiency (bottom) is calculated. Data can
be collected from upwards of 100 molecules per field of view when imaging.
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1.5

Single-molecule fluorescence as a tool to study chaperone function

Owing to the significant structural rearrangements required by Hsp70 during its reaction cycle, it is
perhaps not surprising that single-molecule approaches have been heavily implemented to
characterize this integral component of chaperone function. For instance, confocal-based smFRET
experiments were employed to monitor the conformational dynamics between the NBD and CBD
domains, as well as the CBD𝛼 and CBDβ subdomains (which provides a readout of lid opening and
closing), of the mitochondrial Hsp70 yeast homolog, Ssc1, in response to nucleotides (Mapa et al.,
2010). Interestingly, while the ATP-bound form of Ssc1 exhibited relatively tight FRET distributions,
indicative of a homogenous Ssc1 conformation, the ADP-bound form of Ssc1 was found to be
significantly more heterogeneous and dynamic in structure. The smFRET data revealed fluctuations
between an NBD-CBD docked and undocked state that coincided with conformational fluctuations
of the CBD𝛼 lid subdomain; such results were not readily apparent when ensemble-based FRET
approaches were employed (Mapa et al., 2010). In another study, Ssc1 was encapsulated in lipid
vesicles and tethered to a TIRF-illuminated coverslip to observe the kinetics and conformational
dynamics of a single chaperone, over a period of minutes (Sikor et al., 2013). Dynamic fluctuations
between three well-defined ADP-bound conformations of Ssc1 and a nucleotide-free state contributed
towards the inherent heterogeneity previously observed in the ADP-bound state (Mapa et al., 2010).
Similar results have since been observed with human HspA1 and bacterial DnaK, whereby the
presence of nucleotide and/or co-chaperones biases the conformation of the chaperone toward a
defined state but dynamic interconversion between conformations is still observed (Banerjee et al.,
2016; Wu et al., 2020). Thus, the occurrence of heterogeneous conformations of nucleotide-bound
Hsp70 in the absence of bound clients suggests that the Hsp70 allosteric cycle is significantly more
complex than previously thought, with nucleotides potentially playing a more critical regulatory role.

smFRET has also been implemented to investigate how Hsp binding affects the conformations of
misfolded clients, which is considered to be central to chaperone function. Kellner et al. (2014) used
a combination of confocal-based smFRET and microfluidics to characterize the structural
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heterogeneity of non-native rhodanese in the presence of components of the bacterial Hsp70 system
(e.g., DnaK, DnaJ and GrpE) (Kellner et al., 2014). Binding of DnaJ alone to non-native rhodanese
induced significant heterogeneity between compact (high-FRET) and expanded (low-FRET) states
of rhodanese. However, addition of DnaK in the presence of ATP and sub-stoichiometric amounts of
DnaJ caused a significant decrease in FRET efficiency that was indicative of a highly expanded state.
Kellner et al. (2014) also performed molecular dynamics simulations, based on experimental singlemolecule data, to explore the stoichiometry of DnaK binding to rhodanese. It was suggested that
rhodanese was saturated when 4 - 7 DnaK molecules were bound per rhodanese molecule, thus
maximizing client expansion, and minimizing the possibility of erroneous interdomain interactions.
Similar confocal-based smFRET experiments were performed recently that revealed a mechanism by
which the bacterial Hsp70 system can resolve misfolded structures within chemically-denatured
luciferase and assist in its refolding (Imamoglu et al., 2020). Chemical- or heat-induced denaturation
of luciferase resulted in the formation of a compact, misfolded state (characterized by high-FRET
efficiencies) that was specifically acted on by DnaJ and DnaK, which resulted in significant
conformational expansion of the bound client. Thus, it is appears as though the forced unfolding of a
client protein is a generic mechanism by which ATP-dependent chaperones prime misfolded proteins
for subsequent refolding (Chakraborty et al., 2010; Hofmann et al., 2010; Gupta et al., 2014; Kellner
et al., 2014). Indeed, such a mechanism may not be restricted to misfolded proteins; recent smFRET
data has demonstrated that the unfolding of native argonaute by Hsp70 and Hsp90 is a pre-requisite
for small-RNA duplex loading during the assembly of the RNA-induced silencing complex
(Tsuboyama et al., 2018).

The study of how molecular chaperones prevent protein aggregation, a process which itself is
extremely heterogeneous and dynamic, is also particularly suited for single-molecule approaches. A
recent study by Kundel et al. (2018) investigated the binding kinetics and stoichiometry of complexes
formed between HspA1 and the Alzheimer's disease-associated tau protein using a combination of
confocal and TIRF microscopy in conjunction with smFRET (Kundel et al., 2018). Using TIRF
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microscopy, the authors observed co-localization of HspA1 with oligomeric and fibrillar forms of
tau, but not monomeric species. Further analysis of the fluorescence intensity from co-localized
HspA1 and oligomeric tau species revealed that, at the molar ratios used in the TIRF experiment, the
stoichiometry of binding was one HspA1 to two tau monomers within each tau oligomer. To probe
these interactions further, a smFRET system involving HspA1 and monomeric tau was developed
that allowed the binding affinities of HspA1 to tau species at different stages of aggregation (i.e.,
from oligomers to fibrils) to be determined. From these experiments, it was observed that the binding
affinity of HspA1 to tau oligomers increased as a function of oligomer size, information that would
typically be inaccessible by conventional bulk measurements. This study concluded by suggesting
that HspA1 inhibits the nucleation and elongation of tau fibrils by binding to oligomers and smaller
fibrils formed early during the aggregation process. In this way, binding of HspA1 to oligomeric tau
can reduce the toxicity associated with tau fibrillization in a manner comparable to what has been
observed in similar single-molecule experiments for the binding of sHsps or extracellular chaperones
(e.g., clusterin or 𝛼2-macroglobulin) to α-synuclein or Aβ oligomers and fibrils (Narayan, Meehan,
et al., 2012; Narayan, Orte, et al., 2012; Cox et al., 2018; Whiten et al., 2018). Thus, the binding of
chaperones to oligomeric or fibrillar structures appears to be a general mechanism by which they
mitigate the toxicity associated with these disease-associated processes.

1.6

The rationale and concept of a protein-folding sensor to study chaperone function

The use of protein-folding sensors, by which the conformation of a client protein can be monitored
by a change in fluorescence or FRET efficiency, represents an ideal and direct approach to study the
mechanism by which molecular chaperones are able to fold proteins (Figure 1.8). Such proteinfolding sensors have been previously described (Sharma et al., 2008; Hofmann et al., 2010; Gupta et
al., 2014; Kellner et al., 2014; Tsuboyama et al., 2018; Imamoglu et al., 2020) (see section 1.5) and
have been implemented successfully in single-molecule fluorescence experiments to study Hsp
networks (as well as individual Hsps within it). Protein-folding sensors are defined by three essential
characteristics. Firstly, the protein must have a well-defined monomeric fold whose final native state
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is not dependent on oligomerization. Multi-subunit proteins are not suitable for use as a folding sensor
as folding transitions in individual subunits cannot be monitored since the fluorescence from other
fluorophores on different subunits will be averaged together. Secondly, the folding, unfolding and
aggregation pathway in the presence and absence of chaperones should be well described. Finally,
the folding sensor must be able to report on a change in folded state via a change in fluorescence
intensity or FRET efficiency.

FRET is the most utilized approach to monitor the conformation of client proteins in single-molecule
experiments with molecular chaperones (Hillger et al., 2008; Sharma et al., 2008; Hofmann et al.,
2010; Gupta et al., 2014; Kellner et al., 2014; Tsuboyama et al., 2018; Imamoglu et al., 2020) (Figure
1.8). While such studies have elucidated key and novel aspects of chaperone function, the majority
have employed single-molecule confocal-based approaches that have a limited ability to observe the
process of chaperone-assisted folding with temporal resolution. Thus, chaperone-mediated changes
in the folded state of individual client proteins cannot be observed and key kinetic rates and
parameters (e.g., on/off rates) are unable to be determined. Furthermore, whilst the majority of singlemolecule studies have looked at the function of individual Hsps, only a small number of studies have
examined the effect of multiple components and co-chaperones on protein folding and chaperone
function (Kellner et al., 2014; Ratzke et al., 2014; Nunes et al., 2015; Okuda et al., 2015; Schulze et
al., 2016; Wortmann et al., 2017). Notably, many studies that investigate the function of Hsp70
invariably examine the role of its co-chaperone Hsp40 in its chaperone function. However, the
complexity of the chaperone systems studied using single-molecule techniques have thus far been
limited, due to the difficulty in observing multiple chaperone-client components simultaneously.
Typically, these studies examine the co-operativity of chaperone networks by employing ‘dark’
components, which are elements of the chaperone network or client proteins that are present in the
reaction but not able to be directly observed via fluorescence spectroscopy.
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Consequently, there is a clear need to develop and implement alternative protein-folding sensors that
can be (i) utilized in single-molecule TIRF-based experiments to study the effect of chaperone
function on client conformation in real time (Figure 1.8) and, (ii) develop folding sensors in which
the folded state can be monitored by the fluorescence of a single fluorophore, which would enable
the simultaneous observation of protein conformational changes concomitant with the function of
labelled chaperones.

Figure 1.8: Schematic of the protein-folding sensor concept. To elucidate the fundamental mechanisms by
which molecular chaperones assist in protein folding, the conformation of the client must be able to be
monitored in real time. In this scenario, the client is fluorescently labelled with two fluorophores and its
conformation monitored using smFRET and TIRF microscopy. The association and dissociation of
fluorescently labelled chaperones can also be monitored concurrently with the folded state of the client.
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1.7

Summary and aims

Protein misfolding and aggregation underlies the pathogenesis of some of the most debilitating and
prevalent diseases that currently face the global community. Molecular chaperones play a critical role
in maintaining a healthy proteome and do so by performing a plethora of functions, which include
protein folding and refolding, the prevention of aggregation and protein disaggregation. However,
the significant heterogeneity and transient nature by which these molecular chaperones perform these
roles have made them difficult to study using traditional ensemble-averaging techniques, which has
limited our understanding of the precise molecular details by which chaperones function. Recently,
single-molecule approaches have emerged as an ideal tool to study chaperone function (and protein
aggregation) since the observation of individual proteins and events can be characterized in real time.
However, there is a growing need to develop alternate single-molecule approaches that enable a more
comprehensive investigation into the mechanism by which chaperones fold proteins and prevent their
aggregation.

Thus, the specific aims of the work described in this thesis were to:

i.

Develop firefly luciferase into a protein-folding sensor that can be used as a client in singlemolecule TIRF experiments to study molecular chaperone function in real time.

ii.

Develop rhodanese into a protein-folding sensor that can be used as a client in single-molecule
TIRF experiments to study molecular chaperone function in real time.

iii.

Develop the chloride intracellular channel protein (CLIC1) into a single-color protein-folding
sensor and characterize it as a novel client to study sHsp function.

iv.

Characterize the novel dye ASCP for its suitability as a fluorescent probe to monitor amyloid
fibril formation and the imaging of fibrils via TIRF microscopy.
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2.1

Materials

All reagents used in this work were obtained from Sigma-Aldrich (Missouri, USA), Thermo Fisher
Scientific (Massachusetts, USA), Amresco (Ohio, USA) or Chem-Supply (Australia) unless
otherwise specified. All antibodies or horseradish-peroxidase (HRP)-conjugated proteins used in this
work were purchased from Abcam (Cambridge, UK). Recombinant 𝛼B-crystallin (𝛼B-c) was a kind
gift from Caitlin Johnston (University of Wollongong, Australia). Expression plasmids encoding
DnaJ, DnaK and GrpE were generously donated from Prof. Mattias Mayer (University of Heidelberg,
Germany). Recombinant DnaJ, DnaK and GrpE was a kind gift from Bailey Skewes (University of
Wollongong, Australia).

2.2
2.2.1

General laboratory procedures
SDS-PAGE

Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) was used to determine the
successful expression, purity and cleavage of recombinant proteins during purification. All SDSPAGE procedures were performed using 12% (v/v) acrylamide resolving gels with 4% (v/v)
acrylamide stacking gels. All samples were diluted into SDS-PAGE loading buffer (final
concentrations 25 mM Tris [pH 6.8], 2% (w/v) SDS, 25% (w/v) glycerol, 0.01% (w/v) bromophenol
blue) with 5% (v/v) β-mercaptoethanol (BME) and heated at 95˚C using a heating block (Stuart, UK)
for 5 min prior to loading onto gels. Gels were assembled into a Mini-Protean® Tetra Cell system
(BioRad, USA) and electrophoresed at 150 V for ~ 60 min in SDS-PAGE running buffer (25 mM
Tris, 192 mM glycine, 3.5 mM SDS). Precision-plus protein dual-color standard (BioRad, USA) was
used as a protein size marker. Acrylamide gels were stained with 0.025% (w/v) Coomassie Brilliant
Blue in 40% (v/v) methanol and 10% (v/v) acetic acid and de-stained in 40% (v/v) methanol and 10%
(v/v) acetic acid. All gel images were obtained using an Amersham Imager 600 using colorimetric
trans-illumination (GE Industries, UK) or a Gel Logic2200 Pro Imaging System (Carestream, USA).
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2.2.2

Western blotting

Protein samples to be immunoblotted were prepared and separated on a 12% (v/v) acrylamide
resolving gel as described above (see section 2.2.1). Proteins were transferred onto an ImmunoBlot™
polyvinylidene difluoride membrane (PVDF; BioRad, USA) as described previously (Towbin et al.,
1979). Briefly, protein transfer to the PVDF membrane was performed in ice-cold western transfer buffer
(25 mM Tris [pH 8.6], 192 mM glycine, 20% (v/v) methanol) at 100 V for 1 hr. Membranes were blocked
with 5% (w/v) skim milk in Tris-buffered saline (TBS; 50 mM Tris [pH 7.5] supplemented with 150 mM
NaCl) for 1 hr at room temperature. The blocked membrane was then incubated overnight at 4˚C in 5%
(w/v) skim milk in TBS supplemented with 0.05% (v/v) Tween-20 (TBS-T) containing the primary
antibody or, when assessing whether a protein of interest is biotinylated, a streptavidin-HRP conjugate.
The membrane was then rinsed three times in TBS-T for 10 min. If a primary antibody was used, the
membrane was incubated with 5% (w/v) skim milk in TBS-T containing a corresponding HRP-conjugated
secondary antibody for 1 hr at room temperature. The membrane was then rinsed in TBS-T at least three
times for 10 min at room temperature. Labelled proteins were visualized using either SuperSignal ® West
Pico Chemiluminescent Substrate or SuperSignal® West Dura Extended Duration Chemiluminescent
Substrate according to the manufacturer’s instructions (Thermo Fisher Scientific, USA) and imaged using
the Amersham Gel Imager 600. A table summarizing the antibodies or HRP-conjugated proteins used in
this work and their working concentrations or dilutions is provided in Appendix I.

2.2.3

Protein concentration determination

Protein concentrations were determined using a Nanodrop 2000C spectrophotometer (Thermo Fisher
Scientific, USA) by measuring the absorbance at 280 nm. The concentration of protein was
determined using the Beer-Lambert law (Equation 2.1). A list containing the extinction coefficients
and molecular mass used to determine the concentration of each protein employed in this work is
provided in Appendix II.

37

Chapter 2 – Materials and methods
A280 = C ∙ 𝜀280 ∙ l

Equation 2.1: Beer-Lambert law for calculating protein concentration. A280 = absorbance at 280 nm, C =
concentration (mg/mL), 𝜀280 = extinction coefficient at 280 nm ([mg/mL]-1·cm-1) and l = path length (cm).

2.2.4

Transformation of chemically competent Escherichia coli (E. coli)

One aliquot (100 µL) of chemically competent E. coli cells (DH5𝛼 for plasmid storage or BL21(DE3)
for recombinant protein expression) was thawed on ice before the addition of ~ 100 ng of plasmid
DNA or 10 µL of ligation mix. Cells were incubated on ice for 30 min and then heat-shocked at 42˚C
for 30 s using a block heater. Cells were immediately transferred to ice and resuscitated with a 1:7fold dilution in either Luria-Bertani (LB, 1% (w/v) tryptone, 1% (w/v) NaCl and 0.5% (w/v) yeast
extract) media for plasmid transformation or super optimal broth with catabolite repression (SOC,
2% (w/v) tryptone, 0.5% (w/v) yeast extract, 10 mM NaCl, 2.5 mM KCl, 10 mM MgCl2, 10 mM
MgSO4 and 20 mM glucose) media for ligation transformations. Cells were then incubated for 1 hr
at 37˚C on an orbital shaker (Bioline, Australia). Transformation cultures were then plated onto prewarmed LB agar plates containing the relevant antibiotic and incubated overnight at 37˚C. Plasmid
DNA was extracted from successfully transformed colonies using the Isolate II Miniprep DNA
Purification System (Bioline, UK) according to the manufacturer’s instructions. A single transformed
colony was then used to inoculate LB containing the appropriate antibiotic, which was incubated
overnight at 37˚C and then diluted 1:1 with sterile 30% (v/v) glycerol solution for long term storage
at -80˚C.

2.2.5

Agarose gel electrophoresis

Agarose gel electrophoresis was utilized to determine the successful digestion and amplification of
DNA following PCR procedures. All samples were diluted into DNA loading dye (Thermo Fisher
Scientific, USA) prior to loading. Electrophoresis was performed with 1% (w/v) agarose gels stained
with 0.01% (v/v) SYBR safe and electrophoresed at 80 V for ~ 80 min in TAE running buffer (40
mM Tris [pH 8.3], 20 mM acetic acid and 1 mM ethylenediaminetetraacetic acid [EDTA]). All gels
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were loaded with the appropriate molecular weight markers, Hyperladder I (200 – 10,037 bp) or
Hyperladder II (50 – 2,000 bp). All gel images were obtained on a Gel-Doc XR+ (BioRad, USA)
using the default SYBR green imaging settings.

2.2.6

Restriction-enzyme based cloning

A summary of the primers, annealing temperatures, cloning plasmids and restriction enzymes used
for each restriction-enzyme cloning procedure is given in Appendix III. Primers were designed to
amplify genes encoding the protein of interest from existing plasmid constructs (with appropriate
flanking restriction enzyme sites) for cloning into the multiple cloning site of the destination plasmid
backbone. High fidelity PCR amplification was achieved with a PrimeStar DNA polymerase (0.05
units/µL) and amplification was performed using a Mastercycler ProS (Eppendorf, Germany) set to
run 35 cycles, with each cycle consisting of a denaturation step (10 s at 95˚C), an annealing step (5 s
at 55 - 60˚C, subject to primer melting temperature) and DNA extension step (60 s at 72˚C).
Successful amplification of the PCR insert was confirmed via agarose gel electrophoresis.

The amplified PCR product was purified using an Isolate II PCR and Gel column (Bioline, Australia)
according to the manufacturer’s instructions. The purified PCR product and destination plasmid
backbone were double digested with the appropriate restriction enzymes at 37˚C for 2 hr, before heatinactivation at 80˚C for 20 min and subsequent purification as described above. One reaction in which
the destination plasmid backbone was incubated in the absence of restriction enzymes acted as a
control for successful digestion. Successful digestion of the PCR inserts and destination cloning
plasmid was confirmed via agarose gel electrophoresis. Ligation of the digested PCR insert and the
destination plasmid backbone was performed at 16˚C for 20 hr using T4 DNA ligase (0.26 units/µL).
The ligated product was then transformed into chemically competent E. coli DH5𝛼 cells grown in
SOC media and plated on LB agar plates supplemented with the appropriate antibiotic and grown
overnight at 37˚C.
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Successfully transformed colonies were patched and screened for the ligated insert by PCR using the
same primers used for original amplification of the insert from template DNA or with primers
complementary to the T7 promoter and terminator regions of the plasmid backbone. DNA
amplification was achieved using MyTaq DNA polymerase (0.05 units/µL) and PCR was performed
using a Mastercycler ProS set to run 35 cycles, with each cycle consisting of a denaturation step (15
s at 95˚C), an annealing step (15 s at 48 - 58˚C, dependent on primer melting temperature) and DNA
extension step (15 s at 72˚C). PCR products were subjected to agarose gel electrophoresis to confirm
successful PCR amplification of the insert of interest. A colony positive for the insert was selected
and plasmid DNA purified using the Isolate II Miniprep DNA Purification System according to the
manufacturer’s instructions. Purified plasmids were sequenced to confirm successful cloning.

2.3
2.3.1

Recombinant protein production and labelling
Ubiquitin-like protein (Ulp1, SUMO protease)

A single colony of E. coli BL21(DE3) cells transformed with the plasmid encoding Ulp1 was used to
inoculate a starter culture (~ 100 mL) consisting of LB media supplemented with kanamycin (50
µg/mL) and grown overnight at 37˚C with constant agitation at 180 rpm in an orbital shaker. The
starter culture was diluted 15-fold into LB media expression cultures containing kanamycin (50
µg/mL), which were then incubated at 37˚C shaking at 180 rpm until an optical density at 600 nm
(OD600) of ~ 0.8 was reached. The expression of Ulp1 was induced by addition of isopropyl-β-D-1thiogalactopyranoside (IPTG, 0.25 mM) and cultures were incubated at 37˚C for 4 hr. The cells were
then harvested by centrifugation at 5,000 x g for 10 min at 4˚C (Sorvall RC-6+; Thermo Fisher
Scientific, USA) and the pellet stored at -20˚C until the recombinant protein was extracted.

Recombinant Ulp1 was extracted from bacterial cells via resuspension in 50 mM Tris (pH 8.0)
supplemented with 100 mM NaCl and 0.5 mg/mL lysozyme and incubated for 30 min at 4˚C.
Resuspended cells were lysed by probe sonication for 3 min (10 s on/20 s off) at 45% power and the
lysate clarified by two centrifugation steps for 30 min at 24,000 x g at 4˚C. The entire bacterial lysate
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(~ 40 mL) was loaded onto a 5 mL His-Trap Sephadex column (GE Healthcare, UK) pre-equilibrated
in Ulp1-specific immobilized metal affinity chromatography buffer A (Ulp1 IMAC buffer A, 50 mM
Tris [pH 8.0] supplemented with 300 mM NaCl and 5 mM imidazole). Proteins that did not bind to
the column were eluted with Ulp1 IMAC buffer A until the absorbance at 280 nm and conductivity
had returned to baseline. Protein immobilized to the His-Trap column was then eluted with Ulp1
IMAC buffer B (50 mM Tris [pH 8.0] supplemented with 300 mM NaCl and 500 mM imidazole) and
the eluate was analyzed by SDS-PAGE. Fractions containing recombinant protein were pooled and
dialyzed in phosphate buffered saline (PBS, 135 mM NaCl, 2.7 mM KCl, 1.75 mM KH2PO4, 10 mM
Na2HPO4, pH 7.4) supplemented with 50% [v/v] glycerol overnight at 4˚C. The concentration of
recombinant protein was determined as described in section 2.2.3, snap-frozen in liquid nitrogen and
stored at -20˚C until use.

2.3.2

DnaJB1 and HspA8

DnaJB1 and HspA8 were expressed and purified as previously described with some modifications
(Nillegoda, Kirstein, et al., 2015). Briefly, E. coli BL21(DE3) Rosetta cells transformed with
plasmids encoding SUMO-tagged DnaJB1 or SUMO-tagged HspA8 were streaked onto a LB agar
plate supplemented with kanamycin (50 µg/mL) and chloramphenicol (25 µg/mL) antibiotics and
grown overnight at 37˚C. Cells from a single colony on the LB plate were used to inoculate a starter
culture (~ 100 mL) consisting of 2 x TY media (1.6% (w/v) tryptone, 1% (w/v) yeast extract, 0.5%
(w/v) NaCl, pH 7.0) supplemented with kanamycin (50 µg/mL) and chloramphenicol (25 µg/mL)
antibiotics and grown overnight at 37˚C with constant agitation at 180 rpm in an orbital shaker. The
starter culture was diluted 15-fold into TY media expression cultures containing only kanamycin (50
µg/mL), which were then incubated at 30˚C shaking at 125 rpm until an OD600 of ~ 0.8 was reached.
The expression of DnaJB1 or HspA8 constructs was induced by addition of IPTG (1 mM) and the
cultures were incubated at 30˚C for 4 hr. The cells were then harvested by centrifugation at 5,000 x
g for 10 min at 4˚C and the pellet stored at -20˚C until the recombinant protein was extracted.
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Recombinant protein was extracted from bacterial cells via resuspension in 50 mM HEPES-KOH
(pH 7.4), 5 mM MgCl2, 2 mM BME and 10% (v/v) glycerol supplemented with 750 mM KCl (for
DnaJB1) or 500 mM KCl (for HspA8) that also contained 1 mg of DNase I. Resuspended cells were
lysed by probe sonication for 3 min (10 s on/20 s off) at 45% power and the lysate clarified by two
centrifugation steps for 30 min at 30,000 x g at 4˚C. The entire bacterial lysate (~ 40 mL) was loaded
onto a 5 mL His-Trap Sephadex column pre-equilibrated in the same buffer used to resuspend the
bacterial pellet (IMAC buffer A). Proteins that did not bind to the column were eluted with IMAC
buffer A until the absorbance at 280 nm and conductivity had returned to baseline. Protein
immobilized to the His-Trap column was then washed with 20 column volumes of 50 mM HEPESKOH (pH 7.4), 5 mM MgCl2, 2 mM BME and 10% (v/v) glycerol supplemented with 500 mM KCl
(for DnaJB1) or 100 mM KCl (for HspA8) (IMAC buffer B). For HspA8, an additional wash step
was performed with 5 column volumes of IMAC buffer B supplemented with 10 mM ATP to elute
proteins captured by HspA8. For both DnaJB1 and HspA8, the His-Trap column was then washed a
final time with 5 column volumes of IMAC buffer B supplemented with 20 mM imidazole.
Recombinant protein was then eluted from the IMAC column by addition of the relevant IMAC buffer
B supplemented with 300 mM imidazole (IMAC buffer C). The eluate was analyzed by SDS-PAGE
and fractions containing the recombinant protein were pooled.

To remove the SUMO tag (with N-terminal 6x-His motif) from the recombinant protein, eluted
fractions were dialyzed in the presence of Ulp1 (SUMO protease, 4 µg/mg of recombinant protein)
overnight at 4˚C against the relevant IMAC buffer A. Cleaved recombinant protein was then loaded
onto a 5 mL His-Trap Sephadex IMAC column equilibrated in IMAC buffer A. Cleaved recombinant
protein eluted in the flow-through and was collected. The presence of recombinant protein in the
eluate fractions was confirmed by SDS-PAGE. Fractions containing recombinant DnaJB1 or HspA8
were pooled, concentrated, and loaded onto a Superdex 75 size-exclusion column equilibrated in
DnaJB1 storage buffer (50 mM HEPES-KOH [pH 7.4], 500 mM KCl, 5 mM MgCl2, 2 mM BME,
10% (v/v) glycerol) or HspA8 storage buffer (50 mM HEPES-KOH [pH 7.4], 100 mM KCl, 5 mM
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MgCl2, 2 mM BME, 10% (v/v) glycerol). Fractions containing purified recombinant protein were
pooled and the concentration determined as described in section 2.2.3. Recombinant protein was
subsequently snap frozen in liquid nitrogen and stored at -20˚C until required.

2.3.3

Expression condition screening of MBP- or SUMO-tagged recombinant protein

E. coli BL21(DE3) cells transformed with plasmids encoding MBP- or SUMO-tagged protein were
streaked onto a LB agar plate supplemented with the appropriate antibiotic (ampicillin [100 µg/mL]
or kanamycin [50 µg/mL], respectively) and grown overnight at 37˚C. The starter culture was used
to inoculate expression cultures containing LB media supplemented with the appropriate antibiotic,
with the cultures incubated at 37˚C until an OD600 of ~ 0.6 was reached. Expression cultures were
aliquoted into multiple tubes and expression of recombinant protein was induced by addition of
varying concentrations of IPTG (0.1 – 0.5 mM). Depending on the sample, cultures were incubated
on an orbital shaker either at 18˚C overnight (~ 20 hr), 30˚C for 4 hr (for luciferase) or at 37˚C for 4
hr (for rhodanese). Aliquots were taken at various time points and the OD600 recorded prior to
centrifugation at 5,000 x g for 10 min at 4˚C. The pellet was stored at -20˚C for subsequent SDSPAGE analysis. The bacterial pellets were resuspended to 20 OD/mL in either 100 mM Tris (pH 8.0)
containing 2% (w/v) SDS to determine total protein content or BugBuster® MasterMix (Merck,
USA) to determine soluble protein content. Samples containing BugBuster were incubated on a
rotator for 20 min at room temperature and then insoluble material removed following centrifugation
at 16,000 x g for 20 min at 4˚C. The supernatant of the SDS or BugBuster treated cells were then
loaded onto an SDS-PAGE gel for analysis.

2.3.4

Large-scale expression and purification of SUMO-tagged recombinant protein

E. coli BL21(DE3) cells co-transformed with plasmids encoding biotin ligase (BirA) and the
appropriate protein of interest (i.e., SUMO-tagged luciferase or rhodanese, with N-terminal 6x-His
and C-terminal AviTag motifs) were streaked onto a LB agar plate supplemented with kanamycin
(50 µg/mL) and chloramphenicol (10 µg/mL) antibiotics and grown overnight at 37˚C. Cells from a
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single colony on the LB plate were used to inoculate a starter culture (~ 100 mL) consisting of LB
media supplemented with kanamycin (50 µg/mL) and chloramphenicol (10 µg/mL) and grown
overnight at 37˚C with constant agitation at 180 rpm in an orbital shaker. The starter culture was used
to inoculate four expression cultures containing 500 mL of LB media supplemented only with
kanamycin (50 µg/mL), with the cultures incubated at 37˚C until an OD600 of ~ 0.4 was reached.
Expression cultures were then further incubated at 18˚C until an OD600 of ~ 0.6 - 0.8 was reached. To
promote the in vivo biotinylation of the AviTagged recombinant protein, the media was supplemented
with D-biotin (50 µM final concentration) prepared in 10 mM bicine buffer (pH 8.3) prior to protein
induction. Expression of recombinant protein was induced by addition of IPTG (0.1 mM) and cultures
were incubated on an orbital shaker at 130 rpm overnight (~ 20 hr) at 18˚C. The cells were then
harvested by centrifugation at 5,000 x g for 10 min at 4˚C and the pellet stored at -20˚C until the
recombinant protein was extracted.

Recombinant SUMO-tagged luciferase was extracted from the bacterial pellet via resuspension in 50
mM Tris-HCl (pH 8.0) supplemented with 300 mM NaCl, 5 mM imidazole, 10% (v/v) glycerol
(SUMO IMAC buffer A) that also contained lysozyme (0.5 mg/mL) and EDTA-free cocktail protease
inhibitor. The resuspended pellet was then incubated at 4˚C for 20 min. Recombinant SUMO-tagged
rhodanese was extracted in an identical manner, with the exception that 20 mM sodium thiosulfate
was supplemented during extraction and subsequent IMAC purification steps to stabilize native
rhodanese. To shear extracted DNA and further lyse cells, the lysates were subjected to probe
sonication for 3 min (10 s on/20 s off) at 45% power. The cell debris was then pelleted twice at 24,000
x g for 20 min at 4˚C and the soluble bacterial lysate passed through a 0.45 µm filter to remove
particulates prior to subsequent purification.

SUMO-tagged recombinant proteins (with N-terminal 6x-His tag) were first purified from the
bacterial lysate using IMAC. The entire bacterial lysate (~ 30 mL) was loaded onto a 5 mL His-Trap
Sephadex column pre-equilibrated in the appropriate SUMO IMAC buffer A. Non-recombinant
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proteins were eluted from the column with SUMO IMAC buffer A until the absorbance at 280 nm
and conductivity had returned to baseline. Recombinant protein was then eluted from the IMAC
column by addition of the appropriate SUMO IMAC buffer A supplemented with 500 mM imidazole
(SUMO IMAC buffer B). The eluate was analyzed by SDS-PAGE and fractions containing
recombinant protein were pooled. To remove the N-terminal SUMO tag from the recombinant
protein, eluted fractions were dialyzed in the presence of Ulp1 (4 µg/mg of recombinant protein)
overnight at 4˚C against the appropriate SUMO IMAC buffer A that did not contain imidazole
(SUMO IMAC buffer C). Cleaved recombinant protein was then loaded onto a 5 mL His-Trap
Sephadex IMAC column equilibrated in the appropriate SUMO IMAC buffer C and purified as
previously described, however, this time the recombinant protein did not bind to the column and so
was collected in flow through fractions. The presence of recombinant protein in the eluate fractions
was confirmed by SDS-PAGE.

Fractions containing recombinant protein were pooled and dialyzed into 10 mM Tris (pH 9.0)
supplemented with 0.5 mM EDTA and 10% (v/v) glycerol (IEX buffer A) for further purification by
ion-exchange (IEX) chromatography. Dialyzed protein (5 mL) was loaded onto a MonoQ 5/50
column pre-equilibrated in IEX buffer A and non-bound proteins eluted from the column with IEX
buffer A until the absorbance at 280 nm and conductivity had returned to baseline. Recombinant
luciferase or rhodanese were eluted from the column using a linear salt gradient (0 – 300 mM NaCl
and 0 - 500 mM, respectively) over 20 column volumes, with 500 µL fractions collected. The column
was then washed with > 1 M NaCl to remove tightly bound contaminants. Eluate fractions across the
peak from the chromatogram were analyzed by SDS-PAGE and those fractions containing
recombinant protein were pooled. Recombinant luciferase (50 mM Tris [pH 7.5], 10% (v/v) glycerol)
and rhodanese (50 mM Tris [pH 7.5], 10 mM MgCl2, 5 mM KCl, 10% (v/v) glycerol) were dialyzed
into their respective buffers overnight at 4˚C. Dialyzed protein was concentrated using a Vivaspin
column (10 kDa molecular weight cut-off [MWCO]) and the concentration of recombinant protein
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was determined as described in section 2.2.3. Recombinant protein was aliquoted, snap frozen in
liquid nitrogen and stored at -20˚C until required.

2.3.5

Protein labelling

Recombinant proteins of interest were fluorescently labelled using maleimide reactive variants of
Alexa Fluor 555 (AF555), Alexa Fluor 647 (AF647) or tetramethylrhodamine (TMR) dyes as
described previously (Kim et al., 2008) with some modifications. Briefly, proteins of interest (~ 2
mg/mL) were incubated in the presence of 5 mM tris(2-carboxyethyl)phosphine (TCEP) and 40%
(w/v) ammonium sulfate and placed on a rotator for 1 hr at 4˚C. Proteins were then centrifuged at
20,000 x g for 15 min and resuspended in degassed buffer A (100 mM Na2PO4 [pH 7.4], 200 mM
NaCl, 1 mM EDTA and 40% (w/v) ammonium sulfate). The protein was then centrifuged at 20,000
x g for 15 min and resuspended in degassed buffer B (100 mM Na2PO4 [pH 7.4], 200 mM NaCl, 1
mM EDTA). For proteins that were to be labelled with a single fluorophore, proteins were incubated
in the presence of a 5-fold excess of dye for either 4 hr at room temperature or overnight (~ 20 hr) at
4˚C. For FRET experiments, proteins were incubated in the presence of a 4-fold and 6-fold excess of
pre-mixed AF555 donor and AF647 acceptor fluorophores, respectively, and placed on a rotator
overnight at 4˚C. Following the coupling reaction, excess dye was removed by gel filtration
chromatography using a 7 K MWCO Zebra Spin Desalting column (Thermo Fisher Scientific, USA)
equilibrated in an appropriate storage buffer. The concentration and degree of labelling was calculated
by UV absorbance or denatured mass spectrometry. The proteins were stored at -20°C until use.

Since rhodanese contains a functional cysteine residue buried within the active site, labelling was
performed as described above with modification and in line with previously published protocols
(Kellner et al., 2014). As an alternative to the use of TCEP, exposed cysteine residues were instead
reduced using 20 mM BME and a second wash step with degassed buffer A was used to remove
residual BME prior to addition of the fluorophore.
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2.3.6

Denatured mass spectrometry

Denatured mass spectrometry was performed on a Synapt G1 HDMS (Waters, USA) using a
nanoelectrospray ionization source. Fluorescently labelled proteins were denatured by dialysis into
1% (v/v) formic acid overnight at 4˚C. Instrument conditions were set as previously described
(Aquilina et al., 2003). Key instrument parameters were as follows: capillary voltage (kV): 1.5;
sampling cone (V): 50; extraction cone (V): 4; trap/transfer collision energy (V/V): 6/4; trap gas
(L/hr): 2.5; backing gas (mbar): ~ 2.0. Each protein was electrosprayed from gold-coated borosilicate
glass capillaries (Harvard Apparatus; Massachusetts, USA) prepared in-house. The mass
spectrometer was calibrated using caesium iodide (10 mg/mL) and all spectra were analyzed using
MassLynx V4.1 software. The labelling yield of fluorescent protein was calculated using Equation
2.2.

Labelling yield =

Peak height of labelled protein
peak height of non-labelled protein + peak height of labelled protein

* 100

Equation 2.2: Equation to calculate the labelling efficiency of fluorophore-conjugated proteins using
denatured mass spectrometry.

2.4
2.4.1

Total internal reflection fluorescence (TIRF) microscopy
Instrument setup

Samples were imaged using a custom-built TIRF microcopy system constructed using an inverted
optical microscope (Nikon Eclipse TI) that was coupled to an electron multiplied charged coupled
device (EMCDD) camera (Hamamatsu Photonics K. K., Model C9100-13, Japan). The camera was
established to operate in an objective-type TIRF setup with diode-pumped solid-state lasers (200 mW
Sapphire; Coherent, USA) emitting circularly polarized laser radiation of either 488, 532 or 647 nm
continuous wavelength. The laser excitation light was reflected by a dichroic mirror
(ZT405/488/561/647; Semrock, USA) and directed through an oil immersion objective lens (CFI
Apochromate TIRF Series 60x objective lens, numerical aperture = 1.49) and onto the sample. Total
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internal reflection was achieved by directing the incident ray onto the sample at an angle greater than
the critical angle (θc) of ~ 67˚ for a glass/water interface. The evanescent light field generated
selectively excites the surface-immobilized fluorophores, with the fluorescence emission passing
through the same objective lens and filtered by the same dichroic mirror. The emission was then
passed through a 635 nm long pass filter (BLP01-635R; Semrock, USA) and the final fluorescent
image projected onto the EMCDD camera. The camera was running in frame transfer mode at 20 Hz,
with an electron multiplication gain of 700, operating at - 70˚C with a pixel distance of 110 nm.

2.4.2

Coverslip preparation and flow cell assembly

Coverslips were functionalized with neutravidin as previously described (Chandradoss et al., 2014),
with minor modifications. Briefly, 24 x 24 mm glass coverslips were cleaned by alternatively
sonicating (Unisonics, Australia) for 30 min in 100% ethanol then in 5 M KOH for a total of 2 hr.
The coverslips were rinsed three times with milli-Q water and sonicated in milli-Q water for 5 min
to remove any KOH present. The coverslip surface was then activated via an amino-silanization
reaction, which coats the coverslip surface with reactive amine groups, by incubating with 2% (v/v)
3-aminopropyl trimethoxysilane (Alfa Aesar, USA) in milli-Q for 10 min. The coverslips were then
sonicated for 1 min and incubated in the same solution for a further 10 min. Activated coverslips were
sequentially rinsed three times each with milli-Q water and dried with nitrogen gas. NHS-ester
methoxy-polyethylene glycol, molecular weight 5 kDa (mPEG) and biotinylated-mPEG (bPEG;
LaysanBio, USA), at a 20:1 (w/w) ratio, was dissolved in either 100 mM NaHCO3 (pH 7.4) or 50
mM 4-morpholinepropanesulfonic acid (MOPS, pH 7.4) buffer and sandwiched between two
activated coverslips for a minimum of 4 hr for initial passivation in a custom-made humidity chamber.
PEGylated coverslips were then rinsed with milli-Q and PEGylated again as described above for
overnight (~ 20 hr) passivation. During passivation, the NHS-ester on PEG reacts with the amine
groups on the coverslip. PEGylated coverslips were rinsed with milli-Q water, dried under nitrogen
gas and stored at -20˚C until required. Prior to use, neutravidin (0.2 mg/mL; BioLabs, USA) in milliQ was incubated on the passivated coverslip for 10 min to bind to the bPEG. Neutravidin
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functionalized coverslips were then rinsed with milli-Q, dried under nitrogen gas and bonded to a
polydimethylsiloxane (PDMS) flow cell for use in single-molecule experiments. Finally, to reduce
the non-specific binding of proteins to the coverslip surface, each channel in the microfluidic setup
was incubated in the presence of 2% (v/v) Tween-20 for 30 min as previously described (Pan et al.,
2015) and then washed with imaging buffer.

2.4.3

Surface immobilization of labelled proteins for single-molecule FRET (smFRET)

For smFRET experiments, labelled proteins were specifically immobilized to the neutravidinfunctionalized and Tween-20-coated coverslip. To do so, labelled protein (500 pM final
concentration) was diluted in imaging buffer (50 mM Tris [pH 7.5], 5 mM KCl, 10 mM MgCl2, 200
mM BME and 6 mM 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid [Trolox]) and
incubated in the flow cell for 5 min. These conditions would typically give rise to ~ 200 – 300 FRETcompetent molecules per 100 square microns. Unbound proteins were then removed from the flow
cell by flowing through imaging buffer.

2.4.4

smFRET analysis

Single-molecule time trajectories were analyzed in MATLAB using the MASH-FRET user interface
(https://rna-fretools.github.io/MASH-FRET/) (Hadzic et al., 2018). The approximate FRET value is
measured as the ratio between the acceptor fluorescence intensity (IAcceptor) and the sum of both donor
(IDonor) and acceptor fluorescence intensities after correcting for crosstalk between donor and acceptor
channels. The formula for calculating the FRET efficiency is given by Equation 2.3.

FRET =

CIAcceptor
CIAcceptor + IDonor

Equation 2.3: Equation for calculating FRET efficiency. The corrected acceptor intensity (denoted as
CIAcceptor) is equal to IAcceptor – ( * IDonor) whereby  is the crosstalk correction constant.  is calculated as the
ratio of fluorescence measured in the acceptor and donor detection channels following direct excitation of a
protein labelled with a single donor fluorophore.
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Briefly, donor and acceptor fluorescence channels were aligned following a local weighted mean
transformation of images of TetraSpeck fluorescence beads and donor and acceptor fluorescence
spots co-localized to identify FRET pairs. Molecules that displayed clear donor and/or acceptor
photobleaching events or demonstrated clear anti-correlated changes in donor and acceptor
fluorescence intensity were selected for subsequent analysis. The number of photobleaching events
observed were used to determine the number of fluorophores present; only molecules in which a
single donor and acceptor photobleaching event was observed were used for further analysis. Selected
molecules were smoothed using the NL filter coded in MASH-FRET and data truncated to only
include FRET values acquired before donor or acceptor photobleaching. FRET efficiency data were
exported to the state finding algorithm vbFRET (https://sourceforge.net/projects/vbFRET/) and
trajectories fit to a Hidden Markov Model (HMM) to identify discrete FRET states and the transition
distributions between them. Default vbFRET settings were employed to fit data to the HMM, with
the exception that the mu and beta hyperparameters were changed to 1.5 and 0.5, respectively, to
prevent overfitting of data. The mu parameter influences the total magnitude change in FRET
efficiency required to identify a transition whereas the beta parameter influences the transition
sensitivity. For simplicity, the number of FRET states that could be fitted per trace was set to a
maximum of 5.

Since it is not possible to determine for how long a particular FRET state existed prior to image
acquisition or just prior to photobleaching, the first and last measured residence times were deleted
from the dataset in order to extract true residence times. Since data were smoothed during denoising,
residence times shorter than that given by Equation 2.4 were not considered for further analysis.
Residence timeDelete = 2 · F · NFA

Equation 2.4: Equation used to exclude residence times from smFRET analysis. F is the imaging frame
rate in milliseconds and NFA is the number of frames that were averaged during trace denoising.
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The FRET efficiency of all datapoints for each molecule was collated and is presented as FRET
efficiency distributions. For simple visualization, the FRET efficiency distributions were smoothed
using Python software and the generated data was compared to non-treated distributions to ensure
that smoothing did not introduce any artifacts. Transition density plots (TDPs) were generated by
plotting the idealized FRET state (i.e., the FRET state as determined from HMM analysis) prior to a
transition against the idealized FRET state immediately after the transition. When monitoring the
unfolding or refolding of proteins using smFRET, the total number of datapoints of FRET-competent
molecules that were above the indicated FRET threshold was divided by the total number of
datapoints and plotted as a function of denaturant concentration. To elucidate the effect of molecular
chaperones on the residence times and transition frequencies between FRET states, the initial and
final FRET state of each transition was filtered and analyzed as described in the appropriate chapters.
The residence times were statistically analyzed using a two-way analysis of variance (ANOVA) with
either a Šídák or Tukey’s multiple comparisons post-hoc test, with p ≤ 0.05 determined to be
statistically significant. The precise statistical test performed for each dataset is indicated in the
appropriate figure legend. All data analysis and presentation were performed using custom-written
scripts on Python software or using GraphPad Prism 9 (GraphPad Software Inc; San Diego, USA).
All Python data analysis scripts used to analyze and present smFRET are available from
https://doi.org/10.5281/zenodo.5157894.

2.5

Data analysis

All statistical analysis were performed using GraphPad Prism 9 unless otherwise stated.
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molecular chaperone action

The experiments to generate the data presented in Figure 3.12B of this chapter were performed by Mr B.
Skewes (University of Wollongong, Australia). N. Marzano performed all the other experiments outlined in
this chapter.

Chapter 3 – Development and implementation of luciferase as a protein-folding sensor
3.1

Introduction

The function of many molecular chaperones has often been studied in the context of how they prevent
the aggregation or assist in the refolding of model client proteins. One of the most studied clients for
studies of molecular chaperone action is firefly (Photinus pyralis) luciferase (Fluc), a multi-domain
60 kDa protein. Fluc possesses several characteristics that make it an ideal client protein for the study
of chaperone function; Fluc readily aggregates when incubated at physiologically relevant
temperatures (i.e. ~ 42˚C) or following dilution from chemical denaturant, it has a limited ability to
spontaneously fold or refold (it requires chaperones to do so) and the attainment of its native state
can be readily assessed via a highly sensitive bioluminescence enzymatic assay (Levy et al., 1995;
Nillegoda, Kirstein, et al., 2015; Hristozova et al., 2016). Furthermore, Fluc is not endogenously
expressed in humans and so it is often used as a reporter of cellular proteostasis since loss or gain of
function interferences are minimal (Gupta et al., 2011; San Gil et al., 2017). Consequently, Fluc has
been used as a model client protein for the in vitro study of a vast range of molecular chaperones,
particularly the Hsp40/Hsp70 chaperone systems from bacteria (DnaJ/DnaK) (Schröder et al., 1993;
Szabo et al., 1994; Svetlov et al., 2006; Kellner et al., 2014; Luengo et al., 2018; Imamoglu et al.,
2020), yeast (Ydj1/Ssa1) (Lu et al., 1998a; Fan et al., 2004; Dragovic et al., 2006; Yu et al., 2015)
and humans (e.g., DnaJB1/HspA8) (Freeman et al., 1995; Minami et al., 1996; Terada et al., 1997;
Minami et al., 1999; Hafizur et al., 2004; Tzankov et al., 2008; Baaklini et al., 2012; Rauch et al.,
2014; Luengo et al., 2018; Cabrera et al., 2019) due to their ability to assist in the refolding of Fluc.
However, the precise mechanistic details by which the Hsp70 chaperone system mediates the
refolding of Fluc, and indeed, the refolding of proteins more generally, are unclear. As a result, there
is a need for development of experimental approaches that allow better access to these molecular
details.

As a result of the heterogeneous nature of chaperone-client interactions, single-molecule approaches
have become increasingly popular as a tool to better understand the fundamental mechanisms by
which molecular chaperones affect the folded state of their client proteins. However, there have been
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limited efforts to study the conformation of the client protein when bound to the chaperones (Kellner
et al., 2014; Sekhar et al., 2015; Tsuboyama et al., 2018) and only a single instance in which Fluc
was used as the client protein (Imamoglu et al., 2020). While these previous studies have provided
important insights into the mechanism by which chaperones interact with clients, the majority of them
rely on single-particle confocal-based methodologies to observe chaperone-client interactions, which
restricts the observation of individual client or chaperone-client complexes to the diffusion time of
the particle through the confocal volume (~ 1 ms) (Hou et al., 2019). Consequently, chaperonemediated changes in the folded state of individual client proteins cannot be observed and key kinetic
rates and parameters (e.g., on/off rates) are unable to be determined. As such, there is a clear need to
employ alternative strategies that enable the observation of chaperone-client interactions over
extended periods and, in particular, the real-time monitoring of the client protein conformation whilst
bound by chaperones.

With this in mind, the rationale behind the work described in this chapter of the thesis was to develop
a Fluc construct that can be immobilized to a coverslip surface (via neutravidin/biotin interactions)
such that the conformation of individual Fluc molecules can be monitored through time. To do so, a
method that combined TIRF microscopy and single-molecule FRET (smFRET) was implemented.
The Fluc protein-folding sensor was exploited as a novel tool to study, for the first time, the
mechanistic action of a mammalian Hsp40/Hsp70 refolding system (DnaJB1 and HspA8) and the
bacterial Hsp70 refolding system (DnaK, DnaJ and GrpE) on a client protein with temporal resolution
at the single-molecule level.
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3.2
3.2.1

Methods
Materials

Recombinant wild-type Fluc (FlucWT) was purchased from Sigma-Aldrich (Missouri, USA). Plasmids
encoding GST-tagged Fluc mutants were generously donated by Prof. Till Böcking (UNSW,
Australia).

3.2.2

Rationale and design of Fluc smFRET construct

In order to employ Fluc as a sensor of protein folding using smFRET, we employed a Fluc construct
in which all native cysteines have been substituted with alanines (C81A, C391A) and two cysteine
residues have been introduced for fluorescent labelling with a donor and acceptor fluorophore pair.
The introduced cysteines are positioned on the external faces of the N-terminal domain (K141C) and
C-terminal domain (K491C) of Fluc and span either side of the interdomain cleft (Figure 3.1). Based
on the crystal structure of the protein (PDB 1LCI, Conti et al., 1996), these cysteines are 34.8 Å apart
(measured from C𝛼 – C𝛼), which enables the relative structure and positioning of both Fluc domains
to be monitored via smFRET. The modified Fluc construct (i.e., Fluc∆Cys, K141C, K491C) is herein denoted
as FlucIDS, since the introduced cysteines enable this construct to be used as an interdomain sensor of
protein folding. The C-terminal domain of Fluc folds efficiently and independently (does not require
chaperones), while the N-terminal domain can often misfold and become rate-limiting for folding
(Scholl et al., 2014); owing to the different capacities by which these domains fold, this FlucIDS
construct is ideal for reporting on the overall structure of Fluc at the endpoint of folding.
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Figure 3.1: Crystal structure of Fluc. The structure of Fluc (PDB 1LCI, Conti et al., 1996) with cysteine
residues to be labelled with a FRET fluorophore pair in the FlucIDS construct are shown. The C𝛼 – C𝛼 distance
between labelled residues is shown. The N- and C-terminal domains and the interdomain cleft are indicated.

3.2.3

Optimizing the soluble expression and purification of FlucIDS

3.2.3.1 Expression of GST-tagged FlucIDS
E. coli BL21(DE3) cells transformed with plasmids encoding GST-tagged FlucWT and GST-tagged
FlucIDS were streaked onto a LB agar plate supplemented with ampicillin (100 µg/mL) and grown
overnight at 37˚C (for overview of different Fluc constructs expressed, see Appendix IV). Cells from
a single colony on the LB plate were used to inoculate a starter culture (~ 100 mL) consisting of LB
media supplemented with ampicillin (100 µg/mL), with the culture grown overnight at 37˚C with
constant agitation at 180 rpm in an orbital shaker (Bioline, Australia). The starter culture was diluted
20-fold into expression cultures containing LB media supplemented with ampicillin (100 µg/mL),
which were then incubated at 37˚C until an OD600 of ~ 0.6 was reached. The expression of GSTtagged Fluc constructs was induced by addition of IPTG (0.1 mM) and incubation at 18˚C for 20 hr.
Following incubation, cells were harvested by centrifugation at 5,000 x g for 10 min at 4˚C (Sorvall
RC-6+; Thermo Fisher Scientific, USA) and the pellet stored at -20˚C until the recombinant protein
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was extracted. To determine if expression of the recombinant protein was successful, aliquots of the
expression cultures were taken before and after the induction of protein expression by IPTG and the
bacterial pellet stored at -20˚C for subsequent SDS-PAGE analysis.

Recombinant Fluc was extracted by resuspension of the bacterial pellet in PBS (135 mM NaCl, 2.7
mM KCl, 1.75 mM KH2PO4, 10 mM Na2HPO4, pH 7.4) supplemented with 1 mM EDTA, 1 mM
dithiothreitol (DTT), 0.5 mg/mL lysozyme and EDTA-free cocktail protease inhibitor and incubated
at 4˚C for 20 min. To shear extracted DNA and further lyse cells, the lysate was subjected to probe
sonication for 3 min (10 s on/20 s off) at 45% power. The cell debris was then pelleted at 24,000 x g
for 20 min at 4˚ and the supernatant (containing soluble protein) was subject to SDS-PAGE analysis.

3.2.3.2 Restriction-enzyme based cloning
FlucIDS was cloned into a custom vector (designated pSUMO-AviTag) with the aim of improving its
soluble expression (via the addition of an N-terminal 6x-His-SUMO solubility tag) and, to facilitate
its immobilization to a neutravidin-functionalized coverslip, by the addition of a C-terminal AviTag
motif (see Appendix IV). Restriction-enzyme cloning was performed as outlined in section 2.2.6 and
the appropriate restriction enzymes, primers and annealing temperatures used are summarized in
Appendix III.

3.2.3.3 Expression condition screening of SUMO-tagged FlucIDS
E. coli BL21(DE3) cells transformed with plasmids encoding SUMO-tagged FlucIDS (with an Nterminal 6x-His tag and C-terminal AviTag, see Appendix IV) were streaked onto a LB agar plate
supplemented with kanamycin (50 µg/mL) and grown overnight at 37˚C. The soluble expression
screen of recombinant protein was performed as described in section 2.3.3.
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3.2.3.4 Expression and purification of SUMO-tagged FlucIDS
E. coli BL21(DE3) cells co-transformed with plasmids encoding biotin ligase (BirA) and SUMOtagged FlucIDS (with an N-terminal 6x-His tag and C-terminal AviTag, see Appendix IV) were
streaked onto a LB agar plate supplemented with kanamycin (50 µg/mL) and chloramphenicol (10
µg/mL) antibiotics and grown overnight at 37˚C. The soluble expression, extraction, purification and
confirmation of in vivo biotinylation of recombinant protein were performed as described in sections
2.2.2 and 2.3.4.

3.2.4

Biochemical analysis of FlucIDS unfolding, folding and interaction with molecular
chaperones

3.2.4.1 Fluc enzymatic assays
The ability of denatured FlucIDS to spontaneously refold to a native state was assessed by measuring
the return of enzymatic activity. Denatured FlucIDS was prepared by incubation of native FlucIDS in
unfolding buffer (50 mM HEPES-KOH [pH 7.5], 50 mM KCl, 5 mM MgCl2, 2 mM DTT and 5 M
guanidinium hydrochloride [GdHCl]) for 30 min at room temperature. Spontaneous refolding of
denatured FlucIDS was initiated by a 1:100 dilution into refolding buffer (50 mM HEPES-KOH [pH
7.5], 80 mM KCl, 5 mM MgCl2, 2 mM DTT and 0.05% (v/v) Tween-20) such that the final
concentration of FlucIDS was 10 nM. Refolding reactions with mammalian chaperones (i.e., DnaJB1
and HspA8) were left to incubate at 30˚C for 480 min and reactions with bacterial chaperones (i.e.,
DnaK, DnaJ and GrpE, denoted as the KJE system) were left to incubate at 25˚C for up to 120 min.
Throughout the refolding reactions, aliquots were taken at various times and dispensed into the
bottom of a white 96-well CoStar plate (Sigma-Aldrich, USA). The luminescence reaction was
initiated following injection of a 25-fold excess of assay buffer (25 mM glycylglycine [pH 7.4], 0.25
mM luciferin, 100 mM KCl, 15 mM MgCl2 and 2 mM ATP) into a single well and the luminescence
was measured 5 s after injection for 10 s using a PolarStar Omega (BMG Labtech, Germany) plate
reader. The injection and measurement procedure described above was then performed sequentially
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for each well to ensure consistency between the measurements. All measurements were performed at
25˚C with the gain set to 4,000. Refolding yields were calculated by normalizing to the activity of
native (non-denatured) FlucIDS, which was treated as described above with the exception that GdHCl
was omitted from the unfolding buffer. Experiments in which the activity of native Fluc IDS was
compared to a commercial source of native FlucWT were also performed as described above, and the
relative activity was determined by dividing the luminescence values of Fluc WT or FlucIDS by the
average luminescence of FlucWT.

Chaperone-assisted refolding reactions were performed as described above with the exception that
denatured FlucIDS was diluted into refolding buffer containing chaperones and nucleotide. Briefly,
refolding assays containing mammalian chaperones were performed either with a low concentration
(1 µM DnaJB1 and 2 µM HspA8) or a high concentration (5 µM DnaJB1 and 10 µM HspA8) of
chaperones in the absence or presence of 2 mM ATP. Refolding assays with the bacterial Hsp70
system were performed with either FlucIDS or FlucWT in the presence of 1 µM DnaJ, 3 µM DnaK and
1.5 µM GrpE (when present) supplemented with either 2 mM or 5 mM ATP. To monitor the KJEassisted refolding of misfolded FlucIDS, following 60 min of unassisted refolding (i.e., spontaneously
refolded treatment), an aliquot of FlucIDS was diluted 10-fold (1 nM final concentration) into refolding
buffer containing the KJE chaperone system and the luminescence was measured at various
timepoints. All data were fit to a one-phase association curve to determine the plateau (denoted as
Ymax) and time required to achieve half Ymax (denoted as t1/2) using GraphPad Prism 9 software.

3.2.4.2 Single-molecule FRET (smFRET)
To interrogate whether FlucIDS can be used as a reporter of protein folding via changes in FRET
efficiency, single-molecule experiments were performed in which the folded state of FlucIDS was
perturbed with the chemical denaturant GdHCl. To do so, FlucIDS was fluorescently labelled with a
AF555 (donor) and AF647 (acceptor) fluorophore FRET pair as described in section 2.3.5. Coverslips
were cleaned, functionalized, and assembled into PDMS microfluidic devices as described in section
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2.4.2. Labelled FlucIDS was immobilized to the neutravidin-functionalized coverslip as described in
section 2.4.3.

To monitor protein unfolding, labelled-FlucIDS was imaged in imaging buffer (50 mM Tris [pH 7.5],
5 mM KCl, 10 mM MgCl2, 200 mM BME and 6 mM Trolox) in the absence of denaturant (i.e., native
state) and after 5 min incubation with increasing concentrations of GdHCl (0 – 4 M). The refolding
of FlucIDS denatured in 4 M GdHCl was observed by imaging immediately following the addition of
decreasing concentrations of GdHCl (3 – 0 M). To demonstrate the ability of FlucIDS to report on
structural transitions in real time, immobilized FlucIDS molecules were alternatively incubated in
imaging buffer supplemented with or without 4 M GdHCl and the FRET efficiency measured. To
assess the effect of molecular chaperones on the conformation of FlucIDS, denatured FlucIDS was first
generated by incubation in 4 M GdHCl. Denaturant was removed with imaging buffer containing the
indicated amounts of chaperone(s) and/or nucleotide (e.g., ATP, ADP or AMP-PNP). As a control,
denatured FlucIDS was imaged in the presence of the non-chaperone control protein, ovalbumin, at
the highest concentration of chaperone used (15 µM) and in the presence of 2 mM ATP. An oxygen
scavenging system (OSS) consisting of 5 mM protocatechuic acid and 50 nM protocatechuate-3,4dioxygenase was included in all buffers prior to and during image acquisition.

All data were acquired using a TIRF microscope setup as previously described (see section 2.4.1)
following sample illumination using a 532 nm solid state laser with excitation intensity of 2.6 W/cm2
and the fluorescence of donor and acceptor fluorophores was measured every 200 ms or 500 ms (for
GdHCl-induced folding and unfolding experiments) at multiple fields of view. The smFRET
trajectory analysis was performed as outlined in section 2.4.4.
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3.3
3.3.1

Results
GST-tagged FlucIDS is expressed in an insoluble form

The soluble expression of GST-tagged FlucWT and GST-tagged FlucIDS was assessed by SDS-PAGE
(Figure 3.2). Aliquots of E. coli before and after the induction of protein expression by IPTG
confirmed the over-expression of recombinant GST-tagged FlucWT and FlucIDS (Figure 3.2A-B). Prior
to induction with IPTG, there was no band observed in the extracted total protein lysate that
corresponds to the expected molecular mass of GST-tagged FlucWT or FlucIDS (~ 87 kDa, Figure 3.2AB, lanes NI). After overnight expression of recombinant protein induced by the addition of IPTG, a
strong band at ~ 87 kDa was present in the extracted E. coli cell lysates indicative of the overexpression of GST-tagged FlucWT and FlucIDS (Figure 3.2A-B, lanes I). When the soluble cell lysate
of E. coli cells that had expressed GST-tagged FlucWT was analyzed by SDS-PAGE a prominent band
at ~ 87 kDa was observed, which indicates the soluble expression of GST-tagged FlucWT (Figure
3.2A, lane S). Conversely, no band at ~ 87 kDa was observed in the soluble cell lysate from E. coli
cells that had expressed the GST-tagged FlucIDS construct (Figure 3.2B, lane S), which indicates that
FlucIDS is not expressed as a soluble protein under these conditions. Thus, the removal of native
cysteines at positions 81 and 391 and the addition of cysteines at residues 141 and 491 to Fluc WT
results in the FlucIDS variant being expressed as an insoluble protein under these experimental
conditions.
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Figure 3.2: Assessing the soluble expression of GST-tagged FlucWT and FlucIDS. E. coli BL21 cells
transformed with plasmids encoding (A) GST-tagged FlucWT or (B) GST-tagged FlucIDS were grown to an OD
of 0.6 and the expression of recombinant protein induced following addition of IPTG (0.1 mM) and incubation
at 18˚C for 20 hr. For both panels, lane NI and I represent the total protein content prior to and after addition
of IPTG, respectively. Lane S represents the soluble protein content after the addition of IPTG. Precision-plus
dual-color protein standards (in kDa) for all gels are shown. The expected molecular mass of GST-tagged Fluc
is indicated by the arrow on the right of the gels.

3.3.2

The addition of SUMO and AviTag motifs to FlucIDS improves the soluble expression of
recombinant FlucIDS

Since GST-tagged FlucIDS was not expressed in a soluble form, restriction-enzyme cloning into a
custom vector (pSUMO-AviTag) was performed with the aim of improving the soluble expression
of FlucIDS via the addition of an N-terminal SUMO solubility tag. Concurrently, this isoform was
designed to facilitate immobilization of FlucIDS to a neutravidin-functionalized coverslip via the
addition of a C-terminal AviTag motif.

Successful PCR amplification of the FlucIDS DNA sequence from template DNA was assessed by
agarose gel electrophoresis (Figure 3.3A). When the products from the PCR reaction were loaded
onto an agarose gel, a prominent band was observed at ~ 2,000 bp, which is slightly larger than the
expected length of the sequence encoding FlucIDS (1667 bp, Figure 3.3A, lane I). Crucially, however,
no band was observed when the template DNA was omitted from the PCR reaction (Figure 3.3A,
lane (-)).

Both the PCR amplified FlucIDS insert and the destination vector, pSUMO-AviTag, were incubated
with BamHI and HindIII restriction enzymes and successful digestion was assessed by agarose gel
electrophoresis (Figure 3.3B). The digested PCR-amplified FlucIDS insert showed a clear band at
~ 2500 bp, higher than the expected length of the digested insert (1659 bp). When the destination
vectors were digested with BamHI and HindIII a band was observed above the largest DNA fragment
present in the marker, which was not in accord with the expected length of digested pSUMO-AviTag
(5684 bp). When restriction enzymes were omitted from the digestion reaction with pSUMO-AviTag
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a predominant band was observed at ~ 4500 bp with multiple faint bands observed at larger sizes,
consistent with supercoiling of circularized non-digested DNA fragments.

Colonies of E. coli DH5𝛼 transformed with ligated product were screened using PCR and agarose gel
electrophoresis to determine whether the transformants contained the pSUMO-AviTag vectors with
the cloned FlucIDS insert (Figure 3.3C). As a positive control, amplification of the original template
vector was performed, which showed a band at ~ 2,000 bp corresponding to the expected length of
the FlucIDS sequence (Figure 3.3C, lane (+)). No band was observed when the template DNA was
omitted from the PCR reaction (Figure 3.3C, lane (-)). PCR amplification of five DH5𝛼 colonies each
transformed with ligated product showed the presence of faint or moderate intensity bands at ~ 2,000
bp, which corresponds to the expected length of the FlucIDS insert from the positive control, and
smaller bands at ~ 800 bp.

Once a colony positive for the SUMO-tagged FlucIDS insert was identified, optimal conditions for the
soluble expression of SUMO-tagged FlucIDS were screened and assessed by SDS-PAGE (Figure
3.3D). To determine whether SUMO-tagged FlucIDS could be expressed in a soluble form, aliquots
of E. coli prior to and following induction of protein expression at 18˚C with various concentrations
of IPTG were analyzed by SDS-PAGE. Prior to induction with IPTG, there was no prominent band
observed in the extracted total protein or soluble cell lysate that corresponds to the expected molecular
mass of SUMO-tagged FlucIDS (~ 78 kDa, Figure 3.3D, lanes NI or S). Following the induction of
protein expression by the addition of IPTG, a strong band at ~ 75 kDa was present in the extracted
total protein E. coli cell lysate, indicative of the over-expression of SUMO-tagged FlucIDS (Figure
3.3D, lane I). When SUMO-tagged FlucIDS was expressed at 18˚C, there was a prominent band
observed at ~ 75 kDa in the soluble lysate for all concentrations of IPTG tested (Figure 3.3D, 18˚C
lanes), indicative of the soluble expression of recombinant protein. However, no apparent band at ~
75 kDa was observed in the soluble lysate at any timepoint when SUMO-tagged FlucIDS was
expressed at 30˚C (Figure 3.3D, 30˚C lanes).
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To confirm if the AviTag motif on the C-terminus of FlucIDS was biotinylated upon co-expression
with biotin ligase in vivo, a western blot was performed and the membrane was probed with a
streptavidin-HRP conjugate (Figure 3.3E). No band was observed in the non-induced fraction taken
prior to addition of IPTG, indicating that no protein in the soluble cell lysate was biotinylated (Figure
3.3E, lane NI). Conversely, a band was readily observed at ~ 75 kDa, which corresponds to the
approximate mass of SUMO-tagged FlucIDS, in the soluble cell lysate following protein induction
with IPTG (Figure 3.3E, lane I). No other band was observed in this treatment, indicating that the
biotinylation of SUMO-tagged FlucIDS by biotin ligase is specific to the introduced AviTag motif at
the C-terminus of FlucIDS.
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Figure 3.3: Restriction-enzyme cloning and soluble expression screening of SUMO-tagged FlucIDS. (A)
Agarose gel electrophoresis of DNA products following PCR amplification of the Fluc IDS insert from the
template vector. Lane (-) denotes the negative control in which no template DNA was added to the PCR
reaction. Lane I denotes the sample containing the PCR-amplified insert. (B) Agarose gel electrophoresis of
the PCR-amplified FlucIDS insert (from A, lane I) and pSUMO-AviTag cloning plasmid following restriction
enzyme digestion with BamHI and HindIII. The key at the bottom of the gel denotes whether restriction
enzymes were present (+) or absent (-) in each reaction. (C) Agarose gel electrophoresis of DNA products
formed following PCR amplification of crude DNA extracts from E. coli DH5𝛼 colonies transformed with
ligated DNA. Lane (-) denotes the negative control in which no template DNA was added to the PCR reaction
while lane (+) denotes the positive control in which template DNA containing the insert of interest is present.
The PCR products from crude DNA extracts of different DH5𝛼 colonies are shown (colonies). Hyperladder II
(A) and Hyperladder I (B and C) markers are shown with approximate size of DNA bands in the gel shown on
the left. (D) Assessing the soluble expression of SUMO-tagged FlucIDS under different induction conditions
via SDS-PAGE analysis. Induction conditions tested to improve the soluble expression of SUMO-tagged
FlucIDS are shown above the gel. The specific IPTG concentrations tested (from left to right) were 0.1 mM,
0.25 mM and 0.5 mM IPTG. (E) Immunoblot of non-induced and induced cell lysates to confirm the successful
in vivo biotinylation of SUMO-tagged FlucIDS. Biotinylated species were probed with a streptavidin-HRP
conjugate. For each SDS-PAGE gel, lane NI and I represent the total protein content prior to and after addition
of IPTG, respectively. Lane S represents the soluble protein content after addition of IPTG. In panels D and
E, the expected molecular mass of SUMO-tagged FlucIDS is indicated with an arrow on the right of the gel. For
all SDS-PAGE gels, precision-plus dual-color protein standards (in kDa) are shown.

3.3.3

Purification of SUMO-tagged FlucIDS

The recombinant SUMO-tagged FlucIDS was first purified from contaminant proteins in the cell lysate
using IMAC by exploiting the N-terminal 6x-His tag on the SUMO solubility tag (Figure 3.4A), and
its purity was assessed by SDS-PAGE (Figure 3.4B). A predominant band at 75 kDa was observed
in the E. coli soluble cell lysate loaded onto the IMAC column (Figure 3.4B, lane L), confirming the
presence of soluble recombinant SUMO-tagged FlucIDS in this sample. Following application of the
cell lysate sample on to the IMAC column, the absorbance at 280 nm increased substantially and then
returned to baseline. SDS-PAGE analysis indicated that almost all proteins in the cell lysate eluted in
this peak. The gradual addition of IMAC buffer B resulted in a broad peak in absorbance at 280 nm
that decreased and plateaued at ~ 100 absorbance units. SDS-PAGE analysis of the eluent fractions
collected following the addition of IMAC buffer B indicated the presence of a protein of ~ 75 kDa,
which corresponds to the expected mass of the SUMO-tagged FlucIDS (Figure 3.4B), in these
fractions. Thus, these fractions were pooled for subsequent cleavage and further purification of the
recombinant protein.
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Following overnight incubation with Ulp1 to remove the SUMO (and 6x-His) tag from FlucIDS,
IMAC was again utilized to further purify FlucIDS from contaminant proteins that previously co-eluted
with recombinant SUMO-tagged FlucIDS upon elution with IMAC buffer B (Figure 3.4C). SDSPAGE analysis of the load fraction prior to IMAC purification showed bands at ~ 64 and 14 kDa,
which correspond to FlucIDS and the cleaved SUMO tag respectively (Figure 3.4D). A significant
contaminant band at 32 kDa, which mass spectrometry confirmed to be biotin ligase (BirA, data not
shown), was also observed in this sample. When the sample was loaded onto the IMAC column there
was an increase in absorbance at 280 nm which returned to baseline upon addition of IMAC buffer
C. SDS-PAGE analysis of the eluent fractions containing this peak confirmed the presence of
recombinant FlucIDS and a smaller amount of the BirA contaminant protein in these fractions (Figure
3.4D, lanes 3 – 12). No other major contaminant bands were observed in these fractions, which were
subsequently pooled and dialyzed into ion-exchange (IEX) buffer A for IEX purification. Following
the addition of IMAC buffer B to the column, the absorbance at 280 nm increased and plateaued. The
absorbance at 280 nm returned to baseline levels following the addition of IMAC buffer C. SDSPAGE analysis of the eluent fractions following the addition of IMAC buffer B showed a significant
band at 14 kDa, which corresponds to the SUMO solubility tag, as well as some other contaminant
proteins of varying molecular masses.

IEX chromatography was performed to further purify recombinant FlucIDS from contaminant
proteins (Figure 3.4E). SDS-PAGE analysis of the load fraction prior to IEX purification showed the
presence of FlucIDS and the BirA protein, as indicated by bands at ~ 64 kDa and 32 kDa, respectively
(Figure 3.4F). When the sample was loaded onto the IEX column there was a broad increase in the
absorbance at 280 nm, which returned to baseline upon addition of IEX buffer A. SDS-PAGE analysis
of this peak showed the presence of a single band at ~ 32 kDa, which corresponds to the BirA
contaminant. Following the gradual addition of IEX buffer B to the IEX column, five major peaks in
the absorbance at 280 nm were observed that centered at elution volumes of 35.6 mL (peak 1), 36.9
mL (peak 2), 38.0 mL (peak 3), 39.8 mL (peak 4) and 43.5 mL (peak 5). SDS-PAGE analysis of the
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eluent fractions from peaks 1 to 4 confirmed the presence of recombinant FlucIDS with a small amount
of BirA contaminant. SDS-PAGE analysis of the eluent fraction from peak 5 (which included fraction
54) showed the presence of a contaminant protein at ~ 55 kDa. Since fractions 40 – 48 (which
encompass peaks 2 - 4) had the most recombinant FlucIDS and the lowest amount of contaminant
protein, these fractions were pooled, dialyzed into storage buffer and frozen in liquid nitrogen for
storage at -20˚C. The large-scale expression and purification of SUMO-tagged FlucIDS using these
methods generated 7.2 mg recombinant protein per liter of culture with a purity of 94%.
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Figure 3.4: Purification of recombinant SUMO-tagged FlucIDS. (A) A representative chromatogram
showing the initial IMAC purification of the E. coli cell lysate from IPTG induced cells. The cell lysate was
loaded onto a 5 mL His-Trap Sephadex IMAC column and non-specific protein eluted with 50 mM Tris-base
(pH 8.0) containing 5 mM imidazole, 10% (v/v) glycerol and 300 mM NaCl (IMAC buffer A). Recombinant
SUMO-tagged FlucIDS was eluted with IMAC buffer A supplemented with 500 mM imidazole (IMAC buffer
B, the point at which it was added is indicated in the graph). (B) SDS-PAGE of the eluted fractions from the
initial IMAC purification of SUMO-tagged FlucIDS. (C) A representative chromatogram showing the
subsequent purification of FlucIDS via IMAC. Ulp1-cleaved FlucIDS was loaded onto the IMAC column and
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purified as described for A with the exception that imidazole was omitted from IMAC buffer A (IMAC buffer
C). The addition of IMAC buffer B is indicated in the graph. (D) SDS-PAGE of the eluted fractions from the
subsequent IMAC purification of FlucIDS. (E) A representative chromatogram showing the purification of
FlucIDS via IEX chromatography. IMAC-purified FlucIDS was loaded onto a MonoQ column equilibrated in 10
mM Tris (pH 9.0) supplemented with 0.5 mM EDTA and 10% (v/v) glycerol (IEX buffer A) and non-bound
protein eluted with IEX buffer A. Bound protein was then eluted with a linear salt gradient (0 – 500 mM NaCl)
over 20 column volumes. (F) SDS-PAGE of the eluted fractions from IEX purification of Fluc IDS. For all
chromatograms, protein elution was monitored by measuring the absorbance at 280 nm (black) and
conductivity (mS/cm) is also shown (purple). The greyed areas and numbers at the top of the chromatogram
indicate the fractions collected and analyzed by SDS-PAGE. For all gels, lane L refers to the sample that was
loaded onto the column. The numbers above the gel refer to the eluate fractions from the corresponding
chromatogram. The expected molecular mass of recombinant Fluc IDS is indicated with an arrow. Precisionplus dual-color protein standards (in kDa) are shown for B, D and F.

3.3.4

smFRET can be used to monitor FlucIDS conformational changes in real time

As recombinant FlucIDS was able to be purified in a soluble form, experiments were conducted to
determine whether the folding and unfolding of FlucIDS could be monitored using smFRET. To do so,
FlucIDS was immobilized to a neutravidin-functionalized coverslip and imaged using TIRF
microscopy (Figure 3.5A). In the absence of the denaturant GdHCl, the majority of FlucIDS molecules
exhibited dynamic changes in FRET efficiency (Figure 3.5B), with a distribution centered at 0.7
FRET (Figure 3.5C). Incubation of FlucIDS with increasing concentrations of GdHCl resulted in
decreases in the FRET efficiencies (Figure 3.5C) such that, when in 4 M GdHCl, the FRET
distribution was centered at 0. Furthermore, dynamic changes in FRET efficiency were less
frequently observed in the smFRET traces at higher GdHCl concentrations - this observation is
supported by tighter FRET distributions in the histogram analysis (Figure 3.5B-C).

Interestingly, when the reverse experiment was performed (i.e., stepwise dilution from higher
concentrations of GdHCl into lower concentrations of GdHCl), the FRET efficiency histograms were
shifted to higher FRET values compared to those obtained in the corresponding GdHCl
concentrations during unfolding (Figure 3.5C). This was most evident when FlucIDS was removed
completely from denaturant (i.e., 1 to 0 M GdHCl), whereby the major peak was centered at a
significantly higher FRET value following dilution from 1 to 0 M GdHCl compared to the native
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protein (~ 0.9 vs ~ 0.7, respectively). This unfolding and refolding of FlucIDS was analyzed as the
proportion of time that FlucIDS resides at FRET states greater than 0.5, and this was plotted as a
function of GdHCl concentration (Figure 3.5D). There was no change in the proportion of time
FlucIDS spent at FRET values greater than 0.5 at low concentrations of GdHCl (i.e., 0 – 1 M).
However, at higher concentrations of GdHCl there was a significant decrease in the percentage of
time spent at FRET values greater than 0.5, indicative of protein unfolding, until it reached a plateau
at ~ 3 M GdHCl. When FlucIDS was exposed to increasing concentrations of GdHCl the midpoint of
unfolding (U50) occurred at 1.5 M GdHCl. Interestingly, when FlucIDS was diluted from higher
concentrations of denaturant the midpoint of refolding (R50) was 1.66 M, consistent with the increased
shift in FRET efficiency observed in the histogram analysis and suggests that there may be hysteresis
in the unfolding and refolding of FlucIDS following exposure to denaturant.
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Figure 3.5: The folded state of individual Fluc IDS molecules can be monitored using smFRET. (A)
Schematic of the smFRET imaging setup. AF555/AF647-labelled FlucIDS is immobilized to a neutravidinfunctionalized coverslip surface via the biotinylated C-terminal AviTag. Immobilized protein is illuminated
by a 532 nm laser that selectively excites the AF555 donor fluorophore and the fluorescence from both AF555
and AF647 (acceptor) fluorophores is measured over time and the FRET efficiency calculated. (B)
Representative smFRET traces of individual FlucIDS molecules when incubated with increasing concentrations
of GdHCl (0 – 4 M). (C) Ridgeline plot of the FRET efficiency of FlucIDS when unfolded by increasing
concentrations of GdHCl (0 – 4 M) and during refolding following dilution out of denaturant. (D) Unfolding
and refolding of FlucIDS as a percentage of the time spent at FRET values greater than 0.5 at different
concentrations of GdHCl. Data are calculated as the total number of datapoints of Fluc IDS molecules with FRET
values greater than 0.5 divided by the total number of datapoints of FlucIDS molecules at all FRET values. Data
for panels C and D are collated from at least 76 molecules per treatment tested.
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As a proof of principle of the ability of FlucIDS to act as a sensor of protein folding, FlucIDS was
alternatively incubated in the absence or presence of 4 M GdHCl to observe the unfolding and
refolding of individual immobilized molecules in real time. Native FlucIDS (measured between 0 – 20
s) exhibited a FRET efficiency of ~ 0.7 (Figure 3.6), consistent with previous smFRET data. Upon
addition of 4 M GdHCl, the FRET efficiency rapidly dropped to ~ 0.1 for all Fluc IDS molecules
measured. Upon removal of GdHCl from the flow cell, the FRET efficiency rapidly increased to a
FRET state (~ 0.85) that was higher than that of the native protein (~ 0.7). This observation suggests
that spontaneous refolding of FlucIDS from denaturant results in the formation of a high-FRET,
compacted (and likely misfolded) conformation of FlucIDS, similar to what has been reported
previously (Imamoglu et al., 2020). Similar transitions to low-FRET and high-FRET states were
observed following a second round of injection into and removal of 4 M GdHCl from the flow cell.
Together, these data highlight that smFRET is an ideal tool to monitor the real-time conformational
changes of FlucIDS, and that FlucIDS can be used as a protein-folding sensor.

Figure 3.6: smFRET can be used to monitor conformational changes of individual Fluc IDS molecules at
millisecond resolution. Immobilized FlucIDS was incubated in imaging buffer supplemented with or without
4 M GdHCl and the FRET efficiency was measured every 200 ms. (A) Representative smFRET traces of
individual FlucIDS molecules. The addition and removal of 4 M GdHCl from the flow cell is indicated above
the traces. (B) The FRET efficiency over time for all FlucIDS molecules were collated and plotted as a heatmap
(n = 92 molecules).
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3.3.5

The mammalian Hsp40 and Hsp70 chaperones, DnaJB1 and HspA8, refold chemically
denatured FlucIDS in an ATP-dependent manner

To determine if the developed FlucIDS folding sensor could be used to study chaperone function, the
ability of the human Hsp40 class II co-chaperone, DnaJB1, and the constitutively expressed human
Hsp70 isoform, Hsc70 (HspA8), to refold chemically denatured FlucIDS was assessed. Since a native
fold is required for protein function, Fluc refolding assays were performed to assess the ability of
DnaJB1 and HspA8 to refold GdHCl-unfolded FlucIDS back to an enzymatically active state. First,
the enzymatic activity of FlucIDS was compared to a commercial source of FlucWT (Figure 3.7A).
FlucIDS was observed to be more enzymatically active (~ 1.5-fold) compared to FlucWT and thus was
deemed suitable for use in chaperone-assisted refolding assays.

When FlucIDS was diluted from denaturant into refolding buffer in the absence of chaperones (i.e.,
spontaneous refolding), only ~ 5% of the enzyme activity of the native state was obtained after 480
min (Figure 3.7B). Importantly, when FlucIDS was diluted from denaturant into refolding buffer
supplemented with a low concentration of chaperones (1 µM DnaJB1 and 2 µM HspA8) and ATP,
the refolding of FlucIDS occurred at a faster rate, with 50% refolding (denoted as t1/2) occurring after
115 min. Moreover, the total refolding yield was statistically higher than and almost double (~ 9.5%)
that of spontaneously refolded FlucIDS. Notably, when refolding of FlucIDS was performed with a
higher concentration of chaperones (5 µM DnaJB1 and 10 µM HspA8) and ATP, the refolding rate
(t1/2 = 109 min) and total yield (~ 13%) was further increased. Crucially, when ATP was omitted
from the chaperone-assisted refolding reactions, or if FlucIDS was incubated with the non-chaperone
control protein, ovalbumin, in place of chaperones, then the refolding of FlucIDS was significantly
less than that observed for spontaneously refolded FlucIDS. Thus, these data suggest that the refolding
of FlucIDS occurs in a chaperone-specific and ATP-dependent manner.
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Figure 3.7: Recombinant FlucIDS retains enzymatic activity and can be refolded by DnaJB1 and HspA8
molecular chaperones following chemical denaturation. (A) FlucWT (10 nM) or FlucIDS (10 nM) was diluted
25-fold into assay buffer (25 mM glycylglycine [pH 7.4], 0.25 mM luciferin, 100 mM KCl, 15 mM MgCl2 and
2 mM ATP) and the luminescence measured using a PolarStar Omega plate reader. Luminescence values were
normalized to the average luminescence of FlucWT. (B) FlucIDS (10 nM final concentration) in 4 M GdHCl was
diluted 100-fold into refolding buffer (50 mM HEPES-KOH [pH 7.5], 80 mM KCl, 5 mM MgCl2, 2 mM DTT
and 0.05% (v/v) Tween-20) supplemented with the indicated amounts of protein and nucleotides. Refolding
was performed at 30˚C for 480 min and aliquots were taken at various timepoints for detection of luminescence
(as described in A). All luminescence values were normalized to that of native (non-denatured) FlucIDS. A twoway ANOVA with Dunnett’s multiple-comparisons post-hoc test was performed to determine statistically
significant differences in FlucIDS refolding at different timepoints compared to that of spontaneously refolded
FlucIDS. *** and **** indicates statistical significance where p ≤ 0.001 and 0.0001, respectively. For both
panels, data shown are the mean ± standard error of the mean from three independent experiments.

3.3.6

The molecular chaperones DnaJB1 and HspA8 bind to and maintain Fluc IDS in
expanded conformations

Since smFRET can be used to monitor the conformation of individual FlucIDS proteins with temporal
resolution, we next sought to investigate how the mammalian Hsp40 isoform, DnaJB1, affects the
folded state of FlucIDS. To do so, FlucIDS was allowed to refold from denaturant in the absence or
presence of increasing concentrations of DnaJB1 and the FRET efficiency of individual molecules
was measured. When FlucIDS was allowed to refold in the absence of chaperones, it adopted a highFRET compact conformation centered at ~ 0.8 (Figure 3.8A-B), consistent with previous
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observations as part of this work. Similar results were observed when Fluc IDS was allowed to refold
in the presence of low concentrations of DnaJB1 (i.e., ≤ 2 µM); however, at higher concentrations of
DnaJB1 (e.g., 5 µM or 10 µM) the FRET distributions became broader and a second low-FRET peak
centered at ~ 0.2 – 0.3 was observed (Figure 3.8A-B). Thus, these results suggest that DnaJB1 can
stabilize conformationally expanded states of FlucIDS.

To understand mechanistically how DnaJB1 influences the conformation of Fluc IDS, individual
smFRET trajectories were fit to a Hidden Markov Model (HMM) that enables discrete FRET states
to be identified that are otherwise hidden in the noise and the transition kinetics between these states
to be quantitatively analyzed. The frequency of transition distributions were then plotted as a function
of the FRET state before (FBefore) and after (FAfter) each transition as a transition density plot (TDP,
Figure 3.8C). When FlucIDS was allowed to refold from denaturant in the absence or presence of low
concentrations of DnaJB1 (≤ 2 µM), the TDP demonstrates that the majority of transitions occur
between high-FRET values (i.e., 0.6 – 1.0). Notably, the transition distributions are symmetrically
mirrored on either side of the TDP diagonal, which indicates that the observed transitions occur
reversibly and gradually since the transition density lies close to the diagonal-axis. Similar results
were observed when FlucIDS was incubated in the presence of 5 µM DnaJB1, with the exception of
the appearance of a population of transitions that occur between lower FRET states (i.e., ~ 0.2 – 0.5).
Incubation of FlucIDS with higher concentrations of DnaJB1 (e.g., 10 µM) resulted in an increase in
the proportion of transitions that occur between these low-FRET states.
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Figure 3.8: The mammalian Hsp40 isoform, DnaJB1, shifts the conformational landscape of Fluc IDS
towards low-FRET states. Immobilized FlucIDS was unfolded with 4 M GdHCl and imaged following
removal of the denaturant with imaging buffer alone (i.e., spontaneous) or containing increasing concentrations
of DnaJB1 (1 – 10 µM). (A) Representative smFRET traces of individual Fluc IDS molecules incubated in the
absence or presence of increasing concentrations of DnaJB1 (2 – 10 µM). Data are fit with an HMM (shown
in orange). (B) FRET efficiency histograms of Fluc IDS when folded (i.e., native), following removal of 4 M
GdHCl (i.e., spontaneous) or when incubated with different concentrations of DnaJB1 (1 – 10 µM). (C)
Transition density plots (TDP) showing the initial and final FRET state of Fluc IDS molecules when refolded in
the absence (i.e., spontaneous) or presence of increasing concentrations of DnaJB1. Data in B and C are derived
and collated from the HMM fits of at least 188 individual FlucIDS molecules per treatment.

Since DnaJB1 can change the conformation of FlucIDS molecules as they refold, we next sought to
investigate how the addition of the mammalian Hsp70 isoform, HspA8, affects this process. As the
relative molar ratio of Hsp40 to Hsp70 has been shown to be important for chaperone function
(Luengo et al., 2018), the effect that changing the molar ratio between DnaJB1 and HspA8 has on
the conformation of FlucIDS was also assessed. At all molar ratios of DnaJB1: HspA8 investigated,
individual FlucIDS molecules were observed to be conformationally dynamic (Figure 3.9A).
Moreover, in the presence of DnaJB1 and HspA8, FlucIDS more often occupied low-FRET states
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compared to spontaneously refolded FlucIDS (Figure 3.9A-B). Furthermore, the addition of HspA8
increased the occurrence of an ultra-low FRET population (defined as < 0.1) that was not present
when FlucIDS was incubated with DnaJB1 alone. Notably, the appearance of this ultra-low FRET state
is reliant on the presence of DnaJB1, since HspA8 alone did not significantly affect the FRET
distribution of FlucIDS compared to that observed for spontaneously refolded FlucIDS (Supplementary
Figure 3.1).

In accord with the FRET efficiency distribution data, the TDPs of FlucIDS diluted from denaturant in
the presence of DnaJB1 and HspA8 showed that for all molar ratios of DnaJB1 to HspA8 tested,
transitions occurred either between high-FRET (0.5 – 1.0) states or low-FRET (0 – 0.5) states (Figure
3.9C). The proportion of the low-FRET transitions was smallest when FlucIDS was incubated with
DnaJB1 and HspA8 at a 1:10 molar ratio (DnaJB1: HspA8) but increased in density as the relative
levels of DnaJB1 increased (i.e., at molar ratios of 1:5 – 1:2 DnaJB1: HspA8) (Figure 3.9C). There
were no significant difference in the TDPs between the 1:2 and 1:1 (DnaJB1: HspA8) molar ratios
tested.
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Figure 3.9: Mammalian Hsp40 and Hsp70 chaperones stabilize and promote expanded conformations
of FlucIDS. Immobilized FlucIDS was unfolded with 4 M GdHCl and imaged following removal of denaturant
in the presence of increasing molar ratios of DnaJB1: HspA8 (1:10 – 1:1). For all conditions, the concentration
of HspA8 was 10 µM. ATP (2 mM) was present for all conditions. (A) Representative smFRET traces of
individual FlucIDS molecules when incubated with varying molar ratios of DnaJB1: HspA8 (1:10 – 1:1). Data
were fit with an HMM (shown in orange). (B) FRET efficiency histograms of FlucIDS when folded (i.e., native),
following removal of 4 M GdHCl without chaperone (i.e., spontaneous) or when incubated with different
molar ratios of DnaJB1: HspA8 (1:10 – 1:1). (C) Transition density plots (TDP) showing the initial and final
FRET state of FlucIDS transitions when refolded in the presence of varying molar ratios of DnaJB1: HspA8
(1:10 – 1:1 molar ratio). Data were derived and collated from the HMM fits of at least 242 individual Fluc IDS
molecules per treatment.

The smFRET data enabled further investigation into the effect of molecular chaperones on the
conformation of FlucIDS. Since the histogram and TDP analyses of FlucIDS diluted from denaturant in
the presence of molecular chaperones demonstrates an increase in the proportion of molecules in the
low-FRET (i.e., < 0.5) state compared to when chaperones are not present, a FRET value of 0.5 was
chosen to filter the FRET data. When allowed to spontaneously refold (i.e., in the absence of
chaperones), FlucIDS resided at FRET values less than 0.5 for 14.3% of the total imaging time (Figure
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3.10A). However, FlucIDS spent more time at low-FRET states when incubated with increasing
DnaJB1 concentrations, reaching a maximum of 45% of the total time at 10 µM DnaJB1 (Figure
3.10A). Interestingly, the addition of HspA8 and ATP significantly increased the proportion of time
that FlucIDS resided at low-FRET states compared to when it was incubated with DnaJB1 alone.
Notably, the amount of time that FlucIDS resided at low-FRET states increased dramatically at low
molar ratios of DnaJB1: HspA8 (1:10 - 1:5) before reaching a plateau at a 1:2 molar ratio of DnaJB1:
HspA8 (i.e., final concentrations of 5 µM and 10 µM for DnaJB1 and HspA8, respectively).
Additionally, the number of molecules that exhibited transitions to ultra-low (< 0.1) or low-FRET
states (< 0.5), indicative of HspA8 or DnaJB1-mediated transitions, respectively, was determined
(Supplementary Figure 3.2A). A higher proportion of molecules exhibited transitions to low-FRET
states (< 0.5) in the presence of increasing concentrations of DnaJB1 alone or when supplemented
with HspA8. Interestingly, the proportion of molecules that transitioned to ultra-low FRET states did
not significantly change with increasing concentrations of DnaJB1 (~ 5% maximum). Conversely,
co-incubation with both DnaJB1 and HspA8 resulted in an increased proportion of FlucIDS molecules
that visited the ultra-low FRET state (~ 20%) relative to comparable concentrations of DnaJB1 when
HspA8 was not present. Together, these results suggest that binding of FlucIDS by HspA8 is
predominantly responsible for the ultra-low FRET state observed. Notably, the majority of transitions
to low-FRET states (for DnaJB1 alone) or ultra-low FRET states (when supplemented with HspA8)
originated from low-FRET populations (~ 0 – 0.5); however, some transitions were also observed to
occur from high-FRET states (~ 0.5 – 1) (Supplementary Figure 3.2B).

While TDPs are useful for visualizing the transition distributions of molecules, the HMM fits to the
data can be further interrogated to extract the kinetics, direction and probable occurrence of particular
FRET transitions. Kinetically, there are two possible explanations for the increased occupancy of
FlucIDS at low-FRET states when incubated in the presence of molecular chaperones; (i) low-FRET
states are longer-lived than high-FRET states; or (ii) transitions that result in the accumulation of lowFRET states of FlucIDS are favored. To interrogate this further, the probable occurrence of each
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possible type of FRET transition and its corresponding residence time was calculated.
Complementary to the TDP analysis, the transition direction enables the investigation of transitions
of interest and is denoted generally as TBefore-After, whereby ‘before’ refers to the FRET state prior to
a transition (i.e., FBefore) and ‘after’ refers to the FRET state after the transition (i.e., FAfter). For
simplicity, FRET data were filtered according to whether FBefore or FAfter was greater than 0.5 (high)
or less

than 0.5 (low) and thus

four

different transition directions

are possible:

Thigh-high, Thigh-low, Tlow-low and Tlow-high. Finally, the occurrence of each transition direction were
normalized to the total number of transitions measured and the corresponding mean residence time
(defined as the time that a molecule resides at FBefore prior to transition to FAfter, denoted as Residence)
for each transition class was calculated. An example of such a transition direction analysis is shown
in Figure 3.10B, whereby both FBefore and FAfter are greater than 0.5 and FBefore is present for 57.8 s.
Thus, this particular transition direction is denoted as Thigh-high with a Residence = 57.8 s.

When FlucIDS was diluted from denaturant in the absence of chaperone, Thigh-high transitions were most
commonly observed (81.1% of all transitions) while Thigh-low, Tlow-high and Tlow-low transitions
represented a smaller proportion of the total transitions (7.5%, 7.4% and 4.1%, respectively) (Figure
3.10C). When FlucIDS was diluted from denaturant in the presence of increasing concentrations of
DnaJB1, a steady decrease in the occurrence of Thigh-high transitions were observed. Conversely, the
occurrence of Tlow-low transitions was observed to increase as a function of DnaJB1 concentration.
Interestingly, the addition of HspA8 and ATP resulted in a more pronounced decrease in the
occurrence of Thigh-high transitions and corresponding increase in Tlow-low transitions compared to when
only DnaJB1 was present. Notably, the relative occurrence of Thigh-low and Tlow-high transitions was the
same regardless of whether any of the chaperones were present.

The data were further interrogated to determine whether molecular chaperones affect the transition
direction of FlucIDS molecules dependent on their current FRET state (i.e., FBefore), since this can
provide evidence that chaperones preferentially act on a subset of FlucIDS conformations. To do so,
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the probability that a FlucIDS molecule will transition from a low-FRET state (< 0.5) to a high-FRET
state (> 0.5) was calculated as the occurrence of Tlow-high transitions divided by the summed
occurrence of Tlow-low and Tlow-high transitions and defined as TProblow-high (Supplementary Figure 3.2C).
When FlucIDS was refolded in the presence of DnaJB1, the TProblow-high decreased with increasing
concentrations of DnaJB1 and the data fit well to a one-phase exponential decay (Supplementary
Figure 3.2C). Interestingly, the addition of HspA8 and ATP during FlucIDS refolding resulted in a
much steeper decrease in TProblow-high compared to DnaJB1 alone, indicating that the combination of
DnaJB1 and HspA8 is most productive in stabilizing expanded conformations of FlucIDS.
Next, the Residence for each transition type was plotted as a function of DnaJB1 concentration in the
absence or presence of HspA8 (Figure 3.10D). While not statistically significant, there was a trend
towards higher Residence values for Tlow-high transitions when FlucIDS was incubated in the presence of
increasing concentrations of DnaJB1 (Figure 3.10D, Supplementary Figure 3.2D). There was a
significant increase in Residence when FlucIDS was incubated with high molar ratios of DnaJB1: HspA8
(1:2 – 1:1) compared to in the absence of chaperones (Supplementary Figure 3.2E); however, no
statistical difference was observed between FlucIDS that was incubated with DnaJB1 alone or
supplemented with HspA8 (Figure 3.10D). Additionally, statistically higher Residence values were also
observed for Thigh-high transitions when incubated in the presence of high concentrations of DnaJB1
alone (i.e., 10 µM) compared to in the absence of chaperone, lower concentrations of DnaJB1 or
when supplemented with HspA8 and ATP (Figure 3.10D, Supplementary Figure 3.2D). There was
no discernible trend observed in the Residence values for Tlow-low and Thigh-low transitions in the absence
or presence of molecular chaperones.
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Figure 3.10: Kinetic analyses of smFRET trajectories reveal that molecular chaperones stabilize
expanded conformations of FlucIDS. smFRET trajectories of FlucIDS molecules when refolded in the presence
of increasing concentrations of DnaJB1 (1 – 10 µM) alone (black) or supplemented with HspA8 (10 µM) and
ATP (2 mM) (purple) were analyzed using an HMM and key kinetic details determined. (A) The relative
proportion of time that FlucIDS resided at low-FRET states (i.e., < 0.5). (B) Example smFRET trace with HMM
fit (shown in orange) to identify discrete FRET states and generate kinetic data. FBefore denotes the initial FRET
state immediately prior to a transition to a different FRET state (denoted as FAfter). The residence refers to the
total time a discrete FRET state resides in FBefore before transitioning to FAfter. An example of a transition and
its designation (e.g., Thigh-high, blue) is shown. (C) The relative probability of each transition class as a function
of DnaJB1 concentration. (D) The residence time of each transition class is presented as the mean ± standard
error of the mean. A two-way ANOVA with Šídák multiple-comparisons post-hoc test was performed to
determine statistically significant differences in residence times at each condition (i.e., DnaJB1 concentration)
between treatment groups. ** indicates statistical significance of p ≤ 0.01. ns indicates no significant difference
(p > 0.05). Data for all panels are derived from at least 188 individual FlucIDS molecules per treatment.
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Further smFRET experiments were performed to interrogate how the ATP hydrolysis cycle of HspA8
contributes to the conformational expansion of FlucIDS (Figure 3.11). As described above, refolding
of FlucIDS with DnaJB1, HspA8 and ATP (at the 1:2 molar ratio of DnaJB1: HspA8 tested previously),
resulted in the appearance of a low-FRET population and a broad TDP profile that spanned all
possible FRET values (i.e., 0 – 1 FRET) (Figure 3.11A-C). When FlucIDS was instead refolded in the
presence of chaperones and a non-hydrolysable ATP analog, AMP-PNP, both the FRET distribution
and TDPs were similar to those acquired when FlucIDS was incubated in the absence of chaperones
(Figure 3.11A-C). Similar results were observed when FlucIDS refolding occurred in the presence of
chaperones and ADP. Crucially, when FlucIDS was refolded in the presence of ATP and a nonchaperone control protein, ovalbumin, the FRET efficiency histograms and TDPs were comparable
to those acquired in the absence of chaperones (Figure 3.11A-C). Collectively, these results
demonstrate that ATP hydrolysis by HspA8 is predominantly responsible for the generation of lowand ultra-low FRET species observed during the chaperone-assisted refolding of FlucIDS.

For all conditions tested, the FRET distributions and key kinetic information derived from the HMM
analysis, such as the transition probability and the Residence for each transition class, were collated and
presented as summarized heatmaps (Figure 3.11D). Consistent with the histogram analysis, FlucIDS
only occupied low-FRET states (i.e., < 0.5) in the presence of DnaJB1, HspA8 and ATP (52% of total
time), and not when AMP-PNP (18%), or ADP (24%) replaced ATP, nor when ovalbumin was
substituted in place of the molecular chaperones (21%). Furthermore, the probable occurrence of each
class of transition direction (denoted by the size of each arrow within the heatmap) was consistent
between all treatments tested, with the exception that FlucIDS experienced significantly more Tlow-low
and less Thigh-high transitions when incubated with DnaJB1, HspA8 and ATP (Figure 3.11D). The
Residence for each transition class (denoted by the values adjacent to each corresponding arrow within
the heatmap) were also similar between the different treatments tested, with the exception that FlucIDS
had statistically longer Residence times for Tlow-low and Tlow-high transitions when incubated in the
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presence of molecular chaperones and ATP compared to when ATP was substituted for AMP-PNP
or incubated in the absence of chaperone (Figure 3.11D, Supplementary Figure 3.2F).

Figure 3.11: The conformational expansion of Fluc IDS by HspA8 is dependent on ATP hydrolysis.
Immobilized FlucIDS was unfolded with 4 M GdHCl and imaged following removal of denaturant in the
presence of either a non-chaperone control protein, ovalbumin (15 µM), or DnaJB1 (5 µM) and HspA8 (10
µM) with 2 mM of nucleotide (either ATP, ADP or AMP-PNP). (A) Representative smFRET traces of
individual FlucIDS molecules when incubated in the presence of ovalbumin or chaperones in the presence of
ATP, ADP or AMP-PNP. Data were fit with an HMM (shown in orange). (B) FRET efficiency histograms of
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FlucIDS when folded (i.e., native), following removal of 4 M GdHCl without chaperone (i.e., spontaneous),
with ovalbumin or molecular chaperones and the indicated nucleotide. (C) Transition density plots (TDP)
showing the initial and final FRET state of FlucIDS transitions for each treatment. (D) A summary of the kinetic
data for each dataset represented as annotated heatmaps. For simplicity, the kinetic data were filtered for FBefore
values less than or greater than 0.5 FRET. The color in the heatmap denotes the percentage of time that FlucIDS
resides above or below 0.5 FRET. The direction of each arrow refers to the transition direction, whereby the
origin of each arrow denotes FBefore and the arrowhead denotes FAfter. The size of each arrow is directly
proportional to the normalized occurrence of those particular transitions. The mean Residence for each transition
class is denoted adjacent to its respective arrow. Data for panels B - D are derived and collated from the HMM
fits of at least 242 individual FlucIDS molecules per treatment.

3.3.7

The bacterial Hsp70 system can resolve misfolded FlucIDS species and efficiently refold
them

It is well established that the bacterial Hsp70 system (e.g., DnaK, DnaJ and GrpE, denoted as KJE)
can efficiently refold chemically denatured Fluc (Szabo et al., 1994; Wisén et al., 2008; Bonomo et
al., 2010; Luengo et al., 2018; Imamoglu et al., 2020). To determine if the mechanism of chaperone
function is conserved between bacterial and mammalian systems, we sought to characterize the
refolding of FlucIDS by the bacterial Hsp70 system using refolding assays and the FlucIDS folding
sensor. When FlucIDS was diluted from denaturant into refolding buffer in the absence of chaperones
(i.e., spontaneous refolding), the maximum yield of refolded (native) FlucIDS was only ~ 3.6% (Figure
3.12A). FlucIDS was rapidly and efficiently refolded by the KJE system, with 50% refolding (denoted
as t1/2) occurring after 17.1 min and activity reaching 183% of native (non-denatured) FlucIDS after
90 min (suggesting that some non-native FlucIDS is present in the native FlucIDS sample). Notably, the
bacterial Hsp70 system was also able to rapidly and efficiently refold Fluc IDS that had been allowed
to spontaneously refold. Interestingly, when the nucleotide-exchange factor (NEF) GrpE was omitted
from the refolding reaction the rate and total yield of refolding (10.7% after 90 min) was significantly
less compared to when GrpE was present; however, more refolding still occurred when only DnaK
and DnaJ were present compared to when FlucIDS was allowed to spontaneously refold. Collectively,
these results demonstrate that the bacterial Hsp70 system can efficiently fold Fluc IDS to its native
state, and that GrpE is essential for efficient refolding.
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Interestingly, the amount of spontaneous refolding of FlucIDS (3.6% of the activity of the native [nondenatured] state) was much lower than previously reported for the spontaneous refolding of Fluc WT
(e.g., 58.2% by Imamoglu et al., 2020). To determine if the low spontaneous refolding yield of FlucIDS
is due to the introduced mutations in this isoform of the protein (i.e., C-terminal AviTag and cysteine
substitutions), the refolding experiments were repeated using both FlucIDS and FlucWT (Figure 3.12B).
Additionally, refolding was performed with lower concentrations of ATP as this slows refolding rates
and thus augments differences in the refolding kinetics between these two proteins. Indeed, under
these conditions significantly more FlucWT was able to spontaneously refold to the native state
(29.6%) compared to FlucIDS (2.9%). As expected, dilution of Fluc from denaturant in the presence
of the bacterial Hsp70 system and 2 mM ATP resulted in the efficient refolding of both FlucWT and
FlucIDS, although the rate of refolding was ~ 4-fold faster for FlucWT (t1/2 = 15.9 min) compared to
FlucIDS (t1/2 = 66.0 min). As expected, the rate of chaperone-assisted refolding of FlucIDS was
significantly slower at lower concentrations of ATP (2 mM) compared to when higher concentrations
(5 mM) were present (compare Figure 3.12A and B).
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Figure 3.12: The bacterial Hsp70 system can efficiently refold Fluc IDS. (A) FlucIDS in 4 M GdHCl was
diluted 100-fold (10 nM final concentration) into refolding buffer alone (i.e., spontaneous) or buffer
supplemented with molecular chaperones or the non-chaperone control protein, ovalbumin (15 µM).
Chaperone-assisted refolding was performed with DnaK (3 µM) and DnaJ (1 µM) only (+ KJ) or in
combination with GrpE (1.5 µM) (+ KJE). Rescue of misfolded FlucIDS was performed by 10-fold dilution of
spontaneously refolded FlucIDS (1 nM final concentration) into refolding buffer containing DnaK (3 µM), DnaJ
(1 µM) and GrpE (1.5 µM) (spontaneous + KJE). All treatments contained 5 mM ATP. (B) Refolding of either
FlucIDS or FlucWT (10 nM final concentration) in the absence or presence of the indicated concentration of
chaperones described in panel A. All treatments contained 2 mM ATP. For both panels, refolding was
performed at 25˚C and aliquots were taken at various timepoints for detection of luminescence. All
luminescence values were normalized to that of native (non-denatured) FlucIDS or FlucWT samples. For both
panels, data shown are the mean ± standard error of the mean from three independent experiments.
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Since it was confirmed that the bacterial Hsp70 system can efficiently refold FlucIDS, smFRET
experiments were performed to monitor the conformation of individual FlucIDS molecules during
chaperone-assisted refolding by this system (Figure 3.13). As described above, FlucIDS diluted from
denaturant adopted a high-FRET state, indicative of a collapsed misfolded structure (Figure 3.13AB). Consistent with results acquired with the mammalian chaperones DnaJB1 and HspA8, dilution of
FlucIDS from denaturant into buffer containing DnaK, DnaJ and ATP (denoted as the KJ system)
resulted in the appearance of an ultra-low FRET state (~ 0.05) (Figure 3.13B), with a high proportion
of FlucIDS molecules transitioning to or from this ultra-low FRET state (< 0.1, ~ 28%, Supplementary
Figure 3.3A). Moreover, a large proportion of FlucIDS molecules (52.1%) were characterized by
significant FRET transitions to or from FRET states below 0.3 (Figure 3.13A, additional examples
shown in Supplementary Figure 3.4A, Supplementary Figure 3.3A-B), which is represented by the
increased transition density at low-FRET regimes away from the diagonal in the TDP (Figure 3.13C).
Furthermore, transitions from low-FRET states were long lived in the presence of the KJ chaperone
system (Tlow-low = 13.1 s and Tlow-high = 10.9 s) and indeed, low-FRET to high-FRET transitions were
statistically longer in duration compared to in the absence of chaperone (Tlow-high = 7.4 s) (Figure
3.13D, Supplementary Figure 3.3C). Collectively, these results suggest that the ultra-low FRET
population observed in this treatment constitutes a KJ-bound conformation of FlucIDS.

Next, the role of nucleotide exchange was investigated by supplementing the reaction with GrpE (i.e.,
the KJE system). Notably, the ultra-low FRET population observed in the presence of KJ alone was
not present when GrpE was present, with the majority of FlucIDS molecules occupying high-FRET
states (~ 0.8 – 0.9) in the presence of KJE comparable to that of spontaneously refolded FlucIDS
(Figure 3.13B). Interestingly, many FlucIDS molecules exhibited multiple transitions between high
and ultra-low FRET states (Figure 3.13A, additional examples shown in Supplementary Figure 3.4B).
While not as dramatic as that observed for FlucIDS molecules incubated with KJ alone, there was a
slight increase in the transition density away from the diagonal of the TDP, particularly at low initial
and final FRET values, when KJE was present (Figure 3.13C). Moreover, a significant proportion of
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transitions occurred between high initial and final FRET values (~ 0.7 – 0.9), similar to that observed
when FlucIDS was refolded in the absence of chaperones. Relative to when FlucIDS was incubated with
KJ alone, the addition of GrpE resulted in a statistically significant reduction in the residence times
for low-FRET states, particularly those that immediately preceded a jump to a high-FRET state (Tlowlow

= 9.8 s and Tlow-high = 6.7 s) (Figure 3.13D, Supplementary Figure 3.3C). Incubation of FlucIDS

with either KJ or KJE early during refolding resulted in an increased probability of Tlow-low and Tlowhigh

transitions, and FlucIDS molecules were kinetically less likely to transition away from low-FRET

states compared to when chaperones were not present, consistent with the results observed with
DnaJB1 and HspA8 (Supplementary Figure 3.3D-E).

Finally, since refolding of FlucIDS by KJE was shown to be complete after 90 min, smFRET data was
acquired 90 min after FlucIDS had been initially exposed to GrpE. Interestingly, the FRET efficiency
histogram was shifted to a more native-like distribution (major peak at ~ 0.7) with a corresponding
decrease in the population of FlucIDS molecules exhibiting high-FRET distributions (~ 0.8 – 0.9)
typical of a collapsed, misfolded state (Figure 3.13B). The individual FRET trajectories and TDPs
also showed that these FlucIDS molecules exhibited FRET values ranging from ~ 0.6 – 0.9, with no
significant deviations from the TDP diagonal observed (Figure 3.13A and C, additional examples in
Supplementary Figure 3.4C).
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Figure 3.13: Refolding of FlucIDS by the bacterial Hsp70 system can be monitored in real time using
smFRET. FlucIDS was diluted from denaturant in the presence of DnaK (3 µM), DnaJ (1 µM) and ATP (5
mM) (+ KJ). In the same flow cell channel, KJ-bound FlucIDS was then supplemented with GrpE (1.5 µM) to
observe refolding with the full bacterial Hsp70 refolding system. Data were acquired for the first 30 min
following addition of GrpE (+ KJE (0 – 30 min)) and after 90 min of refolding (+ KJE (90 – 120 min)) (A)
Representative smFRET traces of individual Fluc IDS molecules when incubated in the absence (i.e.,
spontaneous) or presence of the indicated chaperones. Data are fit with an HMM (shown in orange). (B) FRET
efficiency histograms of FlucIDS when folded (i.e., native), and following removal of 4 M GdHCl without (i.e.,
spontaneous) or with the indicated chaperone combinations. (C) Transition density plots (TDP) showing the
initial and final FRET state of FlucIDS transitions when refolded in the absence or presence of the indicated
combinations of molecular chaperones. (D) A summary of the kinetic data for each dataset represented as
annotated heatmaps. For simplicity, the kinetic data were filtered for FBefore values less than or greater than 0.5
FRET. The color of the heatmap denotes the percentage of time that Fluc IDS resides above or below 0.5 FRET.
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The direction of each arrow refers to the transition direction, whereby the origin of each arrow denotes FBefore
and the arrowhead denotes FAfter. The size of each arrow is directly proportional to the normalized occurrence
of those particular transitions. The mean Residence for each transition class is denoted adjacent to its respective
arrow. Data for panels B - D were derived and collated from the HMM fits of at least 242 individual Fluc IDS
molecules per treatment.
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3.4

Discussion

Single-molecule microscopy is becoming increasingly popular as a tool to better understand the
mechanistic details of how molecular chaperones prevent protein aggregation and assist in protein
folding. However, thus far there have been limited attempts to observe how molecular chaperones,
such as Hsp40 and Hsp70, affect the folded state of a client protein by monitoring individual
molecules through time. Consequently, some of the key kinetic and mechanistic details underlying
chaperone function (e.g., on/off rates, conformational transition frequencies etc.) remain to be
resolved. The work in this chapter aimed to address this gap in knowledge by designing a firefly
luciferase (Fluc) construct that can be specifically immobilized to a coverslip surface such that its
folded state can be monitored in real time using a combination of TIRF microscopy and smFRET.
The data presented in this chapter demonstrate that both mammalian and bacterial molecular
chaperones promote transitions to, and stabilize, low-FRET expanded conformations of Fluc.
Moreover, the data suggest that accelerated release of Hsp70 from Fluc (e.g., by addition of a NEF)
results in efficient protein folding.

3.4.1

Soluble expression, purification and biotinylation of FlucIDS

To generate a protein-folding sensor for the study of molecular chaperones, FlucWT was first modified
to enable site-specific labelling with two fluorophores (for smFRET) and immobilization to a
coverslip surface. With this in mind, a cysteine variant of Fluc WT, in which the two native cysteine
residues were substituted with alanine’s (C81A and C391A) and two cysteine residues were
introduced (K141C and K491C) for fluorophore labelling (denoted FlucIDS), was employed.
Unfortunately, however, GST-tagged FlucIDS was not expressed in a soluble form. Since GST-tagged
FlucWT was observed to be highly expressed in the soluble lysate, it appears likely that the introduced
cysteine mutations are responsible for the insolubility of FlucIDS. Indeed, this result is consistent with
the finding that individual or combined mutation of cysteine residues in the Fluc protein from Luciola
mingrelica results in reduced expression levels in E. coli (Modestova et al., 2011). Despite the historic
use of GST as a solubility tag to enhance or rescue the soluble expression of aggregation-prone
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proteins (e.g., Smith and Johnson, 1988; Kim and Lee, 2008), the fusion of GST to FlucIDS did not
assist to maintain it in a soluble form. More recently, GST has been proposed to be a relatively poor
solubility tag for some proteins when compared to other options (e.g., SUMO, MBP, NusA, Trx) and
that this leads to fusion proteins localizing into inclusion bodies (Hammarström et al., 2002, 2006;
Dyson et al., 2004; Marblestone et al., 2006). This may be a side-effect of the homo-dimerization of
GST molecules that can bring together aggregation-prone fusion proteins. The results of this work
show that replacement of the GST tag for a SUMO solubility tag facilitated the soluble expression of
FlucIDS (with a C-terminal AviTag) (Costa et al., 2014).

Co-expression of SUMO-tagged FlucIDS (with C-terminal AviTag) with biotin ligase (BirA) resulted
in the successful biotinylation of the recombinant protein in vivo, as confirmed by western blotting.
High in vivo biotinylation efficiencies (> 90%) of recombinant protein have been observed previously
(Ashraf et al., 2004; Li et al., 2012); however, subsequent mass spectrometry or streptavidin gel-shift
assays (as described by Fairhead and Howarth, 2015) would be required to quantify the degree of
FlucIDS biotinylation. Regardless, the fluorescently labelled FlucIDS could be immobilized to a
neutravidin-functionalized coverslip at a sufficient density.

The large-scale expression and purification of SUMO-tagged FlucIDS undertaken as part of this work
generated a considerable amount of highly pure recombinant protein. Interestingly, a very small
amount of a contaminant protein, which was confirmed via mass spectrometry to be BirA, appeared
to form a stable interaction with FlucIDS since it co-purified after multiple IMAC and IEX
chromatography steps. Interestingly, IEX chromatography was most effective at purifying BirA from
FlucIDS, with BirA predominantly eluting in the flow-through fractions. It is possible that the
transition from a high-salt solution (required for IMAC) to a low-salt environment (required for IEX
chromatography) favors the dissociation of the suspected BirA-FlucIDS complex, which suggests that
the interaction between the two proteins could be hydrophobic in nature (McCue, 2009; Jiang et al.,
2015). In any case, since the final BirA contaminant represented such a minor proportion of the total
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protein content following purification (~ 2%) and BirA does not have an AviTag for immobilization
to a coverslip surface, further purification steps were deemed to not be necessary.

3.4.2

Characterization of the FlucIDS folding sensor using smFRET

This work demonstrates that biotinylated and purified FlucIDS can be employed in smFRET
experiments aimed at characterizing the conformation of a client protein in the absence or presence
of chemical denaturants or molecular chaperones. Interestingly, although native state Fluc IDS
populated a single FRET population, it was observed that individual FlucIDS molecules exhibited
significant and frequent fluctuations in FRET efficiency, which is characteristic of conformational
dynamicity. The observed conformational heterogeneity likely stems from the position in which the
donor and acceptor fluorophores are conjugated to FlucIDS - these fluorophores are positioned on the
N- and C-terminal domains that span either side of the active site cleft. Indeed, it is known that the
N- and C-terminal domains of Fluc are connected via a long and flexible linker, which is not resolved
in the crystal structure and is thought to enable the significant structural rearrangements that occur
during enzyme catalysis (Conti et al., 1996) (Figure 3.1). Furthermore, cross-linking studies have
shown that significant rotation of the C-terminal domain occurs even in the absence of ATP or
substrate (i.e., luciferin) (Branchini et al., 2011; Sundlov et al., 2012), which can result in movements
of ~ 1.5 nm between the cysteine residues employed in this work. Such conformational changes would
correspond to a theoretical range of apparent FRET efficiencies between 0.48 – 0.9, consistent with
the observed results.

Crucially, the folding sensor was able to report on the unfolding of the FlucIDS protein when incubated
with chemical denaturant (via a reduced FRET efficiency) and also on the refolding of FlucIDS
following the removal of denaturant (via an increased FRET efficiency). As expected, increasing
concentrations of denaturant resulted in the conformational expansion of FlucIDS (as indicated by a
reduced FRET efficiency), consistent with the transition to a GdHCl-induced random-coil structure
that has been observed in other single-molecule unfolding experiments (Schuler et al., 2002;
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Kuzmenkina et al., 2005; Tezuka-Kawakami et al., 2006; Rosenkranz et al., 2011). Notably, dilution
of FlucIDS out of denaturant resulted in it having a FRET efficiency that was higher than that of the
native state. These data suggest that upon refolding, FlucIDS adopts a high-FRET, compact misfolded
state. This misfolded state has been observed previously and is thought to occur as a result of the
formation of non-native contacts between residues in the N-terminal domain and/or residues in the
C-terminal domain (Mashaghi et al., 2014; Scholl et al., 2014; Imamoglu et al., 2020). Specifically,
recent single-molecule and hydrogen deuterium exchange (HDX) experiments suggest that GdHClinduced misfolding occurs specifically at the interface between the two subdomains within the
N-terminal domain (Imamoglu et al., 2020). Data from this work and others have shown that the
misfolded FlucIDS conformation is stable, enzymatically inactive and persists for many hours unless
acted on by chaperones (Sharma et al., 2010; Scholl et al., 2014; Imamoglu et al., 2020). Furthermore,
this work shows that the unfolding, refolding and formation of misfolded states by individual FlucIDS
molecules can be observed temporally using the single-molecule approach outlined here.

3.4.3

Refolding of FlucIDS by molecular chaperones

The ability of DnaJB1 and HspA8 to act in concert to refold thermally denatured or aggregated Fluc
has been well established (Minami et al., 1996, 1999; Schumacher et al., 1996; Rampelt et al., 2012;
Nillegoda, Kirstein, et al., 2015). The results of the work presented in this chapter demonstrate that
DnaJB1 and HspA8 are also able to refold chemically denatured Fluc IDS, albeit with a low rate of
refolding and total yield. There are conflicting reports in the literature regarding the ability of DnaJB1
and HspA8 to refold chemically denatured Fluc. For example, DnaJB1 and HspA8 have been
observed to efficiently refold chemically denatured Fluc (e.g., 50% refolding in ~ 45 min and a
refolding yield in excess of 75%) (Freeman et al., 1995; Faust et al., 2020). Alternatively, it has been
suggested that DnaJB1 and HspA8 is relatively inefficient with regard to refolding chemically
denatured Fluc, with refolding yields of ~ 10 - 15% (Terada et al., 1997, 2000), which are consistent
with that observed in this study. The lower-than-expected refolding yield observed by DnaJB1 and
HspA8 in this work could be due to inefficient loading of HspA8 onto misfolded Fluc IDS species,
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which is circumvented by the faster association rates at high concentrations of HspA8. Regardless,
the high concentrations of DnaJB1 and HspA8 employed in this work, which are within a
physiologically relevant range (Terada et al., 1997; Nollen et al., 2000), were able to promote the
refolding of FlucIDS and were thus employed in subsequent smFRET experiments.

In comparison to the mammalian DnaJB1 and HspA8 refolding system, the bacterial Hsp70
chaperone system (i.e., DnaJ, DnaK and GrpE) was able to refold FlucIDS more efficiently and at a
much faster rate. This is consistent with work demonstrating that the bacterial Hsp70 system can
efficiently refold chemically denatured Fluc (Szabo et al., 1994; Wisén et al., 2008; Bonomo et al.,
2010; Luengo et al., 2018; Imamoglu et al., 2020). Of note, the bacterial Hsp70 system was also
found to be efficient in refolding misfolded FlucIDS back to its native state, consistent with these
molecular chaperones rescuing kinetically trapped proteins and shifting the equilibrium towards the
native state (Sharma et al., 2010; Natalello et al., 2013; Imamoglu et al., 2020). DnaJ and DnaK were
found to have a limited capacity to refold FlucIDS to the native state in the absence of the NEF, GrpE,
likely due to the intrinsically slow ADP dissociation rate of DnaK (0.023 – 0.0020 s-1) (Packschies et
al., 1997; Russell et al., 1998; Brehmer et al., 2001), which is rate limiting in the presence of DnaJ
and a client. Consequently, continual accumulation of the ADP-bound form of DnaK results in stable
associations with the client protein, such that refolding cannot proceed efficiently. Addition of GrpE
dramatically enhances (up to 5,000-fold) the release of ADP from DnaK (Packschies et al., 1997),
resulting in concomitant binding of ATP and release of the client protein by DnaK. Thus, repeated
cycles of client binding and release by Hsp70 is favored, enabling the misfolded protein to have many
attempts to refold to the native state.

In contrast to the bacterial Hsp70 system, in which the presence of a NEF is essential for efficient
refolding, no NEF was present in the mammalian refolding reactions performed in this work. While
mammalian NEFs (e.g., Hsp110 or Apg2) have been shown to enhance the rate and efficiency of Fluc
refolding by various human Hsp70 systems (e.g., DnaJB1, DnaJA2, HspA1 or HspA8), the presence
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of a NEF is not essential for efficient Fluc refolding (Terada et al., 1997; Tzankov et al., 2008; Yu et
al., 2015). This can be rationalized by the much faster intrinsic ADP dissociation rates of mammalian
Hsp70 isoforms relative to their Hsp70 homolog, DnaK. For example, the dissociation of ADP from
HspA8 can occur as quickly as 0.24 s-1 or 0.045 s-1 in the absence or presence of inorganic phosphate
respectively (Brehmer et al., 2001; Gassler et al., 2001), which is much faster than the rate of DnaJB1assisted ATP hydrolysis (0.008 s-1) (Gassler et al., 2001). As such, the addition of a NEF, which can
increase the ADP dissociation rate of HspA8 ~ 700 fold (Gassler et al., 2001), would not result in a
significant increase in refolding efficiency since the rate of ATP hydrolysis and initial client binding
by HspA8 remains rate-limiting. Thus, the low refolding yields by DnaJB1 and HspA8 observed in
this work, relative to the bacterial Hsp70 system, is not directly due to the absence of a mammalian
NEF.

3.4.4

The effect of the mammalian Hsp40 chaperone, DnaJB1, on the conformation of FlucIDS

The smFRET experiments demonstrate that the interaction of DnaJB1 with Fluc IDS results in the
conformational expansion of individual FlucIDS proteins, an observation consistent with the Hsp40mediated unfolding of client proteins (Kellner et al., 2014). Interestingly, kinetic analysis of
individual FRET trajectories revealed that a significant number of FRET transitions that occur in the
presence of DnaJB1 are constrained at a FRET efficiency below 0.5. This suggests that DnaJB1bound FlucIDS exists in an unfolded, non-native and expanded state, but remains conformationally
dynamic. Such conformational dynamicity and/or destabilization of a Hsp40-bound client protein has
been observed previously, whereby HDX experiments demonstrated that amide hydrogens exchange
more rapidly upon binding of the client by Hsp40 (Rodriguez et al., 2008). Furthermore, a recent
study found that the client binding site on DnaJB1 spans across the C-terminal subdomain of both
DnaJB1 homodimers (Jiang et al., 2019). Spatial separation of the client across both Hsp40
homodimers results in the stabilization of expanded non-native conformations of the client, prevents
spontaneous collapse and may dissolve secondary and tertiary structural elements of the bound client
(Jiang et al., 2019), consistent with the results of this work.
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It remains to be established whether DnaJB1 selectively binds to a subset of already expanded
conformations of FlucIDS (e.g., a conformational selection model), or if binding by DnaJB1 remodels
the conformation of the client protein to expanded states (e.g., an induced fit model) (Goloubinoff et
al., 2007; Rodriguez et al., 2008; Sharma et al., 2010; Mayer, 2013; Clerico et al., 2015; Sekhar et
al., 2018). Since the residence times of different FRET states and transitions between high- and lowFRET states (e.g., Thigh-low or Tlow-high) does not significantly alter with DnaJB1 concentration, these
data support a model in which DnaJB1 scans non-native states and binds to exposed hydrophobic
regions typically exposed in already expanded client conformations (Rüdiger et al., 2001). However,
it remains possible that DnaJB1 binding can remodel the conformational landscape of its clients, since
the observation of chaperone-mediated transitions (which are likely to be rare) may be masked by
non-chaperone mediated events in these experiments.

Hsp70 is known to preferentially bind unfolded or conformationally expanded client proteins (Sekhar
et al., 2018); thus, the observed conformational expansion and dynamicity of FlucIDS molecules in
the presence of DnaJB1 likely represents a mechanism by which Hsp40 chaperones prime the client
for loading onto Hsp70. Indeed, capture of a client by Hsp40 enhances its binding by Hsp70 via an
increased affinity for typical binding motifs or by exposing suboptimal binding sites typically buried
in the misfolded protein (Rodriguez et al., 2008). Such mechanisms are thought to contribute towards
the promiscuous client diversity of Hsp70 chaperones (Fan et al., 2003; Kampinga et al., 2010; Craig
et al., 2017; Dahiya et al., 2019), which is supported in this work since HspA8-mediated
conformational expansion and unfolding of misfolded FlucIDS only occurs in the presence of DnaJB1
and ATP hydrolysis (Figure 3.11, Supplementary Figure 3.1, Supplementary Figure 3.2). Thus, the
work presented in this chapter supports a model in which the binding of client proteins by Hsp40
chaperones represents the initial stage of chaperone-assisted folding, which is followed by interaction
with Hsp70.
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3.4.5

The effect of Hsp70 homologs, HspA8 or DnaK, on the conformation of FlucIDS

The results from the smFRET experiments reveal that Hsp70-bound FlucIDS molecules (i.e., either
HspA8 or DnaK) are more conformationally expanded compared to Hsp40-bound molecules, as
indicated by the increased proportion of molecules that adopted ultra-low FRET states (i.e., < 0.1) in
the presence of Hsp70. Moreover, Hsp70-bound FlucIDS molecules have longer residence times and
increased abundance at low-FRET states. These data suggest that Hsp70 induces additional unfolding
of FlucIDS, which is consistent with results observed with other client proteins and Hsp70 systems
(Kellner et al., 2014; Dahiya et al., 2019; Imamoglu et al., 2020). As expected, loading of Hsp70
onto misfolded FlucIDS is mediated by Hsp40 and is dependent on ATP hydrolysis, since ADP or the
non-hydrolysable ATP analogue, AMP-PNP, did not enable the conformational expansion of FlucIDS
observed when ATP was present. Furthermore, this work illustrates that the low-FRET
conformationally expanded conformation of FlucIDS constitutes a necessary intermediate for
chaperone-mediated on-pathway folding, since the absence of ATP from refolding assays inhibits
productive FlucIDS refolding.

It has been hypothesized that the Hsp70-induced conformational expansion of clients occurs via a
steric exclusion model, whereby repulsion of multiple Hsp70 molecules bound to a single client
results in unfolding (Kellner et al., 2014; Dahiya et al., 2019; Imamoglu et al., 2020); however, other
work has shown that optimal Fluc refolding occurs following binding by a single Hsp70 and in the
absence of excessive binding (Sharma et al., 2010). It was not possible to determine whether multiple
Hsp70 molecules bind to a single FlucIDS client simultaneously in this work; however, in the case of
HspA8, this is unlikely since the refolding assays indicate that HspA8 association to Fluc IDS is rate
limiting. Additionally, association and binding of multiple Hsp70 molecules to FlucIDS may be
sterically disadvantaged when immobilized to the coverslip surface for smFRET experiments, as has
been observed previously (Terada et al., 2010). The potentially disruptive effect of surface
immobilization on the efficiency of complex formation has been observed previously in the context
of replisome assembly to surface-conjugated DNA replication forks (Tanner et al., 2009; Graham et
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al., 2017; Lewis et al., 2017). Furthermore, ultra-low FRET states were often generated following a
single significant transition from high FRET states, which is particularly evident with the bacterial
Hsp70 system, which is suggestive of a single event of chaperone binding being sufficient for FlucIDS
expansion.

3.4.6

The role of GrpE in the chaperone cycle of the bacterial Hsp70 system

The bacterial Hsp70 system was found to be most effective at refolding chemically misfolded FlucIDS.
Efficient protein refolding was initiated upon addition of GrpE to KJ-bound and surface-immobilized
FlucIDS and resulted in the rapid and almost complete loss of the conformationally expanded KJbound FlucIDS population. This result is consistent with the enhanced rate of ADP dissociation and
subsequent release of client protein by DnaK that occurs in the presence of GrpE (Langer et al., 1992;
Szabo et al., 1994; Packschies et al., 1997; Brehmer et al., 2001). Interestingly, during the early stages
of KJE-assisted protein refolding (e.g., 0 – 30 min), an increased proportion of misfolded FlucIDS was
observed, which indicates that GrpE-mediated release of the client provides an opportunity for
spontaneous refolding. The current dogma of chaperone-mediated folding indicates that should
refolding to the native state be unsuccessful, the released client can become misfolded and undergo
another round of chaperone-mediated binding and release (Sharma et al., 2010; Saibil, 2013;
Koldewey et al., 2017; Rosenzweig et al., 2019; Balchin et al., 2020). In this work and for the first
time, multiple cycles of chaperone binding and release of a single client protein were observed in real
time during chaperone-assisted refolding. This is evidenced by the observation that individual FlucIDS
proteins exhibit repeated FRET transitions to and from the ultra-low FRET state that is typical of KJbound FlucIDS (see Supplementary Figure 3.4B). Such a result implies that the probability of a FlucIDS
molecule to fold correctly upon Hsp70 release is low, which results in a shift towards misfolded
FlucIDS conformations. It should be noted that the refolding probability of FlucIDS upon Hsp70 release
cannot be determined in these experiments since the observation of individual Fluc IDS species is
limited to ~ 3 minutes due to photobleaching of the fluorophores. Optimization of imaging conditions,
such as reducing the laser intensity and increasing the exposure time, may facilitate the observation
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of individual FlucIDS species for longer periods and enable refolding probabilities to be accurately
determined. Crucially, the proposed mechanism of client binding and release by DnaK is supported
by the kinetic data obtained in this work, whereby the residence times of low-FRET states (e.g., Tlowlow

or Tlow-high) are much lower in the presence of GrpE (indicative of faster ADP dissociation and

client release). Additionally, the residence times of high-FRET to low-FRET transitions (e.g., Thighlow)

is not affected by GrpE (indicating that GrpE does not affect association of DnaK to misfolded

FlucIDS).

Excitingly, after 90 min of GrpE-assisted folding, the majority of FlucIDS species were found to have
FRET distributions similar to that observed for the native protein, which indicates successful
refolding. Notably, however, a small population of misfolded FlucIDS remained after 90 min of GrpEassisted folding. Since complete refolding of FlucIDS was observed after 90 min of refolding in the
bulk-ensemble assays, these data indicate that chaperone-assisted refolding of FlucIDS occurs at a
slower rate and may be hindered at the surface of the coverslip during these single-molecule
experiments. Regardless, the current results demonstrate that chaperone-assisted refolding of an
individual client protein can be monitored through time using this smFRET approach.

3.4.7

Conclusion: The mechanism of chaperone-assisted refolding

How does chaperone binding and release promote client refolding? First, the findings of this study,
as well as others, show that binding of client proteins by chaperones helps to resolve foldingincompetent, misfolded structures and that chaperones can conformationally remodel the client for
subsequent refolding attempts (Sharma et al., 2010; Imamoglu et al., 2020). Conformational
remodeling of the bound client by chaperones may occur via a variety of mechanisms, such as by
stabilizing unfolded conformers within a misfolded ensemble (e.g., conformational selection) (Sekhar
et al., 2018), steric repulsion between multiple chaperones bound to a single client (Kellner et al.,
2014; Dahiya et al., 2019; Imamoglu et al., 2020) or via a mechanical unfolding mechanism that
utilizes the energy harnessed following ATP-hydrolysis (in the case of Hsp70) (Sharma et al., 2010).
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The results of this work provide evidence to support the mechanical unfolding mechanism, since
significant structural transitions of FlucIDS from high-FRET misfolded structures to ultra-low FRET
expanded FlucIDS conformations were observed.

Second, it is traditionally thought that release of the client protein from Hsp70 provides an
opportunity for the client to spontaneously refold to the native state. Indeed, recent work has
suggested that the role of Hsp70 is to resolve misfolded Fluc states and unfold it (i.e., ‘unfoldase’
activity), following which the client can spontaneously refold to the native state upon release by
Hsp70 (i.e., similar to denaturant-induced refolding) (Sharma et al., 2010). However, the results of
this work suggest that the ‘unfoldase’ mechanism of Hsp70 chaperone function may not fully
encompass its role in protein folding and that Hsp70 possesses ‘foldase’ characteristics. As evidence
for this, the rate of chaperone-assisted refolding of FlucWT was ~ 4-fold faster than that observed for
FlucIDS; however, the spontaneous refolding efficiency of FlucWT was ~ 10-fold higher than for
FlucIDS. This suggests that the chaperone-assisted refolding mechanism extends beyond simple
release of an unfolded client protein for spontaneous refolding and that there is some other aspect of
chaperone function that accelerates and assists productive folding.

There is a growing body of work that suggests that Hsp70 can direct the folding of proteins in a
manner that is distinct from a simple model of binding and release (Lee et al., 2015; Sekhar et al.,
2015; Dahiya et al., 2019; Lu et al., 2021). Kinetic data obtained in this work demonstrated that there
was a much lower probability that FlucIDS would return to high-FRET compacted states once
conformationally expanded by Hsp70, indicative of some ‘holdase’-like function. Notably, it has been
suggested that regions of the client, distinct from the Hsp70 binding site, can sample different
conformers or form native-like secondary structures whilst still bound to Hsp70 that may act as a
folding nucleus around which native tertiary interactions can form upon release of chaperone (Sharma
et al., 2010; Lee et al., 2015; Sekhar et al., 2015; Koldewey et al., 2017; Dahiya et al., 2019).
Furthermore, molecular dynamics simulations suggests that Hsp70 may remain transiently associated
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with the released client and prevent non-native contacts to accelerate productive refolding (Lu et al.,
2021). While more work is required to validate these hypotheses in the context of FlucIDS folding, it
is clear that Hsp70 can actively remodel the folding landscape of its clients by partitioning them
towards native structures and away from non-productive folding pathways.

Collectively, the results described in this chapter demonstrate the development of Fluc IDS into a
folding sensor that was then implemented in smFRET experiments to provide a detailed
understanding of the mechanism by which the Hsp70 chaperone system refolds client proteins. First,
binding of Hsp40 results in the conformational expansion of the misfolded client, which primes the
client for transfer to ATP-bound Hsp70. Capture of the client by Hsp70 occurs upon ATP hydrolysis
(generating the ADP-bound form of Hsp70), which actively drives additional conformational
expansion and global unfolding of the bound client. Dissociation of ADP from Hsp70, which can
occur spontaneously but is accelerated by a NEF, results in the concomitant rebinding of ATP and
dissociation of the client protein from Hsp70. Upon release, Hsp70 can partition the client protein
towards folding pathways en-route to the native state or the client can spontaneously misfold. The
misfolded protein can then be subject to additional rounds of binding and release by chaperones until
the native state is acquired. Thus, the developed FlucIDS sensor is an ideal tool for the single-molecule
investigation of chaperone function and represents an exciting platform for the future study of other
chaperone systems.
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3.5

Supplementary figures

Supplementary Figure 3.1: HspA8 alone does not affect the conformation of misfolded Fluc IDS.
Immobilized FlucIDS was unfolded with 4 M GdHCl and imaged following removal of denaturant with buffer
containing HspA8 (10 µM) and ATP (2 mM). (A) Representative smFRET traces of individual FlucIDS
molecules when incubated in the presence of HspA8 and ATP. Data are fit with an HMM (shown in orange).
(B) FRET efficiency histograms of FlucIDS when folded (i.e., native), following removal of 4 M GdHCl without
chaperone (i.e., spontaneous) or with HspA8 and ATP. (C) Transition density plots (TDP) showing the initial
and final FRET state of FlucIDS transitions when diluted from denaturant in the absence or presence of HspA8
and ATP. (D) A summary of the kinetic data for each dataset represented as annotated heatmaps. For
simplicity, the kinetic data were filtered for FBefore values less than or greater than 0.5 FRET. The color of the
heatmap denotes the percentage of time that Fluc IDS resides above or below 0.5 FRET. The direction of each
arrow refers to the transition direction, whereby the origin of each arrow denotes FBefore and the arrowhead
denotes FAfter. The size of each arrow is directly proportional to the normalized occurrence of those particular
transitions. The mean Residence for each transition class is denoted adjacent to its respective arrow. Data for
panels B – D were derived and collated from the HMM fits of at least 242 individual Fluc IDS molecules per
treatment.

104

Chapter 3 – Development and implementation of luciferase as a protein-folding sensor

105

Chapter 3 – Development and implementation of luciferase as a protein-folding sensor
Supplementary Figure 3.2: Kinetic analysis of individual Fluc IDS molecules in the presence of DnaJB1
and HspA8 molecular chaperones. smFRET trajectories of FlucIDS molecules when refolded in the presence
of increasing concentrations of DnaJB1 (1 – 10 µM) alone (black) or supplemented with HspA8 (10 µM) and
ATP (2 mM) (purple) were analyzed using an HMM and key kinetic details determined. (A) The percentage
of FlucIDS molecules that visited states below the defined FRET threshold. (B) Violin plot of the FRET
efficiencies of FlucIDS molecules immediately preceding a transition (i.e., FBefore) below a defined FRET state.
The threshold was set to 0.5 or 0.1 FRET for FlucIDS molecules incubated in the presence of DnaJB1 alone
(top) or supplemented with HspA8 (10 µM) and ATP (2 mM) (bottom), respectively. (C) The probability that
a FlucIDS molecule will transition to a high-FRET state (> 0.5) from a low-FRET state (< 0.5). (D) Violin plots
showing the distribution of residence times for each transition class for Fluc IDS incubated in the presence of
increasing concentrations of DnaJB1. (E) Violin plots showing the distribution of residence times for each
transition class for FlucIDS in the presence of increasing molar ratios of DnaJB1: HspA8 (1:10 – 1:1). (F) Violin
plots showing the distribution of residence times for each transition class for Fluc IDS in the presence of
ovalbumin or in the presence of DnaJB1 (5 µM), HspA8 (10 µM) and the indicated nucleotide (2 mM). Data
shown within all violin plots are the median ± interquartile range. For panels D – F, a two-way ANOVA
statistical analysis with Tukey’s multiple-comparisons post-hoc test was performed to determine statistically
significant differences in residence times between treatment groups within each transition class. *, **, *** and
**** indicates statistical significance with p ≤ 0.05, 0.01, 0.001 and 0.0001, respectively. ns or the absence of
markers indicates no significant difference (p > 0.05). Data for all panels were derived and collated from the
HMM fits of at least 188 individual FlucIDS molecules per treatment.
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Supplementary Figure 3.3: Kinetic analysis of FlucIDS molecules in the presence of various components
of the bacterial Hsp70 system. Immobilized FlucIDS was unfolded with 4 M GdHCl and imaged following
removal of denaturant in the absence (i.e. spontaneous) or presence of DnaK (3 µM), DnaJ (1 µM) (+ KJ) and
GrpE (1.5 µM) (+ KJE). The FRET efficiency of FlucIDS in the presence of the complete KJE refolding system
was measured immediately (0 – 30 min, + KJE (early)) or after 90 min of refolding (+ KJE (late)). FRET
trajectories were fit to an HMM and the kinetic details for each experimental condition determined. (A) The
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percentage of FlucIDS molecules that visited states below a defined FRET threshold. Threshold is shown in the
key. (B) Violin plot of the FRET efficiencies of Fluc IDS molecules immediately preceding a transition (i.e.,
FBefore) to an ultra-low FRET state (< 0.1). (C) Violin plots showing the distribution of residence time for each
transition class. A two-way ANOVA statistical analysis with Tukey’s multiple-comparisons post-hoc test was
performed to determine statistically significant differences in residence times between treatment groups within
each transition class. *, **, *** and **** indicates statistical significance with p ≤ 0.05, 0.01, 0.001 and
0.0001, respectively. ns or the absence of markers indicates no significant difference (p > 0.05). Data shown
within violin plots are the median ± interquartile range. (D) The probability that a FlucIDS molecule will
transition to a high-FRET state (> 0.5) from a low-FRET state (< 0.5). (E) The transition probability of each
transition class. Data for all panels were derived and collated from the HMM fits of at least 242 individual
FlucIDS molecules per treatment.
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Supplementary Figure 3.4: Example smFRET trajectories of individual FlucIDS molecules in the
presence of the bacterial Hsp70 system. AF555/647-labelled FlucIDS was immobilized to a coverslip surface
and the FRET efficiency measured in the presence of (A) DnaK (3 µM), DnaJ (1 µM) (+ KJ) or (B – C)
supplemented with GrpE (1.5 µM) (+ KJE). The FRET efficiency of FlucIDS in the presence of the complete
KJE refolding system was measured (B) early during chaperone-assisted refolding (0 – 30 min) or (C) after
90 min of chaperone-assisted refolding. All conditions were performed in the presence of 5 mM ATP.
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Chapter 4 – Development of rhodanese for the real-time study of chaperone function
4.1

Introduction

The Hsp70 system of molecular chaperones are crucial for the correct de novo folding and refolding
of many proteins (~ 30% of the bacterial proteome) (Mayer et al., 2005; Calloni et al., 2012;
Willmund et al., 2013). It is currently thought that the Hsp70 system mediates correct protein folding
by repeated binding and release of client proteins, a process that may resolve misfolded structures
and provides an opportunity for spontaneous refolding to the native state. For a subset of cellular
proteins (~ 10% of the bacterial proteome), the Hsp70 system is insufficient to promote correct
folding - other chaperone systems (e.g., Hsp60 or Hsp90) are required for efficient folding and
conformational maturation (Langer et al., 1992; Kerner et al., 2005; Hartl et al., 2011; Balchin et al.,
2016; Luengo et al., 2019). However, the precise mechanistic details regarding how the Hsp70 system
can either actively fold client proteins or, alternatively, prime folding-incompetent clients for
downstream processing by other chaperones remain an elusive and under-studied aspect of chaperone
function.

A notable example of a difference in the ability of Hsp70 to refold client proteins can be seen when
comparing the ability of the bacterial Hsp70 system to refold the well-characterized client proteins
Bos taurus (bovine) liver rhodanese and Photinus pyralis (firefly) luciferase. Work from this thesis
and others have shown that the bacterial Hsp70 system (e.g., DnaJ, DnaK and GrpE) can efficiently
resolve misfolded states of luciferase, leading to it rapidly (within minutes) refold back to the native
state (Sharma et al., 2010; Imamoglu et al., 2020). In contrast, chemically denatured rhodanese is
unable to be refolded by the bacterial Hsp70 system (Langer et al., 1992). Instead, DnaK-bound
rhodanese must be transferred to the Hsp60 chaperonin GroEL for efficient refolding (Langer et al.,
1992). Despite both rhodanese and luciferase being widely used in studies of molecular chaperone
function, to date only a few studies have interrogated how the function of the Hsp70 chaperone system
diverges between these two clients (Natalello et al., 2013). Moreover, questions remain regarding the
precise molecular mechanisms that underpin the differences in the capacity of Hsp70 alone to refold
these clients. For example, what aspects of the conformation of the misfolded client dictate chaperone
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behavior? Are association and dissociation kinetics the main contributor to the differences in the
capacity of Hsp70 to refold these client proteins? How does the conformation of the client differ when
bound by chaperones and does this affect refolding? How many chaperones are bound to refoldingcompetent or incompetent client proteins? How many cycles of chaperone binding and release are
required for folding? What aspects of chaperone-client complexes promote downstream processing
by other chaperone systems? Consequently, there is a need for a more comprehensive and direct
interrogation into how molecular chaperones affect the folding of different client proteins to address
these crucial aspects of chaperone function.

Such questions have traditionally been difficult to answer using ensemble-based averaging
techniques; however, single-molecule approaches have emerged as a useful tool to help address these
questions since the observation of individual proteins enables the characterization of subpopulations
typically masked in ensemble measurements. Recently, some single-molecule studies have
characterized the conformation of rhodanese (and luciferase) while bound to molecular chaperones
(Hillger et al., 2008; Hofmann et al., 2010; Kellner et al., 2014; Imamoglu et al., 2020); however, all
these studies relied on solution-based particle-analysis techniques, which are limited by diffusion
with regard to the time individual chaperone-client complexes can be observed (~ 1 ms) (Hou et al.,
2019). Consequently, chaperone-mediated changes in the folded state of individual client proteins,
including key kinetic rates and parameters (e.g., on/off rates), could not be determined in these
previous studies or were difficult to do so. As such, there is a pressing need to employ alternative
strategies to observe, in real time, individual chaperone-client interactions.

To address this gap in knowledge, the work in this chapter was aimed at exploiting a rhodanese
construct previously used in diffusion-based single molecule FRET experiments (smFRET) (Kellner
et al., 2014), and developing it for use in single-molecule TIRF microscopy. This would facilitate the
temporal observation of chaperone-rhodanese interactions and thus complement the luciferase
construct developed in Chapter 3. By developing both rhodanese and luciferase as protein-folding
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sensors amenable to single-molecule TIRF microscopy, this would enable a direct comparison of the
manner by which molecular chaperones interact with these client proteins. As a proof of principle, in
this work the modified rhodanese construct was exploited to study the mechanistic action of
mammalian Hsp40 isoforms and the bacterial Hsp70 system (DnaK, DnaJ and GrpE) with temporal
resolution at the single-molecule level.
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4.2

Methods

Rhodanese constructs were generously donated by Prof. Benjamin Schuler (University of Zurich,
Switzerland). pSUMO (plasmid #102622) and pMBP (plasmid #112591) cloning vectors were
purchased from Addgene (Massachusetts, USA).

4.2.1

Rationale and design of the rhodanese folding sensor

To employ rhodanese (Rhod) in real-time smFRET experiments to study chaperone function, the
protein construct required two major characteristics; i) it can report on conformational changes upon
interaction with chaperones, and ii) can be site-specifically immobilized to a coverslip surface. With
this in mind, a previously characterized Rhod construct capable of smFRET, previously designated
∆117 (RhodD102C,

D219C)

(Hillger et al., 2008; Kellner et al., 2014), was exploited. It had been

previously shown that this Rhod construct could be used to follow changes in its folded state upon
interaction with molecular chaperones (Hillger et al., 2008; Kellner et al., 2014). This Rhod construct
has two cysteines available for fluorophore labelling via maleimide chemistry (D102C and D219C)
(Figure 4.1). Based on the crystal structure of the protein (PDB 1RHD, Ploegman et al., 1978), the
introduced cysteines are positioned ~ 9.1 Å apart (C𝛼 - C𝛼 distance) at the interface between the Nand C-terminal domains and thus changes in FRET report on the relative orientation of these two
domains. As such, herein this modified Rhod construct is denoted as RhodIDS, since the introduced
cysteines enable this construct to be used as an interdomain sensor of protein folding. This sensor is
comparable to that of FlucIDS, which was employed in smFRET experiments previously (see Chapter
3) as it reports on the final folded state of RhodIDS once correct folding of the N- and C-terminal
domains is achieved.

The RhodIDS construct was not amenable to specific immobilization to a coverslip surface. Thus, the
addition of a short tag (e.g., 6x-His or AviTag motifs) that can be used for specific immobilization of
RhodIDS to a coverslip surface was required. As the AviTag motif is 15 amino-acid residues in length,
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the C-terminus was chosen as the best site for incorporation since this region is highly flexible and
thus less likely to interfere with the structure or folding of RhodIDS.

Figure 4.1: Crystal structure of Rhod. The structure of Rhod (PDB 1RHD, Ploegman et al., 1978) with
cysteine residues to be labelled with a FRET fluorophore pair in the RhodIDS construct are shown. The C𝛼 –
C𝛼 distance between labelled residues is indicated.

4.2.2

Optimizing the soluble expression and purification of Rhod IDS

4.2.2.1 Cloning of RhodIDS constructs
RhodIDS was cloned into several vectors with the aim of improving its soluble expression and to
facilitate immobilization to a neutravidin-functionalized coverslip. Restriction-enzyme cloning was
performed as outlined in section 2.2.6 and the appropriate restriction enzymes, primers, destination
vectors and annealing temperatures used are summarized in Appendix III. The expected RhodIDS
constructs generated from cloning and the relative position of important structural features (e.g.,
affinity tags) are summarized in Appendix IV.
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4.2.2.2 Assessing the soluble expression and in vivo biotinylation of AviTagged RhodIDS
E. coli BL21(DE3) cells transformed with plasmids encoding non-tagged RhodIDS, or alternatively,
co-transformed with plasmids encoding biotin ligase (BirA) and RhodIDS (with C-terminal AviTag,
denoted as Avi-RhodIDS) were streaked onto a LB agar plate supplemented with ampicillin antibiotic
(100 µg/mL) and grown overnight at 37˚C. All E. coli cells that contain the BirA-encoding plasmid
were grown in media that was supplemented with chloramphenicol (10 µg/mL). Cells from a single
colony on the LB plate were used to inoculate a starter culture (~ 100 mL) consisting of LB media
supplemented with the appropriate antibiotic(s), with the culture grown overnight at 37˚C with
constant agitation at 180 rpm in an orbital shaker (Bioline, Australia). For both non-tagged RhodIDS
and Avi-RhodIDS, the starter culture was used to inoculate LB media expression cultures containing
only ampicillin (100 µg/mL), with the cultures incubated at 37˚C until an optical density at 600 nm
(OD600) of ~ 0.6 was reached. For non-tagged RhodIDS, protein expression was induced by addition
of IPTG (0.25 mM) and incubation at 37˚C for 4 hr. For experiments aimed at improving the soluble
expression of Avi-RhodIDS, protein expression was performed either at 37˚C for 4 hr with 0.25 mM
IPTG or at 18˚C overnight with 0.1 mM IPTG. To promote the in vivo biotinylation of Avi-RhodIDS,
the media was supplemented with D-biotin (50 µM final concentration) prepared in 10 mM bicine
buffer (pH 8.3) prior to induction of protein with IPTG.
Following incubation, cells were then harvested by centrifugation at 5,000 x g for 10 min at 4˚C
(Sorvall RC-6+; Thermo Fisher Scientific, USA) and the pellet stored at -20˚C until the recombinant
protein was extracted. To determine whether the expression of recombinant protein was successful,
aliquots of the expression cultures were taken before and after the induction of protein expression by
IPTG and the bacterial pellet stored at -20˚C for subsequent SDS-PAGE and immunoblotting
analysis.

Recombinant protein was extracted from the bacterial pellet via resuspension in 100 mM Tris (pH
7.0), containing 5 mM EDTA, 20 mM sodium thiosulfate, 0.5 mg/mL lysozyme and EDTA-free
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cocktail protease inhibitor, and incubated at 4˚C for 20 min. To shear extracted DNA and further lyse
cells, the lysate was subjected to probe sonication for 3 min (10 s on/20 s off) at 45% power. The cell
debris was then pelleted twice at 24,000 x g for 20 min at 4˚C and the soluble lysate collected. The
cell lysate was adjusted to pH 5.5 using 2 M glycine sulfate (pH 2.5). While stirring, powdered
ammonium sulfate was slowly added to the lysate (0.4 M final concentration), which was then
centrifuged at 57,000 x g at 4˚C for 10 min. The supernatant was collected, and the previous step
repeated twice with increasing concentrations of ammonium sulfate (to final concentrations of
1.35 M and 2.7 M). After the final ammonium sulfate cut, the pellet was resuspended in 25 mM
sodium acetate (pH 5.4) supplemented with 10 mM sodium thiosulfate and dialyzed in the same
buffer overnight at 4˚C. The dialysate was centrifuged at 57,000 x g for 30 min to remove particulates
prior to SDS-PAGE analysis.

4.2.2.3 Expression and purification of His-tagged RhodIDS from inclusion bodies
E. coli BL21(DE3) cells transformed with a plasmid encoding RhodIDS (with N-terminal 6x-His tag,
denoted as His-RhodIDS, see Appendix IV) was streaked onto a LB agar plate supplemented with
kanamycin antibiotic (50 µg/mL) and grown overnight at 37˚C. Recombinant protein was expressed
as described above (section 4.2.2.2), with the following modifications. Proteins were induced with a
range of IPTG concentrations (0.1 – 0.5 mM) and expression was performed, in the absence of Dbiotin, either at 18˚C overnight or at 37˚C for 4 hr. The bacterial pellet generated following expression
at 37˚C with 0.5 mM IPTG for 4 hr was chosen for subsequent experiments aimed at refolding HisRhodIDS from inclusion bodies. Soluble proteins were extracted as described above (section 4.2.2.2)
and the cell debris (containing inclusion bodies) was stored at -20˚C until required.

To enrich the extracted pellet for inclusion bodies containing His-RhodIDS, contaminant proteins were
removed via repeated washing and sonication steps. First, the pellet was resuspended in 5 mL of 100
mM Tris (pH 7.0) supplemented with 2 M urea, 5 mM EDTA, 5 mM DTT and 2% (v/v) Triton-X100
(washing buffer) per gram of pellet. The resuspended pellet was then probe sonicated for 1 min (5 s
118

Chapter 4 – Development of rhodanese for the real-time study of chaperone function
on/ 10 s off) at 45% power and centrifuged at 22,000 x g for 30 min at 4˚C. The pellet was resuspended
in washing buffer and the sonication and centrifugation step repeated. For the last wash, the pellet
was resuspended in washing buffer that did not contain urea or Triton-X100, sonicated and
centrifuged as described above. The supernatant at each step was removed and stored at 4˚C for
subsequent analysis by SDS-PAGE. Finally, the washed pellet (containing inclusion bodies) was
resolubilized in 4 mL (per gram of pellet) of 10 mM Tris (pH 7.0) containing 10 mM DTT and
5.6 M GdHCl and incubated for 1 hr at room temperature.

To refold His-RhodIDS, ~ 250 µg of solubilized protein (5 µg/mL final protein concentration) was
dialyzed against 1.5 L of 10 mM phosphate (pH 7.0) supplemented with 200 mM sodium thiosulfate
and 5 mM DTT overnight at 4˚C. The dialysate was then concentrated to ~ 100 µL using a Vivaspin
concentrator (10 kDa MWCO) and any insoluble material pelleted following centrifugation at 20,000
x g for 15 min at 4˚C. The final concentration of protein in the supernatant was determined as
described in section 2.2.3 or via comparison to densitometry standards of recombinant RhodIDS using
SDS-PAGE.

4.2.2.4 Soluble expression screens for MBP- or SUMO-tagged Avi-RhodIDS
E. coli BL21(DE3) cells transformed with plasmids encoding either SUMO- or MBP-tagged AviRhodIDS (with N-terminal 6x-His tag and C-terminal AviTag, see Appendix IV) were streaked onto a
LB agar plate supplemented with the appropriate antibiotic (kanamycin [50 µg/mL] or ampicillin
[100 µg/mL], respectively) and grown overnight at 37˚C. The soluble expression screen of
recombinant protein was performed as described for Rhod in section 2.3.3.

4.2.2.5 Large scale expression and purification of SUMO-tagged Avi-RhodIDS
E. coli BL21(DE3) cells co-transformed with plasmids encoding biotin ligase (BirA) and SUMOtagged Avi-RhodIDS (with N-terminal 6x-His tag and C-terminal AviTag, see Appendix IV) were
streaked onto a LB agar plate supplemented with kanamycin (50 µg/mL) and chloramphenicol (10
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µg/mL) antibiotics and grown overnight at 37˚C. The soluble expression, extraction and purification
of recombinant protein was performed as described for Rhod in section 2.3.4.

4.2.3

Single-molecule FRET (smFRET)

For smFRET experiments, Avi-RhodIDS was fluorescently labelled with AF555 and AF647
fluorophores as previously outlined (section 2.3.5). Coverslips were cleaned, functionalized, and
assembled into PDMS microfluidic devices as described in section 2.4.2. Labelled Avi-RhodIDS was
immobilized to the neutravidin-functionalized coverslip as described in section 2.4.3.

To monitor protein unfolding, labelled Avi-RhodIDS was imaged in imaging buffer (50 mM Tris [pH
7.5], 5 mM KCl, 10 mM MgCl2, 200 mM BME and 6 mM Trolox) in the absence of denaturant (i.e.,
native state) and after 5 min incubation with increasing concentrations of GdHCl (0 – 4 M). The
refolding of Avi-RhodIDS denatured in 4 M GdHCl was observed by imaging immediately following
the addition of decreasing concentrations of GdHCl (3 – 0 M). To demonstrate the ability of AviRhodIDS to report on structural transitions in real time, immobilized molecules were alternatively
incubated in imaging buffer supplemented with or without 4 M GdHCl and the FRET efficiency
measured. To assess the effect of molecular chaperones on the conformation of Avi-RhodIDS,
denatured Avi-RhodIDS was first generated by incubation in 4 M GdHCl. Denaturant was removed
with imaging buffer containing the indicated amounts of chaperone(s) and nucleotide (e.g., ATP).
The ability of Avi-RhodIDS to spontaneously refold to the native state was assessed by imaging
immobilized Avi-RhodIDS that had been diluted out of denaturant (4 M GdHCl) for 1 hr. As a control,
denatured Avi-RhodIDS was imaged in the presence of the non-chaperone control protein, ovalbumin
(3 µM), and in the presence of 2 mM ATP. An oxygen scavenging system (OSS) consisting of 5 mM
protocatechuic acid and 50 nM protocatechuate-3,4-dioxygenase was included in all buffers prior to
and during image acquisition.

All data were acquired using a TIRF microscope setup as previously described (see section 2.4.1)
following sample illumination using a 532 nm solid state laser with excitation intensity of 0.9 W/cm2
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and the fluorescence of donor and acceptor fluorophores was measured every 500 ms at multiple
fields of view. The smFRET trajectory analysis was performed as outlined in section 2.4.4.
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4.3
4.3.1

Results
Avi-RhodIDS is insolubly expressed

The soluble expression of non-tagged RhodIDS and Avi-RhodIDS was assessed by SDS-PAGE (Figure
4.2). Aliquots of E. coli in LB media before and after the induction of protein expression by IPTG
were analyzed by SDS-PAGE to confirm the over-expression of non-tagged recombinant RhodIDS
(Figure 4.2A). Prior to induction with IPTG, there was no band observed in the extracted E. coli cell
lysate that corresponded to the expected molecular mass of non-tagged RhodIDS (~ 33 kDa). However,
4 hr after the addition of IPTG, a strong band at ~ 33 kDa was present both in the total and soluble
E. coli cell lysates, indicative of the soluble over-expression of recombinant non-tagged RhodIDS
(Figure 4.2A, lanes I and S). A band at ~ 28 kDa of unknown origin was also observed in the soluble
and total lysate following protein induction.

Similar results were observed for the over-expression of Avi-RhodIDS, whereby no band
corresponding to the recombinant protein (~ 36 kDa) was observed prior to the addition of IPTG but
was present in the cell lysate following induction of protein expression (Figure 4.2B, lanes NI and I).
However, no significant band was observed at ~ 36 kDa in the soluble lysate from cells expressing
recombinant protein for either induction condition tested (Figure 4.2B, lanes S). SDS-PAGE analysis
of the insoluble material following protein extraction confirmed the presence of a significant band at
~ 36 kDa for both induction conditions tested, indicating that the addition of a C-terminal AviTag
results in the insoluble expression of Avi-RhodIDS (Figure 4.2B, lanes P).

Regardless, to investigate if Avi-RhodIDS could be efficiently biotinylated in vivo upon co-expression
with biotin ligase, the cell lysate before and after induction of protein expression with IPTG was
probed via immunoblotting (Figure 4.2C). Moreover, the dependence of D-biotin on the biotinylation
reaction was interrogated by performing the expression of Avi-RhodIDS in the absence or presence of
D-biotin within the expression media. Prior to induction with IPTG, a faint band was observed in the
extracted E. coli cell lysates (Figure 4.2C, lanes NI) that corresponds to the expected molecular mass
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of Avi-RhodIDS (~ 36 kDa). When D-biotin was not supplemented into the expression media, there
was a modest increase in the band intensity observed at ~ 36 kDa following over-expression of
recombinant protein (Figure 4.2C, lane I [- biotin]). However, there was a significant increase in the
band intensity observed at ~ 36 kDa when recombinant protein was expressed in the presence of Dbiotin (Figure 4.2C, lane I [+ biotin]), which suggests that Avi-RhodIDS had been site-specifically
biotinylated in vivo.

Figure 4.2: The addition of a C-terminal AviTag to RhodIDS facilitates its biotinylation in vivo but is
insolubly expressed. (A) Confirmation of the soluble expression of non-tagged RhodIDS in E. coli as assessed
by SDS-PAGE. RhodIDS was expressed in E. coli following induction with IPTG (0.25 mM) and incubation at
37˚C for 4 hr. (B) Exploring the soluble expression of Avi-RhodIDS via different induction conditions, as
assessed by SDS-PAGE. Recombinant protein was expressed at varying temperatures (18˚C or 37˚C) and
IPTG concentrations (0.1 - 0.25 mM). (C) Immunoblot of non-induced and induced cell lysates to confirm the
in vivo biotinylation of Avi-RhodIDS. Recombinant protein was expressed at 37˚C for 4 hr in the presence of
IPTG (0.25 mM) and in the absence (- biotin) or presence (+ biotin) of exogenous D-biotin (50 µM).
Biotinylated species were probed with a streptavidin-HRP conjugate. For each panel, lanes NI and I represent
the total protein content prior to and after addition of IPTG, respectively. Lane S represents the soluble protein
content after addition of IPTG and lane P represents the insoluble protein content present in the pellet after
extraction. The expected molecular mass of recombinant protein is indicated with an arrow. For all gels,
precision-plus dual-color protein standards (in kDa) are shown.
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4.3.2

His-RhodIDS is insolubly expressed

Since the addition of the C-terminal AviTag results in the insoluble expression of RhodIDS, restrictionenzyme cloning was used to create a 6x-His-tagged RhodIDS (His-RhodIDS) fusion protein that could
be specifically immobilized for single-molecule experiments.

Successful PCR amplification of the RhodIDS DNA sequence from template DNA was assessed by
agarose gel electrophoresis (Figure 4.3A). When the products from the PCR reaction were loaded
onto an agarose gel a strong band was observed at ~ 1,000 bp, which corresponds to the expected
length of the DNA sequence encoding RhodIDS (909 bp), indicative of successful amplification of
template DNA (Figure 4.3A, lane I). No band was observed when the template DNA was omitted
from the PCR reaction (Figure 4.3, lane (-)).

Both the PCR amplified RhodIDS insert and the destination vector, pET28c, were then incubated with
NdeI and EcoRI restriction enzymes and successful digestion was assessed by agarose gel
electrophoresis (Figure 4.3B). As expected, the digested PCR-amplified RhodIDS insert showed a
clear band at ~ 1,000 bp, close to the expected length of the digested insert (896 bp). When the pET28c
destination vector was digested with NdeI or EcoRI individually, or in combination, a strong band
was observed above the largest DNA fragment present in the marker, consistent with the expected
length of digested pET28c (5387 bp). When restriction enzymes were omitted from the pET28c
digestion reaction a significantly smaller band was observed compared to when restriction enzymes
were present, consistent with the supercoiling of circularized non-digested DNA fragments.

Colonies of E. coli DH5𝛼 cells transformed with ligated product were screened using PCR and
agarose gel electrophoresis to determine whether the transformants contained the pET28c vector with
the cloned RhodIDS insert (Figure 4.3C). As a positive control, amplification of the empty pET28c
destination vector was performed, which showed a band at ~ 300 bp that corresponds to the expected
length of the multiple cloning site between the T7 promoter and terminator on pET28c (Figure 4.3C,
lane (+)). No band was observed when the template DNA was omitted from the PCR reaction (Figure
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4.3C, lane (-)). PCR amplification of ~ 25 transformed DH5𝛼 colonies showed either the presence of
a band at ~ 300 bp (indicative of an empty pET28c vector) or a band at ~ 1,000 bp, which corresponds
to the expected length of the RhodIDS insert with N-terminal 6x-His tag (1170 bp, Figure 4.3C).

Figure 4.3: Restriction-enzyme cloning of His-RhodIDS. (A) Agarose gel electrophoresis of DNA products
following PCR amplification of the RhodIDS insert. Lane (-) denotes the negative control in which no template
DNA was added to the PCR reaction. Lane I denotes the sample containing the PCR-amplified insert. (B)
Agarose gel electrophoresis of the PCR amplified RhodIDS insert (from A, lane I) and pET28c cloning plasmids
following restriction enzyme digestion with NdeI and EcoRI (pET28c). The key at the bottom of the gel denotes
whether restriction enzymes were present (+) or absent (-) in each reaction. (C) Agarose gel electrophoresis of
DNA products formed following PCR amplification of crude DNA extracts from E. coli DH5𝛼 colonies
transformed with ligated DNA. Lane (-) denotes the negative control in which no template DNA was added to
the PCR reaction while lane (+) denotes the positive control in which template DNA containing an insert
recognized by the primers is present. The PCR products from crude DNA extracts of different DH5𝛼 colonies
are indicated (colonies). Hyperladder I markers are shown for all panels with approximate size of DNA bands
in the gel shown on the left.
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4.3.3

Recombinant His-RhodIDS can be purified from inclusion bodies

The soluble expression of His-RhodIDS and its refolding from inclusion bodies was assessed by SDSPAGE and immunoblotting analysis (Figure 4.4). For each expression condition tested, the soluble
and insoluble protein content before and after the induction of protein expression by IPTG were
analyzed by SDS-PAGE (Figure 4.4A). Prior to induction with IPTG, there was no band observed in
the extracted total protein lysate that corresponds to the expected molecular mass of His-RhodIDS
(~ 35 kDa, Figure 4.4A, lanes NI). Following the induction of protein expression by the addition of
IPTG, a strong band at ~ 35 kDa was present in the extracted total protein lysate for all induction
conditions tested, indicative of the over-expression of His-RhodIDS (Figure 4.4A, lanes I). However,
no significant band was observed that corresponded to His-RhodIDS in the soluble fraction of these
lysates (Figure 4.4A, lanes S). Conversely, when the insoluble material following protein extraction
was analyzed by SDS-PAGE, strong bands at ~ 35 kDa were observed for all expression conditions
tested, demonstrating the insoluble expression of His-RhodIDS into inclusion bodies (Figure 4.4A,
lanes P).

As His-RhodIDS was not expressed in a soluble state in E. coli, we sought to determine if the insoluble
protein could be solubilized and refolded from inclusion bodies. Since over-expression of HisRhodIDS was most effective when E. coli cells were induced with high IPTG concentrations and
incubation temperatures (i.e., 37˚C, 0.5 mM IPTG) (Figure 4.4A), inclusion bodies were isolated
from the extracted bacterial pellet from this induction condition. Prior to washing and solubilization
of the extracted cell pellet a significant band was observed at ~ 35 kDa when analyzed by SDS-PAGE,
which corresponds to the expected mass of His-RhodIDS. Other contaminant bands ranging from 10 250 kDa were also observed in this sample (Figure 4.4B, lane P). The extracted pellet was washed
and the protein content removed from the inclusion bodies after each wash analyzed (Figure 4.4B,
lanes W1-W3). After the first wash step a band at ~ 35 kDa was observed, which corresponds to the
expected mass of His-RhodIDS, with other contaminant protein bands ranging from 10 – 250 kDa also
present (Figure 4.4B, lane W1). Only a faint band at ~ 35 kDa was observed in the second wash
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(Figure 4.4B, lane W2) and no bands were observed in the third wash step (Figure 4.4B, lane W3).
Prior to refolding, the final washed sample containing the inclusion bodies showed a significant band
at ~ 35 kDa with some contaminant proteins observed between 10 – 250 kDa (Figure 4.4B, lane IB).
Finally, the sample containing refolded protein showed a single band at ~ 35 kDa, indicative of the
refolding of His-RhodIDS (Figure 4.4B, lane R). To confirm that the band observed at ~ 35 kDa in the
SDS-PAGE gels was indeed recombinant His-RhodIDS, the inclusion body and refolded samples from
Figure 4.4B (lanes IB and R, respectively) were immunoblotted with an anti-6x-His antibody (Figure
4.4C). A band at ~ 35 kDa was observed in both the inclusion body and refolded samples, confirming
that the protein observed in the SDS-PAGE gels was recombinant His-RhodIDS. The final purity of
refolded His-RhodIDS was determined to be > 99% with a yield of ~ 20 µg from 250 µg of starting
material.

Figure 4.4: His-RhodIDS is insolubly expressed in bacteria but can be refolded from inclusion bodies. (A)
Exploring the soluble expression of His-RhodIDS via different induction conditions, as assessed by SDS-PAGE
analysis. His-RhodIDS was expressed at varying temperatures (18˚C or 37˚C) and IPTG concentrations (0.1 0.5 mM). For each induction condition tested, lanes NI and I represent the total protein content prior to and
after addition of IPTG, respectively. Lane S represents the soluble protein content after the addition of IPTG
and lane P represents the insoluble protein content present in the pellet after extraction. (B) Refolding of HisRhodIDS from insoluble inclusion bodies. The extracted cell pellet (containing inclusion bodies, lane P) was
washed by resuspending, sonicating, and centrifuging the cell pellet and the supernatant of each wash step was
loaded onto the gel to assess removal of contaminant proteins (lanes W1 to W3). The washed inclusion bodies
(lane IB) were solubilized in 10 mM Tris (pH 7.0) containing 10 mM DTT and 5.6 M GdHCl. His-RhodIDS
was refolded from the solubilized inclusion body by dialysis into 10 mM phosphate (pH 7.0) supplemented
with 5 mM DTT and 200 mM sodium thiosulfate overnight at 4˚C. Refolded protein was then concentrated for
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SDS-PAGE analysis (lane R). (C) Immunoblot to confirm the successful refolding of His-RhodIDS from
inclusion bodies. Recombinant protein from panel B (lanes IB and R) were probed with an anti-6x-His primary
antibody. For all gels, the expected molecular mass of His-RhodIDS is indicated with an arrow and precisionplus dual-color protein standards (in kDa) are shown.

4.3.4

SUMO-tagged Avi-RhodIDS can be expressed and purified in a soluble form

While His-RhodIDS was able to be refolded from inclusion bodies, the total yield of refolded protein
was extremely low (µg amounts) and less than that required for ensemble-based assays. Thus,
restriction-enzyme cloning was performed with the aim of improving the soluble expression of AviRhodIDS via incorporation of an additional N-terminal maltose binding protein (MBP) or small
ubiquitin-like modifier (SUMO) solubility tag. Unlike His-RhodIDS, the C-terminal AviTag motif was
retained in this isoform to facilitate immobilization of FlucIDS to a neutravidin-functionalized
coverslip (Appendix IV).

Successful PCR amplification of the DNA encoding Avi-RhodIDS (with C-terminal AviTag) from
template DNA was assessed by agarose gel electrophoresis (Figure 4.5A). When the products from
the PCR reaction were loaded onto an agarose gel a strong band was observed at ~ 1,400 bp, which
is larger than the expected length of the sequence encoding Avi-RhodIDS (994 bp) (Figure 4.5A, lane
I). No band was observed when the template DNA was omitted from the PCR reaction (Figure 4.5,
lane (-)), indicative of successful amplification of template DNA.

Both the PCR amplified Avi-RhodIDS insert and the destination vectors, pSUMO or pMBP, were
incubated with BamHI and XhoI restriction enzymes and successful digestion was assessed by
agarose gel electrophoresis (Figure 4.5B). As expected, the digested PCR-amplified Avi-RhodIDS
inserts showed a clear band at ~ 1,000 bp, close to the expected length of the digested insert (981 bp).
When the destination vectors were digested with BamHI or XhoI individually, or in combination, a
strong band was observed above the largest DNA fragment present in the marker in disagreement
with the expected length of digested pSUMO (5589 bp) or pMBP (5581 bp). Following double
digestion of pSUMO, a faint band at ~ 1,000 bp is observed which corresponds to the expected
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sequence length of the excised DNA insert within pSUMO (978 bp). When restriction enzymes were
omitted from the digestion reaction, a predominant band was observed at ~ 10,000 bp for pSUMO
with multiple faint bands observed at larger sizes, consistent with supercoiling of circularized nondigested DNA fragments. Similarly, when restriction enzymes were omitted from the digestion
reaction with pMBP a band was present that appeared significantly smaller compared to non-digested
pMBP, again consistent with supercoiling of circularized non-digested DNA fragments.

Colonies of E. coli DH5𝛼 cells transformed with ligated product were screened using PCR and
agarose gel electrophoresis to determine whether the transformants contained the pSUMO or pMBP
vectors with the cloned Avi-RhodIDS insert (Figure 4.5C-D). As a positive control, amplification of
the original template vector was performed which showed a band at ~ 1,000 bp that corresponds to
the expected length of the Avi-RhodIDS sequence (Figure 4.5C, lane (+)). No band was observed when
the template DNA was omitted from the PCR reaction (Figure 4.5C-D, lane (-)). PCR amplification
of five DH5𝛼 colonies each transformed with SUMO- or MBP-ligated product showed the presence
of a band at ~ 1100 bp, which corresponds to the expected length of the tagged Avi-RhodIDS insert
(Figure 4.5C-D).
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Figure 4.5: Restriction-enzyme cloning of MBP- or SUMO-tagged Avi-RhodIDS. (A) Agarose gel
electrophoresis of DNA products following PCR amplification of an Avi-RhodIDS insert. Lane (-) denotes the
negative control in which no template DNA was added to the PCR reaction. Lane I denotes the sample
containing the PCR-amplified insert. (B) Agarose gel electrophoresis of the PCR amplified Avi-RhodIDS insert
(from A, lane I), pSUMO and pMBP cloning plasmids following restriction-enzyme digestion with BamHI
and XhoI. The key at the bottom of the gel denotes whether restriction enzymes were present (+) or absent (-)
in each reaction. (C) Agarose gel electrophoresis of DNA products formed following PCR amplification of
crude DNA extracts from E. coli DH5𝛼 colonies transformed with insert and pSUMO or (D) pMBP ligated
DNA. Lane (-) denotes the negative control in which no template DNA was added to the PCR reaction while
lane (+) denotes the positive control in which template DNA containing the insert of interest is present. The
PCR products from crude DNA extracts of different DH5𝛼 colonies are indicated (colonies). Hyperladder II
(A, C and D) and Hyperladder I (B) markers are shown with approximate size of DNA bands in the gel shown
on the left.
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The soluble expression of MBP- or SUMO-tagged Avi-RhodIDS (with N-terminal 6x-His tag,
Appendix IV) was assessed by SDS-PAGE and immunoblotting analysis (Figure 4.6). Prior to
induction with IPTG, there was no band observed in the extracted total protein or soluble cell lysate
that corresponds to the expected molecular mass of MBP-tagged Avi-RhodIDS (~ 80 kDa, Figure
4.6A, lanes NI and 0 hr, respectively). Following the induction of protein expression by the addition
of IPTG, a strong band at ~ 80 kDa was present in the extracted total protein E. coli cell lysate for
both induction conditions tested, indicative of the over-expression of MBP-tagged Avi-RhodIDS
(Figure 4.6A, lanes I). No apparent band at ~ 80 kDa was observed in the soluble lysate at any
timepoint tested when MBP-tagged Avi-RhodIDS was expressed at 37˚C (Figure 4.6A, left, lanes 1, 2
and 4 hr); however, a band at ~ 80 kDa was observed after overnight expression when MBP-tagged
Avi-RhodIDS was expressed at 18˚ (Figure 4.6A, right, lane 20 hr).

Similar to MBP-tagged Avi-RhodIDS, no band was observed at the expected molecular weight for
SUMO-tagged Avi-RhodIDS (~ 50 kDa) in the total or soluble cell lysate prior to induction with IPTG
for either expression condition tested (Figure 4.6B, lanes NI or 0 hr). Following the induction of
protein expression by the addition of IPTG, a strong band at ~ 50 kDa was present in the extracted
total protein E. coli cell lysate for both induction conditions tested, indicative of the over-expression
of SUMO-tagged Avi-RhodIDS (Figure 4.6B, lanes I). No apparent band at ~ 50 kDa was observed in
the soluble lysate at any timepoint tested when SUMO-tagged Avi-RhodIDS was expressed at 37˚C
(Figure 4.6B, left, lanes 1, 2 and 4 hr); however, a prominent band at ~ 50 kDa was observed after
overnight expression when SUMO-tagged Avi-RhodIDS was expressed at 18˚ (Figure 4.6B, right, lane
20 hr).
To confirm that induction of recombinant protein at 18˚C does result in the soluble expression of
MBP- or SUMO-tagged Avi-RhodIDS, the total protein and soluble cell lysates from the SDS-PAGE
analysis were immunoblotted with an anti-6x-His antibody specific for the 6x-His tag located at the
N-terminus of the MBP and SUMO tags. Prior to protein induction with IPTG, only faint bands at ~
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80 or 50 kDa were observed (Figure 4.6C, lanes NI), which correspond to MBP- or SUMO-tagged
Avi-RhodIDS respectively. However, a strong band at these molecular weights was observed in the
total protein lysate following addition of IPTG to induce expression of the recombinant proteins
(Figure 4.6C, lanes I). Similarly, as with the total protein, only faint bands at ~ 80 or 50 kDa were
present in the soluble lysate prior to induction with IPTG (Figure 4.6C, lanes 0 hr). However, the
intensity of these bands increased substantially over the incubation period for both MBP- and SUMOtagged Avi-RhodIDS (Figure 4.6C, lanes 4 hr and 10 hr), indicative of the soluble expression of these
recombinant proteins.
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Figure 4.6: MBP- or SUMO-tagged Avi-RhodIDS can be expressed in a soluble form. Assessing the soluble
expression of MBP- or SUMO-tagged Avi-RhodIDS under different induction conditions via SDS-PAGE
analysis. The expression of (A) MBP-tagged Avi-RhodIDS and (B) SUMO-tagged Avi-RhodIDS was either
performed at 37˚C for 4 hr with 0.5 mM IPTG (left) or at 18˚C overnight with 0.1 mM IPTG (right). (C)
Immunoblot of samples from A and B (right) to confirm the soluble expression of MBP or SUMO-tagged AviRhodIDS. Recombinant protein was probed with an anti-6x-His primary antibody that recognizes the 6x-His
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affinity tag on the MBP and SUMO solubility tags. For all panels, lanes NI and I represent the total protein
content prior to and after addition of IPTG, respectively. Lane 0 h represents the soluble protein content prior
to the addition of IPTG. Protein samples in which the soluble cell lysate from timepoints following addition
of IPTG is denoted above the gel (soluble). For all gels, the expected molecular mass of solubility-tagged AviRhodIDS is indicated with an arrow and precision-plus dual-color protein standards (in kDa) are shown.

Based on reports that MBP-tagged proteins can become insoluble upon removal of the MBP tag
(Ashraf et al., 2004; Raran-Kurussi et al., 2016), the SUMO-tagged Avi-RhodIDS construct was
chosen for subsequent work. The recombinant SUMO-tagged Avi-RhodIDS was first purified from
contaminant proteins in the cell lysate using IMAC by exploiting the N-terminal 6x-His tag on the
SUMO solubility tag (Figure 4.7A), and its purity was assessed by SDS-PAGE (Figure 4.7B). A
strong band at ~ 50 kDa in the sample loaded onto the IMAC column (Figure 4.7B, lane L) confirmed
the presence of SUMO-tagged Avi-RhodIDS in the extracted E. coli soluble lysate prior to IMAC
purification. Following application of the cell lysate sample onto the IMAC column, the absorbance
at 280 nm increased substantially and then returned to basal levels. SDS-PAGE analysis indicated
that almost all proteins in the cell lysate eluted in this peak (Figure 4.7B, lanes 4 - 6). The addition of
IMAC buffer B resulted in a sharp peak in absorbance at 280 nm that decreased and plateaued at ~
200 absorbance units. The absorbance at 280 nm returned to basal levels following the addition of
IMAC buffer A. SDS-PAGE analysis of the eluent fractions collected following the addition of IMAC
buffer B indicated a strong band at ~ 50 kDa, which corresponds to the expected mass of SUMOtagged Avi-RhodIDS (Figure 4.7B). Thus, these fractions were pooled for subsequent cleavage and
purification.

Following overnight incubation with Ulp1 to remove the 6x-His-SUMO solubility tag from the
recombinant protein, IMAC was again utilized to further purify Avi-RhodIDS from contaminant
proteins that had previously co-eluted with recombinant SUMO-tagged Avi-RhodIDS (Figure 4.7C).
SDS-PAGE analysis of the load fraction prior to IMAC purification showed a band at ~ 36 and 14
kDa, which corresponds to Avi-RhodIDS and the cleaved SUMO tag, respectively (Figure 4.7D). A
significant contaminant band at ~ 32 kDa was also observed in this sample. When the sample was
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loaded onto the IMAC column there was an increase in absorbance at 280 nm that returned to baseline
upon addition of IMAC buffer C (Figure 4.7C). SDS-PAGE analysis of the eluent fractions containing
this peak confirmed the presence of recombinant Avi-RhodIDS and a smaller proportion of the ~ 32
kDa contaminant protein in these fractions (Figure 4.7D, lanes 2 - 10). These fractions were
subsequently pooled and dialyzed for subsequent purification. Following the addition of IMAC buffer
B to the column, there was a peak in absorbance at 280 nm. The absorbance at 280 nm and the
conductivity returned to basal levels following the addition of IMAC buffer C. SDS-PAGE analysis
of the eluent fractions following the addition of IMAC buffer B showed a significant band at ~ 14
kDa, which corresponds to the SUMO solubility tag with N-terminal 6x-His motif, and a small
amount of Avi-RhodIDS in these fractions (Figure 4.7D, lanes 12 - 14).

IEX chromatography was performed to further purify recombinant Avi-RhodIDS (Figure 4.7E). SDSPAGE analysis of the load fraction prior to IEX purification showed a band at ~ 36 kDa, which
corresponds to Avi-RhodIDS, and a contaminant band at ~ 32 kDa (Figure 4.7F). When the sample
was loaded onto the IEX column there was no increase in absorbance at 280 nm, suggesting that all
proteins in the sample bound to the IEX column (data not shown). Following the gradual addition of
salt to the IEX column, three major peaks in absorbance at 280 nm were observed that centered at
elution volumes of 14.0 mL, 16.1 mL and 22.4 mL (Figure 4.7E, peaks 1 - 3, respectively). SDSPAGE analysis of the eluent fractions containing the peak centered at 14.0 mL (peak 1) indicated the
presence of the contaminant protein at 32 kDa (Figure 4.7F). SDS-PAGE analysis of the eluent
fractions containing the peak centered at 16.1 mL (peak 2) predominantly contained recombinant
Avi-RhodIDS (at ~ 36 kDa) and a small amount of the contaminant protein (at ~ 32 kDa). Finally,
SDS-PAGE analysis of the eluent fractions containing the peak centered at 22.4 mL (peak 3) indicated
the presence of recombinant Avi-RhodIDS in these fractions. No other major contaminant bands were
observed in these fractions, which were subsequently pooled, dialyzed into storage buffer and frozen
in liquid nitrogen for storage at -20˚C.This purification protocol generated 2.6 mg of Avi-RhodIDS
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per liter of culture and the protein was > 95% pure, as assessed by densitometry of the SDS-PAGE
gel.
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Figure 4.7: Purification of recombinant SUMO-tagged Avi-RhodIDS. (A) A representative chromatogram
showing the initial purification of SUMO-tagged Avi-RhodIDS from the induced E. coli cell lysate by IMAC.
The cell lysate was loaded onto a 5 mL His-Trap Sephadex IMAC column and non-specific protein eluted with
50 mM Tris-base (pH 8.0) containing 5 mM imidazole, 20 mM sodium thiosulfate, 10% (v/v) glycerol and
300 mM NaCl (IMAC buffer A). Recombinant SUMO-tagged Avi-RhodIDS was eluted with IMAC buffer A
supplemented with 500 mM imidazole. (B) SDS-PAGE of the eluted fractions from the initial IMAC
purification of SUMO-tagged Avi-RhodIDS. (C) A representative chromatogram showing the subsequent
purification of Avi-RhodIDS via IMAC. Ulp1-cleaved Avi-RhodIDS was loaded onto the IMAC column and
purified as described for A with the exception that imidazole was omitted from IMAC buffer A (IMAC buffer
C). (D) SDS-PAGE of the eluted fractions from the subsequent IMAC purification of Avi-RhodIDS. (E) A
representative chromatogram showing the purification of Avi-RhodIDS via IEX chromatography. IMACpurified Avi-RhodIDS was loaded onto a MonoQ column equilibrated in 10 mM Tris (pH 9.0) supplemented
with 0.5 mM EDTA and 10% (v/v) glycerol (IEX buffer A) and non-bound protein eluted with IEX buffer A.
Bound protein was then eluted with a linear salt gradient (0 – 500 mM NaCl) over 20 column volumes. Major
peaks analyzed by SDS-PAGE are indicated within the chromatogram. (F) SDS-PAGE of the eluted fractions
from IEX purification of Avi-RhodIDS. For all chromatograms, protein elution was monitored by measuring
the absorbance at 280 nm (black) and conductivity (mS/cm, purple). The greyed areas and numbers at the top
of the chromatogram indicate the fractions collected and analyzed by SDS-PAGE. For all SDS-PAGE gels,
lane L refers to the sample that was loaded onto the column. The numbers above the gel refer to the eluate
fractions from the corresponding chromatogram. The expected molecular mass of recombinant protein is
indicated with an arrow. Precision-plus dual-color protein standards (in kDa) are shown for B, D and F.

4.3.5

The unfolding and refolding of individual Avi-RhodIDS proteins can be monitored in real
time using smFRET

As recombinant Avi-RhodIDS was able to be purified in a soluble form, experiments were conducted
to determine whether its folding and unfolding could be monitored using smFRET. To do so, FRETpair fluorophore labelled Avi-RhodIDS was immobilized to a neutravidin-functionalized coverslip and
imaged using TIRF microscopy. The majority of native (non-denatured) Avi-RhodIDS molecules
exhibited stable FRET efficiencies, with a distribution centered at 0.95 FRET (Figure 4.8A-B).
Incubation of Avi-RhodIDS with increasing concentrations of GdHCl resulted in decreases in the
FRET efficiencies (Figure 4.8A-B) such that, when in 4 M GdHCl, the FRET distribution was
centered at 0.3 and the FRET efficiency of individual molecules were consistently stable.

Interestingly, when the reverse experiment was performed (i.e., stepwise dilution from higher
concentrations of GdHCl), the FRET efficiency histograms were shifted to generally lower FRET
values compared to those obtained in the corresponding GdHCl concentrations during unfolding
(Figure 4.8B). This unfolding and refolding of Avi-RhodIDS was analyzed as the proportion of time
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that Avi-RhodIDS resides at high-FRET states (i.e., > 0.7), and this was plotted as a function of GdHCl
concentration (Figure 4.8C). There was little change in the proportion of time that Avi-RhodIDS spent
at FRET values greater than 0.7 at low concentrations of GdHCl (i.e., 0 – 1 M). However, there was
a significant decrease in the percentage of time that Avi-RhodIDS spent at high-FRET values at higher
concentrations of GdHCl, indicative of protein unfolding, until it reached a plateau at ~ 3 M GdHCl.
The midpoint of unfolding (U50) and refolding (R50) were identical (1.50 M and 1.51 M GdHCl,
respectively); however, the proportion of time that refolded Avi-RhodIDS spent at FRET values
greater than 0.7 did not return to that observed for native (non-denatured) Avi-RhodIDS (Figure 4.8C).
Notably, when Avi-RhodIDS was diluted out of 4 M GdHCl it rapidly adopted a FRET distribution
centered at ~ 0.85, lower than that observed for native (non-denatured) Avi-RhodIDS (~ 0.95) (Figure
4.8D). Interestingly, the FRET distribution of these Avi-RhodIDS molecules did not recover the FRET
distributions characteristic of native Avi-RhodIDS even after 1 hr of imaging. This suggests that AviRhodIDS adopts a stable misfolded conformation following dilution from denaturant and does not
spontaneously refold to the native state.
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Figure 4.8: The conformation of individual Avi-RhodIDS molecules can be monitored using smFRET.
(A) Representative smFRET traces of individual AF555/647-labelled Avi-RhodIDS molecules when incubated
with increasing concentrations of GdHCl (0 – 4 M). Data is fit with an HMM (shown in orange). (B) Ridgeline
plot of the FRET efficiency of Avi-RhodIDS when unfolded by increasing concentrations of GdHCl (0 – 4 M)
and during refolding following dilution out of denaturant. (C) Unfolding and refolding of Avi-RhodIDS
expressed as the percentage of time spent at FRET values greater than 0.7 at different concentrations of GdHCl.
Data is calculated as the total number of datapoints that Avi-RhodIDS molecules resided at FRET values greater
than 0.7 divided by the total number of datapoints. (D) Ridgeline plot of the FRET efficiency of Avi-RhodIDS
following dilution out of denaturant (4 M GdHCl). The spontaneous refolding was monitored for 1 hr. Images
were taken every 6 min and the FRET efficiency histograms were plotted for each timepoint. Data for panels
B and C were derived and collated from a minimum of 55 molecules per treatment. Data for panel D is collated
from a minimum of 34 molecules per treatment.
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Thus far, the work described in this chapter was performed with the aim of generating a Rhod IDS
construct that could be immobilized to a coverslip surface so that the conformation of individual
proteins could be monitored in real time. To demonstrate the utility of the specific immobilization of
the Avi-RhodIDS folding sensor, experiments were performed to visualize the real-time unfolding and
refolding of individual Avi-RhodIDS molecules. Native Avi-RhodIDS (measured between 0 – 20 s)
exhibited a FRET efficiency of ~ 0.9 – 1 (Figure 4.9A-B), consistent with previous smFRET data
(Figure 4.8B). Upon addition of denaturant, the FRET efficiency was observed to rapidly drop to less
than 0.4 for all Avi-RhodIDS molecules measured. Upon removal of GdHCl from the flow cell, the
FRET efficiency rapidly increased back to a high-FRET state (~ 0.9). Similar transitions to low-FRET
and high-FRET states were observed following a second round of injection and removal of denaturant
from the flow cell. Together, these data highlight that conformational changes of individual AviRhodIDS molecules can be monitored via smFRET and that this construct has the potential to be used
to examine the conformation of Avi-RhodIDS during interaction with molecular chaperones.

Figure 4.9: smFRET can be used to monitor conformational changes of Avi-RhodIDS at millisecond
resolution. Immobilized Avi-RhodIDS was incubated in imaging buffer supplemented with or without 4 M
GdHCl and the FRET efficiency was measured every 500 ms. (A) Representative smFRET traces of individual
Avi-RhodIDS molecules. The addition and removal of 4 M GdHCl from the flow cell is indicated above. Data
were fit with an HMM (shown in orange). (B) The FRET efficiency over time for all Avi-RhodIDS molecules
were collated and plotted as a heatmap (n = 44).
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4.3.6

Chaperone-mediated changes in Avi-RhodIDS conformation can be monitored in real
time

Since smFRET can now be used to monitor the conformation of individual Avi-RhodIDS proteins with
temporal resolution, we next sought to investigate how molecular chaperones affect the structure of
Avi-RhodIDS. To do so, increasing concentrations of the class II Hsp40 isoform, DnaJB1, were titrated
in with Avi-RhodIDS as it was removed from denaturant and the FRET efficiency of individual
immobilized Avi-RhodIDS proteins monitored. When denatured Avi-RhodIDS was allowed to refold
in the absence of chaperones, Avi-RhodIDS adopted a high-FRET distribution centered at ~ 0.9 (Figure
4.10A-B), consistent with previous observations as part of this work. Incubation of Avi-RhodIDS with
increasing concentrations of DnaJB1 resulted in the appearance of a population of low-FRET (< 0.7)
species, which is supported by the increased amount of time that Avi-RhodIDS molecules resided at
these low-FRET states with increasing DnaJB1 concentrations (Figure 4.10B and D). Additionally, a
higher proportion of Avi-RhodIDS molecules transitioned to or from ultra-low FRET states (< 0.5)
with increasing concentrations of DnaJB1 (Supplementary Figure 4.1A). Such ultra-low FRET states
are so named because high concentrations of denaturant (> 3 M) are required for Avi-RhodIDS to
significantly populate these FRET states, which are indicative of significantly expanded Avi-RhodIDS
conformations (Figure 4.8B). This is consistent with results of the transition density plots (TDPs),
which provide information on the initial (FBefore) and final (FAfter) FRET states of all Avi-RhodIDS
transitions, whereby an increased transition density at low-FRET regimes (0.2 – 0.7) was observed
when incubated with high concentrations of DnaJB1 (e.g., > 5 µM) compared to in the absence of
chaperone (Figure 4.10C).

For consistency with the work involving FlucIDS (Chapter 3) and to best identify FRET transitions
and states that are attributable to chaperone function, a FRET threshold of 0.7 was used to filter the
kinetic data for Avi-RhodIDS. This threshold was chosen on the basis that native or spontaneously
refolded Avi-RhodIDS rarely occupied FRET states lower than 0.7 (< 5% and ~ 20% of the total time
for native and spontaneous refolding, respectively), whereas chemically unfolded Avi-RhodIDS
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tended to populate FRET states lower than 0.7 (Figure 4.8B). Thus, FRET states greater than 0.7 were
considered ‘high’ and FRET states below 0.7 were considered ‘low’. Kinetic analysis of individual
Avi-RhodIDS molecules indicated that the occurrence of Tlow-low transitions were much higher with
increasing concentrations of DnaJB1 (28.3% and 25.8% at 5 µM and 10 µM, respectively) compared
to in the absence of chaperones (10.7%) (Figure 4.10D, Supplementary Figure 4.1B). Conversely, the
occurrence of Thigh-high transitions decreased with higher concentrations of DnaJB1 (58.2% and 61.9%
for 5 µM and 10 µM, respectively) compared to spontaneously refolded Avi-RhodIDS (70.0%).
Notably, there was no significant difference in the transition probability of Thigh-low and Tlow-high
transitions, or residence times for Thigh-high, Thigh-low or Tlow-high transition classes, with increasing
concentrations of DnaJB1 (Figure 4.10D, Supplementary Figure 4.1C). Avi-RhodIDS incubated with
2 µM DnaJB1 was observed to have a higher residence times for Tlow-low transitions compared to when
incubated with 10 µM DnaJB1 or in the absence of chaperone. Collectively, these results are
consistent with DnaJB1 stabilizing conformationally expanded conformations of Avi-RhodIDS.
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Figure 4.10: High concentrations of DnaJB1 shift the conformational landscape of Avi-RhodIDS to
expanded conformations. Immobilized Avi-RhodIDS was unfolded with 4 M GdHCl and imaged following
removal of denaturant with imaging buffer alone (i.e., spontaneous) or containing increasing concentrations of
DnaJB1 (1 – 10 µM). (A) Representative smFRET traces of individual Avi-RhodIDS molecules when incubated
in the absence or presence of increasing concentrations of DnaJB1 (2 – 10 µM). Data is fit with an HMM
(shown in orange). (B) FRET efficiency histograms of native (non-denatured), spontaneously refolded AviRhodIDS or Avi-RhodIDS incubated with increasing concentrations of DnaJB1 (1 – 10 µM). (C) Transition
density plots (TDP) showing the initial and final FRET state of Avi-RhodIDS transitions when refolded in the
absence or presence of increasing concentrations of DnaJB1. (D) A summary of the kinetic data for each
dataset represented as annotated heatmaps. For simplicity, the kinetic data were filtered for FBefore values less
than or greater than 0.7 FRET. The color of the heatmap denotes the percentage of time that Avi-RhodIDS
resides above or below 0.7 FRET. The direction of each arrow refers to the transition direction, whereby the
origin of each arrow denotes FBefore and the arrowhead denotes FAfter. The size of each arrow is directly
proportional to the normalized occurrence of those transitions. The mean Residence for each transition class is
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denoted adjacent to its respective arrow. Data for panels B - D are derived and collated from the HMM fits of
at least 191 individual Avi-RhodIDS molecules per treatment.

Experiments were performed to determine whether different Hsp40 isoforms, such as the class I cochaperones DnaJA1 and DnaJA2, could affect the conformation of Avi-RhodIDS. Interestingly,
incubation of RhodIDS with DnaJA1 resulted in a significant shift towards low-FRET regimes, with
many molecules exhibiting dynamic transitions to and from ultra-low-FRET states (< 0.5, 50.4%)
(Figure 4.11A-B, Supplementary Figure 4.2A). This is supported by the TDP analysis, whereby AviRhodIDS incubated with DnaJA1 exhibited significant transition density over a wide range of FRET
states (0.2 – 1.0), which was not observed in the absence of chaperone (Figure 4.11C). In contrast,
incubation of Avi-RhodIDS with DnaJB1 or DnaJA2 resulted in FRET trajectories, histograms and
TDP distributions similar to that previously described for Avi-RhodIDS that had been incubated in the
absence of chaperone (Figure 4.11A-C). Similar results were observed when Avi-RhodIDS was
incubated with DnaJB1, with the exception that Avi-RhodIDS occupied FRET distributions similar to
those observed for the native protein. Consistent with the above results, Avi-RhodIDS resided at lowFRET states more often when incubated in the presence of DnaJA1 (50%) compared to when it was
incubated in the presence of DnaJB1 (16%), DnaJA2 (16%) or in the absence of chaperone (19%)
(Figure 4.11D). Crucially, the incubation of Avi-RhodIDS with the non-chaperone control protein,
ovalbumin, resulted in FRET efficiencies and transition kinetics identical to that observed for
spontaneously refolded Avi-RhodIDS, indicating that the changes in Avi-RhodIDS conformation are
likely due to chaperone-specific effects (Supplementary Figure 4.3).

Kinetic analyses revealed that Avi-RhodIDS exhibited a significantly higher proportion of Tlow-low
transitions when incubated with DnaJA1 (39.4%) compared to in the presence of DnaJB1 (15.0%),
DnaJA2 (21.2%) or in the absence of chaperone (10.7%) (Figure 4.11D, Supplementary Figure 4.2B).
Conversely, the occurrence of Thigh-high transitions was much lower when RhodIDS was incubated with
DnaJA1 (31.8%) compared to with DnaJB1 (72.1%), DnaJA2 (62.6%) or in the absence of chaperone
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(70.0%). The occurrence of Thigh-low and Tlow-high transitions also increased when RhodIDS was
incubated with DnaJA1 compared to in the absence or presence of DnaJB1 or DnaJA2. Avi-RhodIDS
exhibited longer Thigh-high residence times when incubated in the presence of DnaJA2 compared to all
other treatments whereas shorter Thigh-high transitions were observed when Avi-RhodIDS was incubated
with DnaJB1 compared to in the absence of chaperone (Figure 4.11D, Supplementary Figure 4.2C).
There was no significant difference in residence times for Tlow-low, Tlow-high or Thigh-low transition classes
between treatment groups. Notably, the combined incubation of DnaJB1 or DnaJA2 with HspA8 did
not significantly affect the FRET efficiencies, transition distributions or kinetics of Avi-RhodIDS
compared to when incubated in the presence of the corresponding Hsp40 isoforms alone
(Supplementary Figure 4.3).
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Figure 4.11: Human Hsp40 isoforms differ in their ability to stabilize conformationally expanded states
of Avi-RhodIDS. Immobilized Avi-RhodIDS was unfolded with 4 M GdHCl and imaged following removal of
denaturant with either DnaJA1 (2 µM), DnaJA2 (1 µM) or DnaJB1 (1 µM). (A) Representative smFRET traces
of individual Avi-RhodIDS molecules when incubated in the presence of the indicated chaperones. Data is fit
with an HMM (shown in orange). (B) FRET efficiency histograms of Avi-RhodIDS when folded (i.e., native),
following removal of 4 M GdHCl without chaperone (i.e., spontaneous) or with the indicated chaperones. (C)
Transition density plots (TDP) showing the initial and final FRET state of Avi-RhodIDS transitions for each
treatment. (D) A summary of the kinetic data for each dataset represented as annotated heatmaps. For
simplicity, the kinetic data were filtered for FBefore values less than or greater than 0.7 FRET. The color of the
heatmap denotes the percentage of time that Avi-RhodIDS resides above or below 0.7 FRET. The direction of
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each arrow refers to the transition direction, whereby the origin of each arrow denotes FBefore and the arrowhead
denotes FAfter. The size of each arrow is directly proportional to the normalized occurrence of those transitions.
The mean Residence for each transition class is denoted adjacent to its respective arrow. Data for panels B – D
were derived and collated from the HMM fits of at least 119 individual Avi-RhodIDS molecules per treatment.

Lastly, in an experiment analogous to that performed with FlucIDS (see section 3.3.7), real-time
smFRET experiments with Avi-RhodIDS in the presence of the bacterial Hsp70 system were
performed (Figure 4.12). Interestingly, incubation of Avi-RhodIDS with either the KJ system (e.g.,
DnaJ, DnaK and ATP) or the complete KJE system (e.g., DnaJ, DnaK, GrpE and ATP) resulted in a
high-FRET population (~ 0.95) similar to that observed for native Avi-RhodIDS and higher than that
for spontaneously refolded Avi-RhodIDS (Figure 4.12B). However, in contrast to native Avi-RhodIDS,
a higher proportion of molecules were observed to transition to or from ultra-low FRET states (< 0.5)
when either chaperone system was present (32.9% or 28.5% for the KJ and KJE system, respectively)
compared to in the absence of chaperone (21.6%) (Figure 4.12A-B, Supplementary Figure 4.4A).
Such a result is consistent with the more pronounced transition density observed at low-FRET states
(0.2 – 0.7) in the TDPs when Avi-RhodIDS was incubated in the presence of the KJ or KJE system
compared to when chaperones were not present (Figure 4.12C).

Avi-RhodIDS resided at low-FRET states more often when incubated in the presence of the KJE
system (< 0.7, 29%) compared to spontaneously refolded Avi-RhodIDS (19%), but less so compared
to when GrpE was not present (36%) (Figure 4.12D). Kinetic analysis of individual FRET trajectories
revealed that Avi-RhodIDS exhibited a higher proportion of Tlow-low transitions when incubated with
KJ or KJE system (26.4% and 20.5%, respectively) compared to in the absence of chaperone (10.7%)
(Figure 4.12D, Supplementary Figure 4.4B). Conversely, the occurrence of Thigh-high transitions was
reduced when Avi-RhodIDS was incubated with the KJ or KJE system (60.2% and 63.7%,
respectively) compared to in the absence of chaperone (70.0%). The occurrence of Thigh-low and Tlowhigh

transitions for Avi-RhodIDS were not significantly affected by the presence of the chaperones.
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Additionally, there was no statistically significant difference in the corresponding residence times for
each transition class between different treatments (Figure 4.12D, Supplementary Figure 4.4C).

Figure 4.12: The bacterial Hsp70 system can induce conformational changes of Avi-RhodIDS.
Immobilized Avi-RhodIDS was unfolded with 4 M GdHCl and imaged following removal of denaturant with
DnaK (3 µM), DnaJ (1 µM) and ATP (5 mM) (+ KJ). After 40 min, the buffer was supplemented with GrpE
(1.5 µM) (+ KJE) and Avi-RhodIDS molecules were imaged. (A) Representative smFRET traces of individual
Avi-RhodIDS molecules when incubated in the presence of the indicated chaperones. Data is fit with an HMM
(shown in orange). (B) FRET efficiency histograms of Avi-RhodIDS when folded (i.e., native), following
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removal of 4 M GdHCl without chaperone (i.e., spontaneous) or with the indicated combination of chaperones.
(C) Transition density plots (TDP) showing the initial and final FRET state of Avi-RhodIDS transitions for each
treatment. (D) A summary of the kinetic data for each dataset represented as annotated heatmaps. For
simplicity, the kinetic data were filtered for FBefore values less than or greater than 0.7 FRET. The color of the
heatmap denotes the percentage of time that Avi-RhodIDS resides above or below 0.7 FRET. The direction of
each arrow refers to the transition direction, whereby the origin of each arrow denotes FBefore and the arrowhead
denotes FAfter. The size of each arrow is directly proportional to the normalized occurrence of those transitions.
The mean Residence for each transition class is denoted adjacent to its respective arrow. Data for panels B – D
were derived and collated from the HMM fits of at least 274 individual Avi-RhodIDS molecules per treatment.
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4.4

Discussion

It is well established that the Hsp70 chaperone system mediates the folding of many different client
proteins in vivo, either by actively refolding misfolded or unfolded clients, or by directing foldingincompetent clients to other chaperone systems (e.g., Hsp60 or Hsp90) for efficient folding. However,
the precise molecular details as to why Hsp70 alone can refold some client proteins but not others, as
well as how Hsp70 primes folding-incompetent clients for transfer to other chaperone systems,
remains poorly understood. Thus, there is a pressing need to interrogate the manner by which Hsp70
interacts with client proteins it alone can and cannot refold as this will provide a fundamental
understanding of how molecular chaperones work to refold proteins back into their native
conformations. With this in mind, the work outlined in the chapter aimed to further develop a Hsp70
folding-incompetent client protein, RhodIDS, into a protein-folding sensor that could be used in TIRFbased smFRET experiments. In doing so, this work builds on and complements the work described
in Chapter 3, which involved the development of the Hsp70 folding-competent client FlucIDS into a
protein-folding sensor that could also be used in such approaches. The data presented in this chapter
demonstrates the development of a recombinant RhodIDS isoform that is expressed in a soluble form
when expressed in bacteria, acts as protein-folding sensor and can be immobilized to a coverslip
surface for real-time smFRET experiments. Using this RhodIDS construct, this work, for the first time,
monitored temporal changes in the conformation of RhodIDS during its unfolding and refolding.
Moreover, the data presented in this chapter demonstrates that RhodIDS becomes conformationally
expanded upon incubation with some mammalian Hsp40 isoforms and the bacterial Hsp70 system.

To facilitate the specific immobilization of RhodIDS to a coverslip surface, a necessity for temporal
smFRET experiments, a previously described RhodIDS construct (Kellner et al., 2014) was modified.
Surprisingly, the addition of short tags (i.e., an N-terminal 6x-His tag or C-terminal 15 residue
AviTag) dramatically reduced the soluble expression of RhodIDS such that it was predominately found
in inclusion bodies following expression in E. coli. Owing to their small size, these short tags tend to
not significantly affect the structure, function or solubility of recombinant proteins (Terpe, 2003;
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Kimple et al., 2013), although some detrimental effects on protein solubility has been observed in
rare cases (Zhu et al., 2013). Interestingly, insoluble expression of the fusion Rhod IDS protein
occurred regardless of whether the tag was incorporated at the N-terminus (e.g., 6x-His tag) or Cterminus (e.g., AviTag), suggesting that RhodIDS is particularly susceptible to any modification to its
native structure. The addition of MBP or SUMO solubility tags resulted in the rescue of soluble AviRhodIDS expression, consistent with the previously reported ability of such tags to enhance the soluble
expression of unstable and aggregation-prone client proteins (Terpe, 2003; Malakhov et al., 2004;
Butt et al., 2005; Marblestone et al., 2006; Kimple et al., 2013).

As when purifying FlucIDS, a contaminant at ~ 32 kDa was partially co-purified with Avi-RhodIDS.
This contaminant is most likely the BirA protein that is over-expressed during induction, and further
illustrates that over-expression results in non-specific interactions between the recombinant protein
and BirA, which are likely mediated via interactions with the introduced AviTag. Crucially, the
SUMO-tagged Avi-RhodIDS protein generated in this work could be effectively biotinylated in vivo
(when supplemented with exogeneous biotin during expression) and purified to homogeneity.

A significant finding from this work is that the purified, biotinylated, and fluorophore-labelled AviRhodIDS can be site-specifically immobilized to a coverslip surface and the conformation of individual
proteins monitored over time using smFRET. This finding was demonstrated by performing
microfluidic experiments in which individual immobilized Avi-RhodIDS molecules were alternately
incubated in the presence and absence of chemical denaturant - a concomitant decrease (unfolding)
and increase (refolding) in FRET efficiency for individual proteins was observed. Such observations
are not possible using the confocal-based single-molecule approaches used previously to investigate
the folded state of RhodIDS. Thus, these data provide the proof of principle that the Avi-RhodIDS
construct generated through this work can be used to monitor its folded state and, importantly, the
impact that molecular chaperones have on the conformation of individual proteins over time.
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Following the development of this Avi-RhodIDS protein-folding sensor, work was performed to take
advantage of this system to characterize the denaturant-induced unfolding and refolding of this
protein. As expected, native Avi-RhodIDS exhibited a high-FRET efficiency (~ 0.95) consistent with
the proximity of the two labelled cysteine residues (~ 9.1 Å, expected FRET efficiency of ~ 1.0).
Unfolding of Avi-RhodIDS with increasing concentrations of denaturant resulted in the gradual
decrease in FRET efficiency, consistent with the transition to a globally expanded random-coil-like
state that has been observed for other proteins (Schuler et al., 2002; Kuzmenkina et al., 2005; TezukaKawakami et al., 2006; Rosenkranz et al., 2011; Kellner et al., 2014; Imamoglu et al., 2020).
Removal of denaturant and subsequent refolding of Avi-RhodIDS results in the formation of a nonnative high-FRET misfolded ensemble of Avi-RhodIDS, consistent with previous findings (Kellner et
al., 2014). Interestingly, the FRET distribution of misfolded Avi-RhodIDS was not found to shift
significantly to native-like FRET distributions during the timescale of these experiments (~ 1 hr),
indicating that Avi-RhodIDS does not spontaneously refold under these conditions. This observation
is in contrast to previous work that has suggested that Rhod can spontaneously refold back to the
native state at low protein concentrations (picomolar - nanomolar) (Mendozas et al., 1991; Hofmann
et al., 2010; Kellner et al., 2014). The inability of Avi-RhodIDS to appreciably refold to the native
state under the experimental conditions used in this work suggests that the addition of the C-terminal
AviTag to RhodIDS and/or its tethering to the surface of a coverslip results in the formation of a
misfolded state that interferes with correct folding. Typically, the C-terminal domain of Rhod
normally folds first, followed by concomitant folding of the N-terminal domain and domain linker
(Hoffman 2010). Thus, it is possible that slower folding of the C-terminal domain of Avi-RhodIDS,
due to interference with the AviTag motif, leads to an overall reduced ability of Avi-RhodIDS to
spontaneously refold that could be exacerbated when the C-terminus is tethered to the coverslip
surface.

The Avi-RhodIDS folding sensor was next exploited to interrogate how a range of different Hsp40
isoforms (e.g., DnaJA1, DnaJA2 and DnaJB1) affects the folded state of this client protein.
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Interestingly, only DnaJA1 and high concentrations of DnaJB1 dramatically altered the
conformational landscape of Avi-RhodIDS, with smFRET kinetic analysis revealing that expanded
Avi-RhodIDS states are stabilized and remain conformationally dynamic in the presence of these two
Hsp40 isoforms. The stabilization of expanded Avi-RhodIDS conformations by DnaJA1 likely
represents a mechanism by which DnaJA1 inhibits the well-described aggregation of Rhod following
removal of denaturant (Minami et al., 1999). Typically, Hsp40 chaperones bind to and recognize
hydrophobic regions exposed in misfolded clients, sequestering them to prevent non-native
intermolecular contacts with other aggregation-prone species, preventing aggregation (Rüdiger et al.,
2001; Terada et al., 2010; Jiang et al., 2019). Thus, from this work it can be inferred that binding of
DnaJA1 results in the sequestration of hydrophobic motifs and maintenance of Avi-RhodIDS in a
conformationally expanded state, which partitions it away from aggregation by preventing
spontaneous collapse of the client to aggregation-prone misfolded states.

Notably, inhibition of Rhod aggregation is thought to be mediated by the zinc finger-like region
(ZFLR) of DnaJA1, which has been shown to the be main client-recognition motif for the yeast
DnaJA1 homolog Ydj1 (Lu et al., 1998b). The ZFLR is generally thought to contribute to the
enhanced ability of class I Hsp40 chaperones to prevent the aggregation of client proteins compared
to class II Hsp40 chaperones, such as DnaJB1, which do not possess the ZFLR motif (Minami et al.,
1996, 1999; Lu et al., 1998b; Linke et al., 2003; Li et al., 2009). Such an observation can likely be
attributed to a higher affinity of class I Hsp40 isoforms to their clients as a result of additional clientrecognition sites compared to their class II Hsp40 counterparts (Jiang et al., 2019). Such findings are
supported in this work, whereby much higher concentrations of DnaJB1 were needed before
significant conformational expansion of Avi-RhodIDS was observed (Figure 4.10B-D, Supplementary
Figure 4.1). However, this does not explain why DnaJA2 had a limited ability to stabilize expanded
conformations of Avi-RhodIDS. It is known that DnaJA1 and DnaJA2 have different abilities to cooperate with Hsp70 to refold chemically denatured Fluc (Tzankov et al., 2008; Baaklini et al., 2012),

153

Chapter 4 – Development of rhodanese for the real-time study of chaperone function
which suggests that there must be some other factor(s) (i.e., differences in the CTD-I or CTD-II clientbinding subdomains) that directs the specificity and/or affinity of these chaperones to client proteins.

Finally, smFRET experiments were performed to observe the interaction of the bacterial Hsp70
system (e.g., DnaJ, DnaK and GrpE) with individual Avi-RhodIDS molecules over time. Incubation
of Avi-RhodIDS in the presence of the KJ or KJE systems resulted in more transitions to, and
stabilization of, low-FRET states of Avi-RhodIDS compared to when the chaperones were not present.
Of note, a subset of Avi-RhodIDS molecules were observed to exhibit multiple transitions to or from
low-FRET states when incubated with the various components of the KJE system, consistent with the
chaperone-mediated conformational changes also observed with FlucIDS (see Chapter 3). Thus, these
experiments enable individual Avi-RhodIDS molecules to be monitored as the bacterial Hsp70 system
remodels their conformational landscape through time. Surprisingly, native-like FRET populations
of Avi-RhodIDS were also observed upon addition of the bacterial Hsp70 system. How these nativelike FRET populations arise remains unclear given that spontaneous refolding to the native occurs
slower than the timeframe of these experiments (if at all) and it is well established that the KJE system
is incapable of catalyzing the refolding of Rhod to an enzymatically active state (Langer et al., 1992).
It is possible that Rhod may populate misfolded, non-functional conformations that exhibit a similar
FRET efficiency as the native species; future work in which ensemble-based chaperone-assisted
refolding assays are performed (with either human or bacterial Hsp70 systems) would enable the
functional state of rhodanese to be correlated with the observed smFRET distributions. It was also
surprising that no significant difference was observed when Avi-RhodIDS was incubated in the
presence of the KJ system alone compared to when GrpE was present (i.e., the KJE system). Similar
findings have previously been attributed to the rapid re-association of DnaK to the client protein
immediately following GrpE-mediated release (Kellner et al., 2014). Considering the low loading
efficiency of DnaK onto the Avi-RhodIDS client employed in this work, as evidenced by the smaller
than expected conformational expansion of Avi-RhodIDS molecules when DnaK was present, it is

154

Chapter 4 – Development of rhodanese for the real-time study of chaperone function
more likely that the low proportion of DnaK-bound clients makes the addition of GrpE to this system
functionally redundant.

The addition of the bacterial Hsp70 system led to only a modest conformational expansion of AviRhodIDS in this work. This contrasts with previously published findings, which have demonstrated a
complete shift to KJ-mediated expanded states of RhodIDS upon addition of this bacterial Hsp70
system (Kellner et al., 2014). Whilst the precise reason(s) for the discrepancies between the findings
of this work and these previously published studies remain unclear, it is most likely due to a reduced
ability of DnaK to bind to and stabilize expanded conformations of Avi-RhodIDS in this work. This
may be due to a variety of reasons. First, this work employed lower concentrations of DnaK than used
by Kellner et al., (2014) (3 µM versus 10 µM), which would effectively reduce the loading of DnaK
onto Avi-RhodIDS. As such, the associated conformational expansion that occurs upon binding of
multiple DnaK molecules to a single Avi-RhodIDS client is not possible. It should also be noted that
precise comparisons in chaperone: client stoichiometries is not possible due to the effectively
‘infinite’ dilution of surface-immobilized client proteins in these experiments. Second,
immobilization of Avi-RhodIDS to the coverslip surface, which is required for the experiments
performed in this work, may sterically hinder the binding of molecular chaperones onto Rhod IDS;
such a possibility is avoided when performing the confocal-based diffusion-limited experiments
described previously by Kellner et al., (2014). The functionality of the chaperones used in this work
has been demonstrated previously, as indicated by their ability to efficiently refold chemically
denatured FlucIDS (see section 3.3.7). Thus, future work should be aimed at using higher
concentrations of chaperone or forming chaperone-client complexes ex situ, to resolve this issue so
that a more comprehensive investigation into chaperone function can be performed.

Taken together, the results presented in this chapter demonstrate the successful development of AviRhodIDS as a protein-folding sensor that can be used to observe real-time changes in conformation
through smFRET. By exploiting this sensor, it was found that the human Hsp40 isoform DnaJA1
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stabilizes expanded conformations of this client protein. Additionally, incubation of Avi-RhodIDS
with various components of the bacterial Hsp70 system resulted in conformational expansion of AviRhodIDS, with a subset of molecules exhibiting multiple changes in conformation typical of
chaperone-mediated events. Thus, this Avi-RhodIDS protein-folding sensor represents an excellent
and exciting platform that, with further development, can be employed alongside other client proteins
(e.g., FlucIDS) to enable the thorough and detailed investigation into the precise molecular
mechanisms by which chaperones interact with and assist in the folding of a diverse range of client
proteins.
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4.5

Supplementary figures

Supplementary Figure 4.1: Kinetic analysis of Avi-RhodIDS molecules in the presence of increasing
concentrations of DnaJB1. Immobilized Avi-RhodIDS was unfolded with 4 M GdHCl and imaged following
removal of denaturant with imaging buffer alone (i.e., spontaneous) or containing increasing concentrations of
DnaJB1 (1 – 10 µM). FRET trajectories were fit to an HMM and the kinetic details for each experimental
condition determined. (A) The percentage of Avi-RhodIDS molecules that visited ultra-low FRET states (i.e.,
< 0.5). (B) The transition probability of each transition class. (C) Violin plots showing the distribution of
residence times for each transition class. A two-way ANOVA statistical analysis with Tukey’s multiplecomparisons post-hoc test was performed to determine statistically significant differences in residence times
between treatment groups within each transition class. * and ** indicates statistical significance with p ≤ 0.05
and 0.01, respectively. ns or the absence of markers indicates no significant difference (p > 0.05). Data shown
within the violin plot is the median ± interquartile range. Data for all panels are derived and collated from the
HMM fits of at least 191 individual Avi-RhodIDS molecules per treatment.
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Supplementary Figure 4.2: Kinetic analysis of Avi-RhodIDS molecules in the presence of various Hsp40
isoforms. Immobilized Avi-RhodIDS was unfolded with 4 M GdHCl and imaged following removal of
denaturant with imaging buffer alone (i.e., spontaneous) or in the presence of either DnaJA1 (2 µM), DnaJA2
(1 µM) or DnaJB1 (1 µM). FRET trajectories were fit to an HMM and the kinetic details for each experimental
condition determined. (A) The percentage of Avi-RhodIDS molecules that visited ultra-low FRET states (i.e.,
< 0.5). (B) The transition probability of each transition class. (C) Violin plots showing the distribution of
residence times for each transition class. A two-way ANOVA statistical analysis with Tukey’s multiplecomparisons post-hoc test was performed to determine statistically significant differences in residence times
between treatment groups within each transition class. *, **, *** and **** indicates statistical significance
with p ≤ 0.05, 0.01, 0.001 and 0.0001, respectively. ns or the absence of markers indicates no significant
difference (p > 0.05). Data shown within violin plots are the median ± interquartile range. Data for all panels
were derived and collated from the HMM fits of at least 119 individual Avi-RhodIDS molecules per treatment.
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Supplementary Figure 4.3: Addition of HspA8 does not affect the FRET efficiency of Avi-RhodIDS
incubated in the presence of Hsp40 isoforms. Immobilized Avi-RhodIDS was unfolded with 4 M GdHCl and
imaged following removal of denaturant with DnaJB1 (1 µM) or DnaJA2 (1 µM) alone or in combination with
HspA8 (2 µM) and ATP (2 mM). As a control, denatured Avi-RhodIDS was also incubated with the nonchaperone control protein, ovalbumin (3 µM). (A) Representative smFRET traces of individual Avi-RhodIDS
molecules when incubated in the presence of chaperone or ovalbumin. Data is fit with an HMM (shown in
orange). (B) FRET efficiency histograms of Avi-RhodIDS when folded (i.e., native), following removal of 4 M
GdHCl without chaperone (i.e., spontaneous) or with the indicated combination of chaperones or ovalbumin.
(C) Transition density plots (TDP) showing the initial and final FRET state of Avi-RhodIDS transitions for each
treatment. (D) A summary of the kinetic data for each dataset represented as annotated heatmaps. For
simplicity, the kinetic data were filtered for FBefore values less than or greater than 0.7 FRET. The color of the
heatmap denotes the percentage of time that RhodIDS resides above or below 0.7 FRET. The direction of each
arrow refers to the transition direction, whereby the origin of each arrow denotes FBefore and the arrowhead
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denotes FAfter. The size of each arrow is directly proportional to the normalized occurrence of those transitions.
The mean Residence for each transition class is denoted adjacent to its respective arrow. Data for panels B – D
were derived and collated from the HMM fits of at least 119 individual Avi-RhodIDS molecules per treatment.

Supplementary Figure 4.4: Kinetic analysis of Avi-RhodIDS molecules in the presence of various
components of the bacterial Hsp70 system. Immobilized Avi-RhodIDS was unfolded with 4 M GdHCl and
imaged following removal of denaturant in the absence (i.e., spontaneous) or presence of DnaK (3 µM), DnaJ
(1 µM) (+ KJ) and GrpE (1.5 µM) (+ KJE). FRET trajectories were fit to an HMM and the kinetic details for
each experimental condition determined. (A) The percentage of Avi-RhodIDS molecules that visited ultra-low
FRET states (i.e., < 0.5). (B) The transition probability of each transition class. (D) Violin plots showing the
distribution of residence times for each transition class. A two-way ANOVA statistical analysis with Tukey’s
multiple-comparisons post-hoc test was performed to determine statistically significant differences in
residence times between treatment groups within each transition class. ns indicates no significant difference
(p > 0.05). Data shown within violin plots are the median ± interquartile range. Data for all panels were derived
and collated from the HMM fits of at least 274 individual Avi-RhodIDS molecules per treatment.
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Chapter 5: Characterization of the unfolding, aggregation
and interaction of molecular chaperones with CLIC1
and its development into a protein-folding sensor

Portions of this chapter have been previously published in the following work
C. Johnston, N. Marzano, B. Paudel, G. Wright, J. Benesch, A. M van Oijen, H. Ecroyd. Single-molecule
fluorescence-based approach reveals novel mechanistic insights into human small heat-shock protein
chaperone function. Journal of Biological Chemistry. 2021. 296:100161
The results presented in Figure 5.3 and Figure 5.4 of this chapter appear as Figure 1 in this published work. N.
Marzano performed all the work, analysis and figure assembly for the work presented in this thesis chapter.
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5.1

Introduction

The small heat-shock protein (sHsp) family of molecular chaperones are a key component of the
protein homeostasis (proteostasis) network due to their role in binding to and preventing the
aggregation of misfolded proteins into toxic aggregates (Haslbeck et al., 2015; Treweek et al., 2015;
Webster et al., 2019). These molecular chaperones are unique in that the majority of mammalian
sHsps, which includes the ubiquitously expressed sHsps 𝛼B-crystallin (𝛼B-c, [HSPB5]) and Hsp27
(HSPB1), form dynamic, heterogeneous and large oligomeric assemblies (Aquilina et al., 2003; Sun
et al., 2005; Basha et al., 2012; Jovcevski et al., 2015). These sHsp complexes undergo rapid and
dynamic subunit exchange, which is thought to mediate their chaperone action via release of smaller
(monomeric and/or dimeric) species (Haslbeck et al., 1999; Benesch et al., 2008; Peschek et al.,
2013; Jovcevski et al., 2015). The current model of sHsp action is that the larger oligomeric
assemblies act as a reservoir for the release of the smaller, more chaperone-active sHsp species. These
dissociated species can then bind to aggregation-prone proteins and sequester them into soluble highmolecular mass complexes (Ehrnsperger et al., 1997; Lee et al., 1997; Veinger et al., 1998; Haslbeck
et al., 1999; Ecroyd et al., 2007; Kulig et al., 2012; Ungelenk et al., 2016). Alternatively, sHsps may
also interact transiently with client proteins to temporarily stabilize them and direct them down their
intrinsic folding pathway to the native state (Hatters et al. 2001; Kulig et al., 2012; Treweek et al.
2015).
However, despite a growing appreciation for the basic functions that sHsps play within the cell, the
precise molecular mechanisms by which sHsps bind to destabilized proteins is still a matter of debate.
For instance, there is currently no conclusive evidence demonstrating that dissociated sHsps are the
sole species capable of recognizing and binding to aggregation-prone proteins. Furthermore, the exact
stoichiometries and kinetic processes (i.e., on/off rates of client binding) that underly the interactions
of sHsps with their clients remain unclear. Studying these fundamental aspects of sHsp function have
traditionally been difficult to address with conventional ensemble-averaged measurements due to the
dynamic, transient and polydisperse nature of sHsps and the low abundance of individual species in
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the heterogeneous population.
Single-molecule fluorescence techniques represent an ideal approach to study the molecular
mechanisms of chaperone function as they eliminate ensemble averaging via direct observation of
individual protein trajectories in real time, which enables the kinetic characterization of rare, transient
and intermediate events (Ueno et al., 2004; Sikor et al., 2013; Mashaghi et al., 2014). To date, the
complexity of the chaperone systems studied using single-molecule techniques has been limited, due
to the difficulty in observing multiple chaperone-client components simultaneously. This is
particularly the case for single-molecule fluorescence experiments, in which each observable
component needs to be labelled with fluorophores that are spectrally separated to prevent fluorescent
bleed through. Most studies employ fluorescence resonance energy transfer (FRET)-based
approaches to look at either chaperone dynamics or client conformations (i.e., two-color
experiments). These studies typically examine chaperone function by employing ‘dark’ components,
which are elements of the chaperone network (or the client protein itself) that are present but not able
to be directly observed via fluorescence spectroscopy. Consequently, there is a growing need to
develop a protein-folding sensor in which only a single fluorophore is used to report on its folding
and unfolding, since this would enable other fluorophores to be used to observe and measure
chaperone and co-chaperone components. This work sought to determine whether the chloride
intracellular channel protein 1 (CLIC1) was a suitable aggregation-prone protein for the study of the
molecular chaperone action of sHsps. Moreover, this work aimed to explore whether CLIC1 could
be developed it into a single-color protein-folding sensor that would enable its structure and
interaction with sHsps (and indeed other chaperone systems) to be examined by single-molecule
techniques.

The CLIC proteins are a highly conserved family of ion channels, with six paralogs (CLIC1 - CLIC6)
present in vertebrates (Littler et al., 2010). The CLIC proteins are unique in that they are
metamorphic, existing in both a soluble monomeric state in the cytoplasm and a membrane bound
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form (Harrop et al., 2001; Littler et al., 2010). The soluble form of CLIC1 was chosen for this work
as it possesses attributes that make it attractive for use as a model client protein for the study of the
molecular chaperone action of sHsps and as a potential protein-folding sensor, namely (i) CLIC1 is
monomeric and hence the final functional state is not dependent on oligomerization, (ii) CLIC1 is
amenable to site-specific fluorescent labelling (Goodchild et al., 2011); (iii) CLIC1 is reported to
populate partially-folded intermediate states with a high degree of solvent-exposed hydrophobicity,
causing it to be aggregation prone and therefore typical of sHsp clients (Fanucchi et al., 2008;
Parbhoo et al., 2011); and (iv) CLIC1 adopts a glutathione-S-transferase like fold that has been shown
to be a client for plant sHsps in vivo (Préville et al., 1999; McLoughlin et al., 2016).

In this chapter, the unfolding and aggregation of CLIC1, as well as its interaction with sHsps, were
characterized to assess its use as a protein-folding sensor to study the molecular action of sHsps in
single-molecule fluorescence experiments.
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5.2
5.2.1

Methods
Plasmids

To ensure specific labelling of CLIC1 for single-molecule fluorescence studies, a previously
described CLIC1 mutant in which all but two native cysteine residues have been substituted to alanine
(CLIC1C89A,

C178A, C191A, C233A,

denoted henceforth as CLIC1CysL) was employed in this work

(Goodchild et al., 2010). The pET28a expression plasmid containing CLIC1 CysL was kindly donated
by Dr. Louise Brown (Macquarie University, Australia) and transformed into E. coli BL21(DE3)
codon (+) RIPL cells (Novagen, Merck). A 6x-His purification tag and thrombin cleavage sequence
were previously incorporated at the N-terminus of this CLIC1CysL construct.

5.2.2

Expression and purification of CLIC1CysL

E. coli BL21(DE3) codon (+) RIPL cells transformed with the plasmid encoding CLIC1CysL were
streaked onto a LB agar plate supplemented with kanamycin antibiotic (50 µg/mL) and
chloramphenicol (10 µg/mL) and a single colony was used to inoculate a starter culture (~ 100 mL)
that was grown overnight at 37˚C. The starter culture was used to inoculate expression cultures
containing LB media supplemented with kanamycin (50 µg/mL), with the cultures grown at 37˚C
until an OD600 of 0.6 was reached. Expression of recombinant protein was induced by addition of
IPTG (0.1 mM) and incubated on an orbital shaker at 18˚C overnight at 120 rpm. The cells were then
harvested by centrifugation at 5,000 x g for 10 min at 4˚C and the pellet stored at -20˚C. Recombinant
protein was extracted from the bacterial pellet via re-suspension in 50 mM Tris (pH 8.0) containing
100 mM NaCl and protease inhibitor. Cells were lysed following incubation with lysozyme (0.5
mg/mL) and probe-sonication (3 min at 45% power, 5 s on/10 s off). Cell debris was then pelleted
twice at 24,000 x g for 20 min at 4˚C and the soluble bacterial lysate collected and filtered (0.45 µm).
The cell lysate was applied to a 5 mL HisTrap Sephadex column (GE Healthcare, USA) equilibrated
in 50 mM Tris-base (pH 8.0) containing 5 mM imidazole and 300 mM NaCl (CLIC1 IMAC buffer
A). The bound recombinant protein was then eluted with CLIC1 IMAC buffer A supplemented with
500 mM imidazole. Fractions containing recombinant protein were loaded onto an Superdex 75 size165
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exclusion column equilibrated in 50 mM phosphate buffer (pH 7.4). Fractions containing recombinant
protein were concentrated and the concentration was determined as described in section 2.2.3.
Recombinant protein was snap-frozen in liquid nitrogen and stored at −20˚C until use.

5.2.3

Far-UV circular dichroism (CD)

The chemical- or temperature-induced unfolding of CLIC1CysL was assessed using far-UV CD. To
monitor protein unfolding by chemical denaturant, CLIC1CysL (2 µM) was incubated in 5 mM
phosphate buffer (pH 7.4) supplemented with various concentrations of urea (0 - 7 M). Samples were
then loaded into a quartz cuvette (Hellma Analytics, Germany) and CD spectra between 190 - 260
nm obtained (average of 6 accumulations) using a Jasco-810 spectropolarimeter (JASCO, Japan).
Only values in which the high tension (HT) voltage was below 700 V were included for subsequent
analysis. When monitoring the temperature-induced unfolding of protein, CLIC1CysL (2 µM) was
incubated in 5 mM phosphate buffer (pH 7.4) and loaded into a quartz cuvette. The temperature was
increased at an average rate of 0.3˚C/min and CD spectra between 190 – 260 nm obtained (average
of 6 accumulations) every 2˚C.
As CLIC1 is predominantly α-helical in structure (Harrop et al., 2001), the signal at 222 nm (a
minimum in the CD spectra that corresponds to the signal originating from 𝛼-helical content within
proteins) was examined to monitor the loss of secondary structure in the protein. CD signals were
corrected for concentration to yield molar ellipticity ([∅m]) (deg·cm2·dmol-1), calculated using
Equation 5.1.

[∅m ] =

100 · ∅
C·l

Equation 5.1: Equation to calculate the molar ellipticity. C is the concentration (mol/L), l is the path length
(cm) and ∅ is the ellipticity in degrees and ∅ = CD signal/(C x 10-6).
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Data for [∅m] at 222 nm was plotted and fit to a Boltzmann sigmoidal curve and the midpoint of
unfolding (U50, i.e., the concentration of urea or the temperature at which [∅m] is 50%) was determined
using GraphPad Prism 9 software. All spectra were corrected for buffer effects and samples
equilibrated for 1 hr at 20˚C prior to measurement.

5.2.4

Interaction of CLIC1CysL with molecular chaperones

The ability of sHsps to prevent the aggregation of CLIC1CysL was assessed using light scattering
assays. CLIC1CysL (50 µM) was added to 50 mM phosphate buffer (pH 7.4) in the presence or absence
of varying molar ratios of Hsp27 or 𝛼B-c (1:0.5 – 1:125, chaperone: CLIC1CysL) and incubated at
37˚C for ~ 22 hr. CLIC1CysL incubated in the presence of ovalbumin (1:0.5 molar ratio, ovalbumin:
CLIC1CysL) acted as a control for chaperone-specific inhibition of CLIC1CysL aggregation. The sHsps
Hsp27 or αB-c alone in buffer, at the highest concentration used in the assays, acted as a negative
control. The aggregation of CLIC1CysL was monitored over time by measuring the light scatter at 340
nm using a BMG Polarstar Omega spectrometer (BMG Labtech, Germany). In each assay, duplicates
for each sample were included and the signals averaged, corrected for signals arising from the buffer
(which were negligible) and the change in light scatter over time was calculated. The percent
inhibition (i.e., protection afforded by chaperones against the aggregation of CLIC1 CysL) was
calculated using Equation 5.2.

% protection=

∆I - ∆Is
∆Ic

· 100

Equation 5.2: Equation to calculate the percent protection against aggregation afforded by chaperones.
∆Ic and ∆Is are the change in absorbance when in the absence and presence of chaperone, respectively.

The experiment was repeated three times and the data reported as the mean ± the standard error of
the mean of these biological repeats. Results were analyzed with a one-way ANOVA and Tukey’s
post-hoc test using GraphPad Prism 9 software, with p ≤ 0.05 considered to be statistically significant.
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To further characterize the interaction between CLIC1CysL and the sHsps, samples of CLIC1CysL that
had been incubated in the absence or presence of αB-c or Hsp27 (at a 1:0.5 molar ratio) from the
aggregation assay described above were analyzed via size-exclusion chromatography (SEC) and
SDS-PAGE. Samples of CLIC1CysL (50 µM), Hsp27 (100 µM) or 𝛼B-c (100 µM) pre- and postincubation, as well as samples in which CLIC1CysL had been incubated with either αB-c or Hsp27,
were centrifuged for 10 min at 20,000 x g and the supernatant loaded onto a Superdex 200 10/300
analytical column (GE Healthcare, UK) pre-equilibrated in 50 mM phosphate buffer (pH 7.4). A flow
rate of 0.5 mL/min was used to elute protein, which was monitored by an in-line UV detector powered
by an ÄKTA prime plus purification system (GE Healthcare, UK) and 0.5 mL fractions collected.
The Superdex 200 column was calibrated with standards (BioRad, USA) that included bovine
thyroglobulin (670 kDa), bovine 𝛾-globulin (158 kDa), chicken ovalbumin (44 kDa) and horse
myoglobin (17 kDa). The protein composition of peaks that eluted from the column was then
determined by SDS-PAGE.

5.2.5

Rationale and design of CLIC1CysL folding sensor

To develop CLIC1 into a folding sensor, we sought to take advantage of the fluorescence selfquenching phenomenon of tetramethylrhodamine (TMR) dyes when in close proximity to each other.
TMR is a well characterized organic fluorophore, with a relatively low quantum yield (~ 0.4) and
molar extinction coefficient (78,000 cm-1·M-1) (Figure 5.1). The characteristic self-quenching
behavior of TMR has been implemented previously for the study of kinesin and ribosomal proteins
(Hamman et al., 1996; Rosenfeld et al., 2002) and has been employed at the single-molecule level to
monitor the ADP-induced sub-nanometer conformational changes of the ParM protein (Zhou et al.,
2011). For TMR self-quenching to be feasible, the conjugation points of the two fluorophores (e.g.,
cysteine residues if using maleimide chemistry) should be within ~ 1.5 nm of each other and be ideally
orientated for optimal dye stacking. With this in mind, we sought to take advantage of and
fluorescently label the two remaining native cysteine residues within CLIC1CysL (Cys24 and Cys59),
on the basis that these residues are proximally located (~ 1.6 nm apart) and ideally orientated since
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these residues are known to form an intramolecular disulfide under oxidative conditions (Littler et
al., 2004) (Figure 5.1). It is hypothesized that when CLIC1CysL is correctly folded the two TMR
fluorophores will be proximally located and the fluorescence of the fluorophores will be quenched;
however, unfolding or misfolding of CLIC1CysL will result in unstacking of the dyes and thus both
fluorophores will become fluorescent.

Figure 5.1: Crystal structure of CLIC1 and chemical structure of the tetramethylrhodamine (TMR) dye
employed in this chapter. The structure of CLIC1 (left, PDB 1K0N, Harrop et al., 2001) with cysteine
residues to be labelled with TMR dye (right) are shown. The C𝛼 – C𝛼 distance between labelled residues is
indicated. The relative position of the N- and C-terminal domains, as well as key secondary structural regions,
are indicated.

5.2.6

Single-molecule characterization of the TMR-labelled CLIC1CysL folding sensor

To interrogate whether CLIC1CysL can be used as a reporter of protein folding via changes in TMR
fluorescence intensity, single-molecule experiments were performed in which the folded state of
CLIC1CysL was perturbed with the chemical denaturant urea. For these experiments, CLIC1CysL was
fluorescently labelled with TMR fluorophores as previously outlined (section 2.3.5). The neutravidin
and Tween-20 coated coverslip and microfluidic flow cell were assembled as described in section
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2.4.2. To facilitate immobilization of CLIC1CysL to the coverslip surface, biotinylated anti-6x-His
antibody (1 µg/mL) in imaging buffer (50 mM phosphate buffer [pH 7.4] supplemented with 6 mM
Trolox) was flowed into the channel and incubated for 10 min. The channel was then washed with
imaging buffer. TMR-labelled CLIC1CysL (400 pM) in imaging buffer was flowed into the channel
and incubated for 10 min to enable binding to the immobilized anti-6x-His antibody. Finally, unbound
TMR-labelled CLIC1CysL molecules were removed from the channel by washing with imaging buffer.
To reduce blinking and irreversible photobleaching of fluorescent dyes during imaging, an oxygen
scavenging system consisting of 2.5 mM protocatechuic acid and 50 nM protocatechuate-3,4dioxygenase was included in all buffers during image acquisition. Immobilized TMR-labelled
CLIC1CysL molecules were imaged in the absence of denaturant (i.e., native-folded state) and after 5
min incubation with urea (4 M) in imaging buffer. Data were acquired following excitation of
immobilized TMR-labelled CLIC1CysL using a 532 nm solid state laser and the fluorescence was
measured every 100 ms for at least 3 min at multiple fields of view.

5.2.7

Image analysis

Images were corrected for electronic offset and inhomogeneity of the excitation laser before
fluorescence intensity traces were generated for all fluorescent molecules using custom-written
scripts in Fiji (Schindelin et al., 2012). Molecules that occupied non-zero fluorescence states or
exhibited clear fluorescence transitions were selected for further analysis. The fluorescence intensity
of all molecules for each dataset were collated, binned and plotted into a frequency histogram using
custom written code in Python.
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5.3
5.3.1

Results
Characterizing the unfolding and aggregation of CLIC1 CysL and its interaction with
molecular chaperones

5.3.1.1 Circular dichroism (CD)
To employ CLIC1CysL as a sensor of protein folding upon interaction with chaperones, the unfolding
of CLIC1CysL was first characterized. Thus, the stability and unfolding of CLIC1CysL with increasing
temperature was monitored using far-UV CD spectroscopy. At all temperatures tested (24˚C - 60˚C),
CLIC1CysL exhibited a clear CD spectrum with minima in [∅m] at 207 nm and 222 nm and a maximum
at 190 nm (Figure 5.2A), consistent with a folded α-helical protein. Upon heating (to 60˚C) there was
a small increase in the [∅m] at 207 and 222 nm and a reduced [∅m] at 190 nm for CLIC1CysL, consistent
with a slight loss in secondary structure upon heating. The increase in [∅m] at 222 nm for CLIC1CysL
with increasing temperature was observed to occur in a sigmoidal manner, with the midpoint of
unfolding (defined as U50) determined to be 39.2˚C (Figure 5.2B).
The unfolding of CLIC1CysL in urea was also monitored using far-UV CD spectroscopy. At 20˚C and
in the absence of urea, CLIC1CysL again displayed a CD spectra characteristic of an 𝛼-helical protein,
with clear minima in [∅m] observed at 210 and 222 nm (Figure 5.2C). At low concentrations of urea
(1 - 2 M), there were minimal changes in the CD spectra or the [∅m] at 222 nm observed for CLIC1CysL
(Figure 5.2C-D). However, when CLIC1CysL was incubated with higher concentrations of urea the
CD spectra visibly changed and the [∅m] at 222 nm increased until it reached a plateau at ~ 6 M urea.
The U50 for CLIC1CysL was determined to occur at 3.3 M urea (Figure 5.2D).
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Figure 5.2: Characterizing the unfolding of CLIC1 CysL with temperature or urea by far-UV CD.
CLIC1CysL (2 µM) was incubated in 5 mM phosphate buffer (pH 7.4) and CD spectra generated between 190
and 260 nm with increasing temperature (24 - 60˚C) or urea concentration (0 - 7 M) and the molar ellipticity
([∅m]) calculated. The unfolding of CLIC1CysL was observed by monitoring the change in [∅m] at 222 nm (a
minima in the CD spectra for α-helices). (A) Representative CD spectra of CLIC1CysL with increasing
temperature. (B) The calculated [∅m] at 222 nm for CLIC1CysL at each temperature tested is plotted and fit to a
Boltzmann sigmoidal curve and the midpoint of unfolding (U50) denoted. (C) Representative CD spectra of
CLIC1CysL with increasing concentrations of urea. (D) The calculated [∅m] at 222 nm for CLIC1CysL at each
concentration of urea tested is plotted and fit to a Boltzmann sigmoidal curve and the U50 denoted. Data were
corrected for buffer effects with the Boltzmann sigmoidal curve derived using GraphPad Prism 9 software.

5.3.1.2 The sHsps 𝛼B-c and Hsp27 inhibit the aggregation of CLIC1CysL by forming stable sHspclient complexes
Since an overall goal of this work was to use CLIC1CysL to study how molecular chaperones affect
the folded state of a client, the ability of the sHsps αB-c and Hsp27 to prevent the heat-induced
aggregation of CLIC1CysL was investigated. When CLIC1CysL was incubated at 37˚C, there was a
significant increase in the light scatter at 340 nm, indicative of protein aggregation (Figure 5.3A).
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There was a similar increase in light scatter observed when CLIC1CysL was incubated with ovalbumin
(a non-chaperone control protein) at a 1:0.5 molar ratio (ovalbumin: CLIC1 CysL) compared to when
CLIC1CysL was incubated in buffer alone. Thus, the addition of a non-chaperone protein does not
significantly affect the aggregation kinetics of CLIC1CysL.
When CLIC1CysL was incubated with αB-c at a 1:0.5 – 1:1 molar ratio (𝛼B-c: CLIC1CysL), a minimal
increase in light scatter at 340 nm was observed over time (Figure 5.3A). When CLIC1CysL was
incubated with progressively lower amounts of 𝛼B-c (i.e., molar ratios of 1:2 – 1:125, 𝛼B-c:
CLIC1CysL), there was an increase in light scatter at 340 nm over time such that, at the 1:125 (𝛼B-c:
CLIC1CysL) molar ratio, it approached that of CLIC1CysL incubated in the absence of chaperone
(Figure 5.3B).
Similar results were obtained when CLIC1CysL was incubated with Hsp27 at a 1:0.5 – 1:1 molar ratio
(Hsp27: CLIC1CysL). Hence, whilst there was an increase in light scatter at 340 nm over time when
CLIC1CysL was incubated in the presence of Hsp27, this increase was significantly less than when
CLIC1CysL was incubated in buffer alone (Figure 5.3C). Moreover, there was a larger increase in light
scatter over time when CLIC1CysL was incubated with lower amounts of Hsp27 (i.e., molar ratios of
1:2 – 1:125, Hsp27: CLIC1CysL) (Figure 5.3D). Notably, the percent inhibition of CLIC1CysL
aggregation afforded by Hsp27 was significantly less than that observed for 𝛼B-c at the same molar
ratios (Figure 5.3B and D). Interestingly, both 𝛼B-c and Hsp27 appeared to have little effect on the
aggregation of CLIC1CysL at the earlier stages of aggregation (~ 0 - 4 hr) but inhibited the increase in
light scatter at 340 nm at later stages of CLIC1CysL aggregation (Figure 5.3A and C).
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Figure 5.3: Characterizing the ability of the sHsps αB-c and Hsp27 to prevent the amorphous
aggregation of CLIC1CysL. CLIC1CysL (50 µM) was incubated in 50 mM phosphate buffer (pH 7.4), either in
the absence or presence of the sHsps (at molar ratios of sHsp: CLIC1CysL between 1:0.5 – 1:125) or the nonchaperone control protein ovalbumin (1:0.5, ovalbumin: CLIC1CysL) for 22 hr at 37˚C. The chaperones alone
in buffer were used as negative controls. The aggregation of CLIC1 CysL was monitored by measuring the
change in light scatter at 340 nm of samples over time. (A) Representative traces of CLIC1CysL incubated in
the presence of 𝛼B-c. (B) The percent protection against CLIC1CysL aggregation afforded by 𝛼B-c at varying
molar ratios, reported as the mean ± standard error of the mean. (C) Representative traces of CLIC1CysL
incubated in the presence of Hsp27. (D) The percent protection against CLIC1CysL aggregation afforded by
Hsp27 at varying molar ratios, reported as the mean ± standard error of the mean (n = 3). A one-way ANOVA
with Tukey’s multiple-comparisons post-hoc test was performed to determine statistically significant
differences in the protection against aggregation afforded by different molar ratios of sHsp. * and ** indicates
statistically significant differences between group means, whereby p ≤ 0.05 and 0.01, respectively.
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To determine if the sHsps prevent the aggregation of CLIC1CysL by forming a stable complex with it,
samples from the light scattering assays in which αB-c or Hsp27 inhibited the aggregation of
CLIC1CysL (i.e., 1:0.5 sHsp: CLIC1CysL molar ratio) were subjected to SEC and the eluate analyzed
by SDS-PAGE (Figure 5.4). Non-incubated CLIC1CysL eluted from the column predominantly as a
single peak at an elution volume of 15.6 mL (Figure 5.4A), corresponding to a molecular mass of ~
30 kDa, which was confirmed by SDS-PAGE (Figure 5.4B). A smaller peak centered at an elution
volume of 14.4 mL, corresponding to a molecular mass of ~ 60 kDa, was also present in the nonincubated CLIC1CysL sample. In contrast, when CLIC1CysL was incubated alone at 37˚C no discernible
peak was observed at any elution volume, consistent with the protein not remaining soluble in solution
(i.e., it had completely aggregated into insoluble particles and therefore was removed during the
centrifugation step that preceded SEC). The absence of soluble CLIC1CysL in the eluent fractions from
the column in this sample was confirmed by SDS-PAGE (data not shown). When αB-c was incubated
at 37˚C alone, it eluted as a broad peak centered at 10.5 mL (Figure 5.4A). Subsequent analysis of
the eluent fractions containing this peak by SDS-PAGE confirmed the presence of αB-c at ~ 22 kDa
(Figure 5.4B). In comparison, there were notable differences in the elution profile when CLIC1 CysL
and αB-c were incubated together at a 1:0.5 molar ratio (αB-c: CLIC1CysL) compared to when either
protein was incubated alone. Notably, a peak centered at 7.8 mL was observed when CLIC1CysL and
αB-c were incubated together, suggesting the presence of large molecular-mass complexes in this
sample (Figure 5.4A). SDS-PAGE analysis of the eluant fractions from this peak confirmed the
presence of both 𝛼B-c and CLIC1CysL, indicative of a high-molecular mass complex being formed
between these two proteins. A second peak was observed at 10.5 mL and a much smaller peak at 15.6
mL was observed by SEC in this sample; SDS-PAGE analysis of the eluate from these peaks
confirmed the presence of 𝛼B-c and CLIC1CysL, respectively.
When Hsp27 was incubated alone at 37˚C and loaded onto the size-exclusion column a single peak
centered at 10.2 mL was observed, with subsequent SDS-PAGE analysis of the eluate fractions
confirming the presence of Hsp27 at ~ 26 kDa (Figure 5.4C-D). As with 𝛼B-c, when CLIC1CysL was
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incubated with Hsp27 at a 1:0.5 molar ratio (Hsp27: CLIC1CysL) and the sample loaded onto the
column, a peak was observed at 7.8 mL. However, the relative abundance of this peak was
significantly less than that observed when CLIC1 CysL was incubated with 𝛼B-c. Only CLIC1CysL (at
~ 27 kDa) was detected in the eluate from this peak (Figure 5.4D). A second peak was observed at
10.2 mL and a much smaller peak at 15.6 mL, with SDS-PAGE analysis of the eluate from these
peaks confirming the presence of Hsp27 and CLIC1CysL, respectively.

Figure 5.4: Biochemical characterization of the molecular interaction between CLIC1 CysL and the sHsps
αB-c and Hsp27 using SEC and SDS-PAGE. Samples of CLIC1CysL following the aggregation assay
described in Figure 5.3 were taken directly from the microtiter plates, centrifuged at 20,000 x g for 10 min and
the supernatant loaded onto a Superdex 200 analytical size-exclusion column. Eluate from peaks of interest
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were taken and analyzed by SDS-PAGE. (A) SEC chromatograms of CLIC1CysL (50 µM) before (green) and
after (black) incubation at 37˚C and soluble post-incubation samples of αB-c alone (100 µM) (blue) and
incubated with CLIC1CysL (purple) (at a 1:0.5 molar ratio, αB-c: CLIC1CysL) is shown. (B) SDS-PAGE gel of
eluted fractions collected during SEC. (C) SEC chromatograms of CLIC1CysL (50 µM) before (green) and after
(black) incubation at 37˚C and soluble post-incubation samples of Hsp27 alone (100 µM) (blue) and incubated
with CLIC1CysL (purple) (at a 1:0.5 molar ratio, Hsp27: CLIC1CysL) is shown. (D) SDS-PAGE gel of eluted
fractions collected during SEC. The SDS-PAGE gel containing samples from the non-incubated CLIC1CysL
treatment is the same as that presented in panel B. In A and C, the elution volume for protein standards (kDa)
used for calibration of the column is indicated at the top of the chromatograms with Vd representing the void
volume. All chromatograms are normalized to the maximum absorbance of sHsp alone. The numbers at the
top of the SDS-PAGE gels indicate the elution volume (mL) across the peaks from the chromatogram that was
loaded onto the gel.

5.3.2

Development and characterization of the CLIC1CysL protein-folding sensor

The results above demonstrate that CLIC1 can be used as a model aggregation-prone protein for the
study of the molecular chaperone function of sHsps. Work was therefore conducted to determine
whether dual TMR-labelled CLIC1CysL could be used as a sensor of protein folding to study the folded
state of CLIC1 when in complex with chaperones. To determine whether changes in the folded state
of CLIC1 could be observed at the single-molecule level, TMR-labelled CLIC1CysL was immobilized
onto the surface of a coverslip and imaged in the absence or presence of urea using TIRF microscopy
(Figure 5.5A). It was hypothesized that upon addition of urea, the TMR fluorophores conjugated to
CLIC1CysL would unstack from the dimeric ‘quenched’ state and thus transition to a highly fluorescent
state. The fluorescence intensity of all the TMR-labelled CLIC1CysL molecules were binned and
plotted into a frequency histogram (Figure 5.5B). Natively-folded TMR-labelled CLIC1CysL was
predominantly in a low fluorescence state centered just above 0 fluorescence units; however, some
molecules also occupied (albeit less-frequently) higher fluorescence states of up to 40,000
fluorescence units. Notably, the fluorescence intensity profile did not appear significantly different
to those molecules that were imaged in the presence of 4 M urea (conditions in which a significant
loss of secondary structure is expected based on the CD data) (Figure 5.2D, Figure 5.5B).

Interestingly, inspection of individual fluorescence intensity time-traces of TMR-labelled CLIC1CysL
molecules incubated in the absence or presence of urea revealed a complex and heterogeneous
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ensemble of fluorescence dynamics between states of different intensities (Figure 5.5C-D). The
fluorescence intensity traces observed could be broadly classed into five categories; molecules that
(1) experience many rapid transitions between two fluorescence intensity states; (2) predominantly
exist in either a high or low fluorescent state and make short (< 10 s) excursions to the other state; (3)
exhibit transitions between multiple, longer-lived (> 10 s) fluorescent states; (4) show typical singleor double-photobleaching behavior and (5) exhibit a combination of the different categories described
above. The occurrence of each class of fluorescence intensity trace remained similar when CLIC1 CysL
was incubated in the absence or presence of urea (Figure 5.5E). Since the fluorescence of individual
TMR-labelled CLIC1CysL molecules often reached and then left the ground state, it was not possible
to determine with confidence when photobleaching had occurred and this contributes to a proportion
of the histogram peak centered at ~ 0 fluorescence units (Figure 5.5B).
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Figure 5.5: Single-molecule TIRF microscopy of TMR-labelled CLIC1CysL in the absence or presence of
urea. (A) Schematic of the TIRF microscopy imaging setup. TMR-labelled CLIC1CysL is immobilized to a
coverslip via interactions between the anti-6x-His antibody, which is conjugated to the coverslip surface via
neutravidin/biotin interactions, and the N-terminal 6x-His tag of CLIC1CysL. Immobilized protein is illuminated
by a 532 nm laser and the fluorescence measured over time. (B) Fluorescence intensity histogram of TMRlabelled CLIC1CysL molecules imaged in the absence (black) or presence (purple) of 4 M urea. Example singlemolecule fluorescence traces of individual TMR-labelled CLIC1CysL molecules incubated in the absence (C)
or presence (D) of 4 M urea are shown. The numbers at the top or bottom right of each example trace denotes
the category that each trace was classified into as described in text. Data derived and collated from at least 126
individual CLIC1CysL molecules. (E) Each fluorescence intensity trace from individual CLIC1CysL molecules
was manually classified into five categories (see results text above) and the relative occurrence of each class
is depicted as a pie-chart.
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5.4

Discussion

As a result of the heterogeneous and transient nature of the interactions molecular chaperones can
have with client proteins, single-molecule fluorescence methods are promising approaches to better
understand the precise molecular mechanisms by which chaperones assist protein folding and prevent
aggregation (Johnston et al., 2018). However, to date there have been limited efforts to
simultaneously monitor the folded state of the client protein and binding interactions of molecular
chaperones at the same time. To address this, the work described in this chapter sought to characterize
CLIC1 as a potential model protein for the study of sHsp chaperone action and determine whether it
could be developed into a single-color protein-folding sensor. The results of this work show that
𝛼B-c and Hsp27 can inhibit the aggregation of CLIC1CysL and therefore it is a suitable aggregationprone protein for the study of complexes formed between sHsps and client proteins. However, singlemolecule analysis of individual TMR-labelled CLIC1CysL molecules revealed that the TMR
fluorescence states of CLIC1 CysL are complex, heterogeneous, and dynamic. This precludes the use
of TMR-labelled CLIC1CysL as a reliable sensor of protein folding for the study of sHsp (and other
molecular chaperone) function.

To assess the suitability of CLIC1 CysL to be used as a sensor of protein folding, far-UV CD was
employed to monitor the unfolding of CLIC1CysL with increasing temperature or concentrations of
denaturant. Notably, only a minor loss in secondary structure content was observed with increasing
temperatures (up to 60˚C) while significant loss of secondary structure was observed when CLIC1 CysL
was incubated with urea. Importantly, the far-UV CD spectra of CLIC1CysL was observed to be almost
identical to a previously reported spectra of wild-type CLIC1 (Goodchild et al., 2010), which
indicates that removal of four of the native cysteines (i.e., C89A, C178A, C191A and C223A) does
not significantly affect the secondary structure of CLIC1. The almost native-like secondary structure
of CLIC1CysL observed at high temperatures is explained by the different mechanisms by which
temperature and denaturant mediate the unfolding of CLIC1CysL. Urea is thought to act as a chemical
denaturant by forming favorable contacts (e.g., hydrogen bonds) with the peptide backbone and/or
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with amino acid side-chains via electrostatic attractions, which results in significant loss of secondary
and tertiary structure (Scholtz et al., 1995; Stumpe et al., 2009; Candotti et al., 2013). In contrast,
temperature affects the vibrational motion of the protein, whereby the stochastic nature of thermallyinduced protein fluctuations result in a thermal folding equilibrium (Wang et al., 2010). Thus, at any
particular temperature only a portion of CLIC1 CysL molecules exist in an intermediate or unfolded
state (i.e., lack secondary structure in some regions of the protein) (Chi et al., 2003). This accounts
for the smaller change in molar ellipticity at 222 nm observed with increasing temperature compared
to with high concentrations of urea. Based on these results, high concentrations of denaturant were
used to unfold CLIC1CysL in subsequent single-molecule experiments.

In order to employ CLIC1CysL as a sensor of protein folding upon interaction with molecular
chaperones, the ability of the sHsps 𝛼B-c and Hsp27 to interact with and prevent the aggregation of
CLIC1CysL was first characterized. Both 𝛼B-c and Hsp27 inhibited the heat-induced aggregation of
CLIC1CysL in a concentration-dependent manner. Importantly, the addition of ovalbumin, a nonchaperone control protein, did not prevent the aggregation of CLIC1CysL thus demonstrating that the
inhibition of CLIC1CysL aggregation by 𝛼B-c and Hsp27 is due to their chaperone activity.
Interestingly, 𝛼B-c was found to be a much more effective inhibitor of CLIC1 CysL aggregation
compared to Hsp27. The enhanced inhibition of aggregation afforded by 𝛼B-c compared to Hsp27 is
consistent with previously reported observations, whereby 𝛼B-c has been shown to be more effective
at inhibiting the thermally-induced amorphous and fibrillar aggregation of proteins in vitro, while
Hsp27 is more effective at inhibiting reduction-induced protein aggregation (Aquilina et al., 2013;
Yerbury et al., 2013; Mymrikov et al., 2017; Selig et al., 2020). The ability of sHsps to prevent
protein aggregation has long been associated with their ability to form stable complexes with the
aggregation-prone client (Ehrnsperger et al., 1997; Rajaraman et al., 1998, 2001; Yerbury et al.,
2013; Mainz et al., 2015; Mymrikov et al., 2017). Indeed, the results of the current work demonstrate
that 𝛼B-c inhibits the aggregation of CLIC1CysL via forming stable high-molecular mass complexes
with the client protein (as determined by their co-elution during SEC). In contrast, the formation of a
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stable complex between CLIC1CysL and Hsp27 was not observed - this likely explains the differing
capacities of these two sHsps to inhibit CLIC1 CysL aggregation. Previous work has shown that sHsps,
including Hsp27, prevent the amorphous or fibrillar aggregation of some client proteins via transient
interactions (i.e., without forming stable sHsp-client complexes) (Raman et al., 2005; Kulig et al.,
2012; Cox et al., 2016). It is possible that the inhibition of CLIC1CysL aggregation by Hsp27 observed
in this study may be due to a similar mechanism of transient interactions with the client protein,
although further work is needed to confirm if this is the case.

Of particular interest is that neither 𝛼B-c or Hsp27 were able to inhibit CLIC1CysL aggregation at
early timepoints (i.e., 0 – 2.5 hr) - sHsp-specific inhibition of aggregation occurred only after this
period. This suggests that both 𝛼B-c and Hsp27 do not bind to monomeric aggregation-prone forms
of CLIC1CysL, but instead preferentially interact with larger, soluble CLIC1CysL oligomers (that may
scatter light at 340 nm) to prevent their further aggregation and precipitation. This result is consistent
with a recent study that performed single-molecule fluorescence analysis of the complexes formed
between 𝛼B-c and another variant of CLIC1, which found that smaller species of 𝛼B-c preferentially
bind to CLIC1 oligomers (Johnston et al., 2020). Together, these experiments demonstrate that
CLIC1 can be used as a model aggregation-prone protein for the study of the chaperone function of
sHsps.

Since it was demonstrated that CLIC1 CysL could form stable complexes with 𝛼B-c, studies were
conducted to determine whether CLIC1CysL could be developed into a protein-folding sensor for use
in single-molecule fluorescence experiments to study sHsp function. To do so, CLIC1 CysL was
fluorescently labelled with maleimide-functionalized TMR fluorophores targeted to the two
remaining cysteines in CLIC1CysL (Cys24 and Cys59) and the fluorescence of individual molecules
measured using TIRF microscopy. In principle, the two TMR fluorophores conjugated to native
CLIC1CysL are proximally located and the fluorescence is quenched upon dye stacking; unfolding of
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CLIC1CysL (e.g., when in the presence of urea) should result in spatial separation of the fluorophores
and a return in fluorescence.

Interestingly, there appeared to be little change in the total fluorescence of TMR-labelled CLIC1CysL
molecules when incubated in the absence of presence of 4 M urea (conditions in which a significant
loss of secondary structure occurs as demonstrated by far-UV CD) (Figure 5.2D). Due to the
dynamics of the fluorescence signal and the observed transitions originating from low fluorescence
states, the analysis of single-molecule trajectories was not possible since it was too difficult to identify
and remove fluorescence data acquired after photobleaching of individual TMR-labelled CLIC1CysL
molecules. Consequently, the histogram data is heavily biased with molecules that have low
fluorescence, and this may mask potential differences in fluorescence states of CLIC1 CysL molecules
incubated in the absence or presence of urea. Of interest, photobleaching events have been observed
in other studies that have employed the use of TMR self-quenching at single-molecule resolution,
whereby the ‘quenched’ fluorescent state occupies a low, non-zero fluorescent state that then
transitions to a zero fluorescent state upon photobleaching (Zhou et al., 2011). However, such traces
were not commonly observed in this study (< 1%) and as such no definitive and robust approach
could be implemented to determine which transitions to low or zero fluorescence states were a result
of TMR self-quenching or photobleaching.

It is currently unclear as to why there is no significant difference in fluorescence intensity of TMRlabelled CLIC1CysL molecules that are folded compared to those that are unfolded (i.e., when
incubated in urea), or why the fluorescent states of individual TMR-labelled CLIC1CysL molecules
are dynamic. One possible explanation for the dynamics in the fluorescence signal could be the
inherent flexibility and conformational plasticity of the N-terminal domain of CLIC1. It has been
shown that regions of the N-terminal domain of CLIC1 undergo significant structural rearrangements
to prime CLIC1 for insertion into lipid membranes as part of its role as an intracellular chloride
channel (Harrop et al., 2001; Goodchild et al., 2011). Additionally, the presence of different cis- and
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trans-conformers of the proline-rich interdomain linker of CLIC1 alters the relative orientation of 𝛼helix 1 (which contains Cys24 at the extreme amino terminus) and 𝛼-helix 3 (Figure 5.1), and these
changes are propagated throughout the N-terminal domain resulting in a conformationally plastic
domain interface (Harrop et al., 2001). Furthermore, hydrogen deuterium exchange experiments and
molecular dynamic simulations have shown that 𝛼-helix 2 of the N-terminal domain, which contains
Cys59 at the extreme carboxyl terminus, and its flanking loop regions, undergo significant
conformational dynamicity (Stoychev et al., 2009; Jones et al., 2013). Such conformational dynamics
could significantly affect the distance between and orientation of the two TMR fluorophores attached
to CLIC1CysL in this work. This would result in a dynamic equilibrium between the formation of
stacked TMR-dimers (i.e., ‘quenched’) and TMR monomers (i.e., ‘fluorescent’) which may
contribute to the dynamics in fluorescence observed in many of the molecules in this work.

An alternate explanation for the fluorescence dynamics observed for individual TMR-labelled
CLIC1CysL molecules is that the TMR fluorophores are quenched in a manner that is independent of
TMR self-quenching. It is well established that the fluorescence of organic fluorophores, including
TMR, can be statically or dynamically quenched when in close proximity (~ 1 nm) to tryptophan and
tyrosine (albeit to a lesser degree) residues (Marmé et al., 2003; Doose et al., 2005, 2007, 2009;
Neuweiler et al., 2009; Mansoor et al., 2010; Choi et al., 2011; Li et al., 2011; Jones-Brunette et al.,
2014). CLIC1 has eight tyrosine residues and a single tryptophan residue, some of which are expected
to be within quenching distance to the TMR fluorophores. Notably, one of the cysteine residues
labelled in this study (Cys24) is within 11 Å (C𝛼 – C𝛼 distance) of Tyr233, which is known to form
hydrogen bonds with Cys24 (Jones et al., 2013). The proximity of these two residues enhances the
probability that tyrosine-induced quenching of TMR fluorescence can occur, thus contributing to the
stochastic fluorescence fluctuations observed in the single-molecule experiments. Denaturation of
CLIC1CysL in urea may also bring together TMR-labelled cysteine and aromatic residues that are close
in the sequence but spatially separated when the protein is folded. For example, Cys24 and Cys59 are
within 9 and 10 residues of the sole tryptophan of CLIC1 (Trp35) and Tyr69, respectively.
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Proteins that are unfolded in chemical denaturants (e.g., urea or guanidinium hydrochloride) typically
exist as a random coil, whereby molecules exist in an ensemble of typically expanded states due to
the absence of a preferred backbone orientation (Smith et al., 1996; Kohn et al., 2004). However, it
is known that chemically unfolded proteins exist in equilibria between expanded and compact
conformations within the random coil and that steric clashes between adjacent residues (~ 4 - 5
residues apart) are common (Calmettes et al., 1993; Smith et al., 1996; Baldwin et al., 2000; Pappu
et al., 2000). Consequently, it is possible that the chemical unfolding of CLIC1 CysL facilitates an
additional mechanism by which TMR fluorescence could be quenched by stochastic interactions
between the TMR dyes and nearby tyrosine or tryptophan residues. The combination of large-scale
conformational changes of the N-terminal domain and amino-acid-induced quenching of the TMR
fluorophores may explain why the total fluorescence and dynamic behavior of TMR-labelled
CLIC1CysL molecules is similar in folded and unfolded CLIC1CysL molecules - stochastic quenching
of the TMR fluorophores (either by TMR self-quenching or via tryptophan or tyrosine residues) is
possible regardless of the folded state of the proteins. Moreover, while the labelling of CLIC1CysL
typically resulted in double-labelled molecules, heterogenous labelling with TMR dyes may still
occur. This would result in a situation in which a subset of CLIC1 molecules is labelled with only a
single fluorophore, rather than the two required for TMR self-quenching to occur. Consequently, the
heterogenous labelling of CLIC1CysL may further contribute to the small differences observed for
CLIC1CysL fluorescence when incubated in the absence or presence of urea since the single-labelled
CLIC1CysL species are unable to report on changes in conformation via TMR self-quenching. Finally,
TMR has, in rare instances, proven to hydrophobically interact with or destabilize proteins of interest
upon conjugation (Pelikan Conchaudron et al., 2006; Zanetti-Domingues et al., 2013). Thus, it is
possible that the hydrophobic TMR dye may non-specifically interact with CLIC1 CysL in a manner
that may affect its structure; however, this was not explored further in this work.

186

Chapter 5 – Development of CLIC1 into a protein-folding sensor
The results of this chapter describe for the first time the use of CLIC1 as an aggregation-prone client
protein for the study of sHsp chaperone function. Critically, this work provides further evidence for
the multi-faceted manner by which sHsps can prevent the aggregation of proteins (i.e., either via the
formation of stable, high-molecular mass complexes or through transient interactions with the client)
(Rajaraman et al., 1998, 2001; Yerbury et al., 2013; Cox et al., 2016). This chapter also describes
work towards developing CLIC1 into a single-color protein-folding sensor for use in single-molecule
fluorescence experiments to study chaperone function. However, due to the dynamics of the
fluorescence traces observed for dual TMR-labelled CLIC1CysL molecules, it was concluded that this
system was not suitable to reliably monitor the folded state of a protein during its interactions with
chaperones. As an alternative approach, a promising avenue for future work is the combined use of
fluorescence resonance energy transfer (FRET) and black-hole quenchers (Chen et al., 2012). Such
an approach would be advantageous since FRET is a well understood phenomenon and is less
sensitive to minor (dynamic) conformational changes in protein structure owing to its broader
quenching distance (~ 1 - 10 nm) compared to TMR self-quenching (< 1 nm). The development of
such a system could enable the simultaneous observation of protein folding and molecular chaperones
using single-molecule fluorescence-based approaches.
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Chapter 6 – Characterization of ASCP as a novel dye to study protein aggregation
6.1

Introduction

The aggregation of proteins into amyloid fibrils is associated with a variety of protein conformational
disorders, including neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease,
and Amyotrophic Lateral Sclerosis. Amyloid fibril formation typically occurs via a nucleationdependent process (Serpell et al., 2000), which results in the formation of soluble oligomeric species
to which partially folded or unfolded monomers are added, in a two-dimensional process, to form a
fibril (Chiti et al., 2006). Amyloid fibrils are characterized by a well-defined cross β-sheet structure
that runs perpendicular to the long axis of the fibrils (Sunde et al., 1997). Much of the research into
protein aggregation over the last few decades has focused on fibrillogenesis due to its close
association with disease states (Chiti et al., 2017). Whilst the toxicity of amyloid fibril formation has
been recognized for some time, there has been considerable debate regarding which species is
responsible for the observed cytotoxicity of amyloid fibrils. Increasing evidence suggests that soluble
pre-amyloid oligomeric species, rather than the mature fibrils themselves, are the most cytotoxic
species and may be responsible for disease pathogenesis (Kayed et al., 2003; Glabe, 2006).
Consequently, there is a continuing need to develop in vitro approaches that enable the process of
fibril formation to be better understood at the molecular level and in the context of disease onset and
progression.

Amyloid-binding dyes have been extensively used to study the aggregation of proteins into amyloid
fibrils in vitro. Thioflavin T (ThT) is the best characterized and the most commonly used fluorescent
dye for the detection of amyloid fibrils (Malmos et al., 2017). Structurally, ThT consists of a
dimethylaminobenzene ring coupled to a positively charged benzothiazole ring by a rotatable C-C
bond; internal rotation around this bond quenches the locally excited state of the molecule to a dark,
twisted intramolecular charge transfer state that results in a low fluorescence yield of ThT when free
in solution (Amdursky et al., 2012). When the intramolecular rotations of ThT are inhibited, such as
upon binding to the -sheet rich motifs that are enriched in amyloid, the excited state is preserved
and the quantum yield of fluorescence increases dramatically (Biancalana et al., 2010).
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Unfortunately, ThT has a limited ability to detect oligomeric species that are present early during the
aggregation into amyloid fibrils (Lindgren et al., 2005; Groenning, 2010). Furthermore, ThT also has
a relatively small Stokes shift (~ 50 nm), which can be problematic when used in conjunction with
other spectrally similar molecules (Hudson et al., 2009). This is particularly relevant in the context
of fluorescence imaging techniques that exploit the selective amyloid binding properties of ThT, such
as total internal reflection fluorescence (TIRF) microscopy. Such methods have enabled the
visualization of individual amyloid fibrils (Cox et al., 2018), and facilitated the observation of fibril
elongation in real time (Ban et al., 2006; Ferkinghoff-Borg et al., 2010; Patil et al., 2011; Yagi et al.,
2014; Wördehoff et al., 2015). However, due to the relatively small Stokes shift of ThT, experiments
that also require fluorescently labelled proteins can be technically challenging owing to the
requirement of multiple excitation sources to avoid spectral overlap.

Recently, efforts have been made to develop novel aggregation-induced emission (AIE) fluorophores
that have enhanced spectral qualities and can overcome some of the limitations of ThT (Hong et al.,
2011; Gao et al., 2013). For example, a tetraphenylethene tethered to triphenylphosphonium (TPETPP) dye has been recently described with superior ability to detect oligomeric species formed early
during the aggregation of proteins into amyloid fibrils (Leung et al., 2015; Kumar et al., 2017; Das
et al., 2020). However, the maximum fluorescence emission for both ThT and TPE-TPP is in the blue
region of the spectrum (i.e., an emission maximum of ~ 480 nm) and this can restrict their use in cells
or tissues due to significant interference as a result of autofluorescence from these samples. The
present study aimed to characterize the AIE fluorophore ASCP for its suitability as a fluorescent
probe to monitor amyloid fibril formation and the imaging of fibrils via TIRF microscopy. Whilst the
design, synthesis and application of ASCP for imaging of cellular organelles has been previously
described (Yu et al., 2016), here we show that ASCP is fluorogenic in the presence of species formed
during the fibrillation and amorphous aggregation of proteins. Moreover, we demonstrate that ASCP
has enhanced affinity to amyloid fibrils compared to ThT and has advantages over ThT in its use in
single-molecule TIRF microscopy experiments as a result of its large Stokes shift that enables a single
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excitation source to be used to simultaneously monitor the emission from a fluorescently labelled
protein and ASCP-stained aggregates.
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6.2
6.2.1

Methods
Materials

ThT was purchased from Sigma-Aldrich (Missouri, USA) while the ASCP dye was synthesized
following previous reported procedures (Yu et al., 2016). Both dyes were solubilized in 100%
dimethyl sulfoxide (DMSO) to a final concentration of 5 mM. All buffers and solutions were filtered
using 0.22 µm filters before use and contained 0.02% (w/v) NaN 3 to prevent bacterial contamination.
The proteins κ-casein, insulin and 𝛼-lactalbumin were obtained from Sigma-Aldrich (Missouri,
USA). A1-42 was purchased from AnaSpec and stocks prepared in 10 mM NaOH at a final
concentration of 1 mg/mL. κ-casein was reduced and carboxymethylated (RCM) as previously
described to generate RCM κ-casein (Shechter et al., 1973). Recombinant 𝛼-synuclein was expressed
and purified as described (Hoyer et al., 2002). Recombinant 𝛼B-crystallin (𝛼B-c) was expressed and
purified as described previously (Horwitz et al., 1998), and fluorescently labelled with Alexa Fluor
488 (AF488)-maleimide as per the manufacturers instruction to generate AF488-𝛼B-c. AF488labelled superoxide dismutase 1 (SOD1) was a gift from Prof. Justin Yerbury and Dr. Luke McAlary.
All protein stocks were stored in aliquots at −20˚C until required.

6.2.2

Aggregation of 𝛼-synuclein

Fibrils of 𝛼-synuclein were generated as described previously (Buell et al., 2014), with some
modifications. Briefly, to produce α-synuclein seeds (fibril fragments), aliquots of monomeric αsynuclein (200 μM) were prepared in 20 mM phosphate buffer (pH 6.3) and incubated at 45˚C with
maximal stirring, using a Teflon flea on a WiseStir heat plate for 24 hr to facilitate the formation of
fibrils. The sample was then sonicated using a Digital Sonifier 250 (Branson, USA) for three cycles
of 10 sec at 30% power. The incubation and sonication steps were then repeated. The seed fibrils
were collected via centrifugation at 50,000 x g for 20 min at 4˚C and the resulting pellet containing
the seed fibrils resuspended in 20 mM phosphate buffer (pH 7.4). Aliquots of the 𝛼-synuclein seeds
were stored at -20˚C. To produce mature α-synuclein fibrils, α-synuclein seeds (2.5 μM) were
incubated with monomeric α-synuclein (50 μM) in 20 mM phosphate buffer (pH 7.4) at 45˚C without
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agitation for 48 hr. The fibrils were then centrifuged at 50,000 x g for 20 min at 4˚C and the pellet
containing the mature fibrils was resuspended in 20 mM phosphate buffer (pH 7.4) and stored at room
temperature. The concentration of fibrils and seed fibrils are reported as the equivalent monomeric
concentration used to prepare them.

6.2.3

Absorbance and fluorescence spectra of dyes

Absorbance spectra of ThT and ASCP dyes were determined on a Nanodrop 2000C (Thermo Fisher
Scientific, USA). Spectra were determined in 20 mM phosphate buffer (pH 7.4) and in the presence
of monomeric and fibrillar 𝛼-synuclein (50 µM) to determine if any shift in absorbance occurs upon
binding of dyes to the protein. Spectra were generated with 100 µM of dye. Data were corrected for
signals produced by an equivalent concentration of DMSO alone.

The fluorescence spectrum of ThT and ASCP were determined using a Varian Cary Eclipse
Fluorometer, following excitation at the maximum absorbance wavelength for the individual dye (412
or 460 nm for ThT and ASCP, respectively). The fluorometer was set with excitation and emission
slit widths of 5 nm and 10 nm, respectively, and data collected at a scan rate of 300 nm/min and an
averaging time of 0.5 s. All samples were loaded into a quartz fluorescence cuvette. Increasing
concentrations of each dye (0 - 50 µM) in the presence of monomeric or fibrillar 𝛼-synuclein (20 µM)
were tested. Controls consisted of dye alone (20 µM) without 𝛼-synuclein, and 𝛼-synuclein (20 µM,
monomer or fibril) in the presence of an equivalent concentration of DMSO alone. Values from
appropriate controls were subtracted from the corresponding raw data.

6.2.4

Binding affinity and competition of ThT and ASCP to α-synuclein fibrils

To determine the binding affinity of ThT and ASCP to 𝛼-synuclein fibrils, the fluorescence intensity
at the maximum emission wavelength (480 nm for ThT and 605 nm for ASCP) for each concentration
of dye in the presence of 𝛼-synuclein fibrils were determined and normalized against the maximum
fluorescence value. Each normalized peak fluorescence was plotted against dye concentration and the
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apparent equilibrium binding constant (Kb) was determined by fitting the data to a one-site specificbinding model using Equation 6.1.

Y=

Bmax · X
Kb +X

Equation 6.1: Equation used to fit to a one-site specific-binding model. Kb is the equilibrium binding
constant and Bmax is the maximum specific binding of ASCP. Data were fit using GraphPad Prism 8 software.

To determine whether ASCP can out-compete ThT for binding sites on fibrillar 𝛼-synuclein, ThT (20
μM) was incubated in the absence or presence of 𝛼-synuclein fibrils (20 μM) in 20 mM phosphate
buffer (pH 7.4) at room temperature for 5 min. Different concentrations of ASCP (0 - 20 μM) were then
added to 𝛼-synuclein samples containing ThT and the fluorescence intensities for ThT (440 nm
excitation, 490 nm emission) and ASCP (485 nm excitation, 620 nm emission) were recorded using
a FLUOStar plate reader (BMG Labtech, Germany). The fluorescence values were normalized to the
maximum fluorescence intensity, plotted against ASCP concentration and the data were fit to a onesite specific-binding model (for ASCP) and a one-phase dissociation model (for ThT) using GraphPad
Prism 8 software.

6.2.5

Monitoring the fibrillar and amorphous aggregation of RCM κ-casein, A1-42 peptide,
𝛼-lactalbumin and insulin using ThT and ASCP in situ

To test the ability of ASCP to monitor the formation of amyloid fibrils by proteins other than 𝛼synuclein, ThT (20 µM) or ASCP (2 - 20 µM) was added to either RCM κ-casein (50 µM) in 50 mM
phosphate buffer (pH 7.4) or A1-42 peptide (20 µM) in phosphate buffered saline (PBS). To test
whether ASCP was selectively fluorogenic in the presence of amyloid aggregates, the amorphous
aggregation of 𝛼-lactalbumin and insulin in the presence of ThT and ASCP was also monitored.
𝛼-lactalbumin in 50 mM imidazole (pH 7.0) supplemented with 5 mM CaCl2 and 100 mM NaCl or
insulin in 50 mM phosphate buffer (pH 7.4) were incubated in the presence of various concentrations
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of dye (2 – 20 µM). Amorphous aggregation of 𝛼-lactalbumin and insulin was initiated following
addition of dithiothreitol (DTT, 20 mM or 2 mM, respectively), similar to previously reported
protocols (Ecroyd and Carver, 2008).
Aggregation assays were performed in a FLUOstar or POLARstar plate reader set at either 37˚C for
RCM κ-casein, 𝛼-lactalbumin and insulin and at either 30˚C or 37˚C for A1-42 peptide. For amyloid
forming proteins, assays were performed in black 384 well plates and the fluorescence was measured
every 12 min (RCM κ-casein) or 24 min (A1-42) until the fluorescence signal had plateaued (~ 48 or
72 hr for RCM κ-casein or A1-42, respectively). For 𝛼-lactalbumin and insulin, assays were
performed in black 96 well plates and the absorbance at 340 nm and the fluorescence of the dyes was
measured alternatively every 3.3 min for 300 min total. For the aggregation of RCM κ-casein, A1-42
and insulin, plates were shaken for 30 s before each cycle. The following excitation/emission
wavelengths were used; ThT 𝜆ex = 440 nm, 𝜆em = 490 nm; ASCP 𝜆ex = 485 nm, 𝜆em = 590 nm. The
change in fluorescence intensity is reported for each dye - results were normalized by dividing the
fluorescence intensity at each time point by the maximum fluorescence for easy comparison of dyes.
RCM κ-casein assays were run in duplicate, while A1-42, 𝛼-lactalbumin and insulin aggregation
assays were run in triplicate. Dye alone (20 µM) in the appropriate assay buffer served as a control
for each sample. Data from the RCM κ-casein assay were fitted with a specific binding with hill slope
model using GraphPad Prism 8 software.

To determine whether the addition of ASCP may influence the kinetics of A1-42 aggregation,
experiments were performed in which ASCP was omitted from the aggregation reaction, incubated
as described above and aliquots taken at various timepoints (0, 6, 12, 24, 36 and 72 hr). Each timepoint
was then diluted in ASCP for fluorometry (final concentration of 2.5 µM and 20 µM for A1-42 and
ASCP, respectively). The fluorescence spectra of each timepoint were collected using a fluorometer
set with excitation and emission slit widths of 5 nm and 10 nm, respectively, and data acquired at a
scan rate of 200 nm/min and an averaging time of 0.5 s. ThT and ASCP were excited with their
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previously determined maximum absorbance wavelengths (412 or 460 nm for ThT and ASCP,
respectively). The maximum fluorescence value for each timepoint was determined and normalized
to the maximum fluorescence intensity of the 36 hr timepoint.

6.2.6

ThT and ASCP as in situ reporters of α-synuclein fibril elongation

The seeded aggregation of α-synuclein was monitored in situ using a microplate assay, as previously
described (Cox et al., 2016). Duplicate samples, containing varying concentrations of ThT or ASCP
(0 - 50 μM) in the presence or absence of α-synuclein (50 μM monomeric, 2.5 μM seed) were
incubated in 20 mM phosphate buffer (pH 7.4) for 48 hr at 37˚C without shaking. The fluorescence
was measured every 15 min using the excitation and emission filters of 440/490 nm for ThT and
485/610 nm for ASCP. The fluorescence values from samples in the absence of α-synuclein were
subtracted from equivalent readings containing α-synuclein to correct for signals produced by the dye
alone (which were negligible). The fluorescence intensity values obtained from each sample of the
assay were normalized to the maximum fluorescence intensity of that sample. The raw ASCP
fluorescence values and the normalized values from both dyes were plotted as a function of time and
fitted with a one-phase association model using GraphPad Prism 8 software.
At the end of the in situ α-synuclein fibril formation assay an aliquot was taken from each sample
and centrifuged at 50,000 x g for 20 min at 4˚C to separate the supernatant, which contains soluble
monomeric α-synuclein, from the pellet that contains the fibrillar α-synuclein. The supernatants were
collected, and the pellets were resuspended to the same initial volume using 20 mM phosphate buffer
(pH 7.4) for subsequent analysis via SDS-PAGE.

6.2.7

Assessing the ability of ThT and ASCP to monitor the aggregation of 𝛼-synuclein ex situ

𝛼-synuclein was aggregated as described previously (see section 6.2.2) and aliquots of 𝛼-synuclein
were taken at t = 0, 1, 3, 6, 12, 24 and 72 hr following the start of aggregation and stored at 4˚C to
prevent further aggregation. The fluorescence spectra of 𝛼-synuclein fibrils (20 µM) in the presence
of dye (20 µM) at each time point were collected using a fluorometer set with excitation and emission
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slit widths of 5 nm and data acquired at a scan rate of 200 nm/min and an averaging time of 0.2 s.
ThT and ASCP were excited with their previously determined maximum absorbance wavelengths
(412 or 460 nm for ThT and ASCP, respectively). The maximum fluorescence value for each
timepoint was determined and normalized to the maximum fluorescence intensity of the 72 hr
timepoint. The normalized fluorescence values were graphed and fit with a one-phase association
curve using GraphPad Prism 8 software.

6.2.8

Preparing coverslips for TIRF microscopy

To prepare slides for microscopy, 24 x 24 mm glass coverslips were cleaned by alternatively
sonicating for 30 min in 100% ethanol then in KOH (2 M) for a total of 2 hr, and with a final
sonication in milli-Q water for 5 min. The coverslips were then incubated for 30 min at room
temperature with 0.01% (w/v) poly-L-lysine and washed three times with 20 mM phosphate buffer
(pH 7.4). Coverslips, with loaded sample, were placed onto the TIRF objective lens coated with
immersion oil (n = 1.518; Olympus, UK).

6.2.9

Monitoring α-synuclein fibril elongation ex situ using TIRF microscopy

The seeded aggregation of α-synuclein was monitored ex situ using TIRF microscopy. Fibrillar
𝛼-synuclein was generated as described previously (see section 6.2.2), with the exception that
samples were incubated at 37˚C, and aliquots were taken at various time points (0, 1, 3, 6, 12, and 24
hr). Aliquots were centrifuged at 50,000 × g for 20 min at 4˚C to remove monomeric α-synuclein that
was not incorporated into the fibrils. Samples were diluted 4,000-fold into 20 mM phosphate buffer
(pH 7.4) containing 6 mM Trolox and ASCP (5 µM). The sample (50 μL) was then loaded onto the
coverslip and imaged. Prior to imaging, samples were randomized so the user was blinded to the
sample identity. All data were acquired using a TIRF microscope setup as previously described (see
section 2.4.1) following sample illumination using a 488 nm solid state laser with excitation intensity
of 4.6 W/cm2.
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6.2.10 Direct observation of αB-crystallin binding to fibrillar 𝛼-synuclein
To demonstrate the ability of ASCP to be used in single-laser two-color TIRF microscopy
experiments, the well-characterized interaction between the small heat-shock protein (sHsp) 𝛼Bcrystallin (αB-c, [HSPB5]) and mature α-synuclein fibrils was investigated (Cox et al., 2016).
Samples containing α-synuclein fibrils (50 μM) and AF488-labelled αB-c (1 μM) were incubated
together at room temperature for 5 min in 20 mM phosphate buffer (pH 7.4) containing 6 mM Trolox
and diluted 1,000-fold into the same buffer containing ASCP (5 μM). Samples (50 μL) were loaded
onto the coverslip and imaged. Samples were randomized prior to imaging so the user was blinded to
the sample identity. All data were acquired using a TIRF microscope setup as previously described
(see section 2.4.1) following sample illumination using a 488 nm solid state laser with excitation
intensity of 4.6 W/cm2.

6.2.11 Image analysis
Using custom plugin software operated through Fiji (Schindelin et al., 2012), background
fluorescence and laser beam profiles were subtracted from the acquired images. The images were Zprojected, averaging all the frames attained during acquisition, and the brightness and contrast
adjusted for clear visualization.
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6.3
6.3.1

Results
Absorbance and fluorescence spectra of ThT and ASCP

Absorption spectra were acquired to determine the maximum absorbance wavelength (𝜆max) and the
effect of monomeric and fibrillar 𝛼-synuclein on the absorbance of ThT and ASCP (Figure 6.1A-B).
The maximum absorbance for ThT and ASCP in solvent alone or in the presence of monomeric 𝛼synuclein was 412 nm and 430 nm, respectively. There was no shift in 𝜆max for ThT when bound to
fibrillar 𝛼-synuclein. Interestingly, ASCP was observed to have a higher absorbance in the presence
of monomeric or fibrillar 𝛼-synuclein and exhibited a significant shift (30 nm) in 𝜆max to 460 nm
when bound to fibrillar 𝛼-synuclein. Based on the absorbance spectra, excitation wavelengths (𝜆ex)
of 412 nm (ThT) and 460 nm (ASCP) were used to examine the fluorescent properties of the dyes in
solvent alone or bound to 𝛼-synuclein.

Both ThT and ASCP demonstrated significant fluorescent enhancement when bound to fibrillar 𝛼synuclein as compared to when the dye was in solvent alone or in the presence of monomeric 𝛼synuclein (Figure 6.1C-D). The fluorescence intensity of 50 µM of ThT and ASCP was minimal
when in solvent alone with negligible increases in fluorescent intensity when bound to monomeric 𝛼synuclein. The maximum emission wavelength (𝜆em) for ThT (50 µM) was 480 nm, while ASCP (50
µM) exhibited a significant Stokes shift of ~ 145 nm with a 𝜆em of 605 nm.

199

Chapter 6 – Characterization of ASCP as a novel dye to study protein aggregation

Figure 6.1: Absorbance and fluorescence spectra of ThT and ASCP in the presence or absence of
monomeric or fibrillar 𝛼-synuclein. The dyes ThT (A) and ASCP (B) (100 µM) were added to 20 mM
phosphate buffer (pH 7.4) in the presence or absence of monomeric or fibrillar 𝛼-synuclein (50 µM).
Absorbance spectra were measured from 300 - 700 nm. The chemical structures of ThT (A, inset) and ASCP
(B, inset) are shown. The fluorescence emission spectra of both ThT (C) and ASCP (D) (0 - 50 µM) in the
presence of monomeric or fibrillar 𝛼-synuclein (20 µM) were then measured using a spectrofluorometer,
following excitation at 412 nm and 460 nm for ThT and ASCP, respectively.

6.3.2

Binding affinity and competition of ThT and ASCP to α-synuclein fibrils

The normalized fluorescence at each concentration of ThT and ASCP was used to determine the
apparent binding constant (Kb) of each dye to fibrillar 𝛼-synuclein (Figure 6.2A). By fitting a onesite specific-binding model, the binding affinity of ASCP (Kb = 5.5 ± 0.7 µM) was determined to be
almost twice that of ThT (Kb = 9.9 ± 1.5 µM). Competition experiments were then performed to
determine whether ASCP outcompetes ThT for binding to fibrillar 𝛼-synuclein (Figure 6.2B). In the
presence of 𝛼-synuclein fibrils that had been pre-incubated with ThT (20 μM), increasing
concentrations of ASCP resulted in an increase in the intensity of ASCP fluorescence and a
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simultaneous decrease in ThT fluorescence intensity. At a molar ratio of 1:2 (ASCP: ThT) there was
a greater than 95% reduction in ThT fluorescence, which indicated that ThT was competitively
dissociated from fibrils by ASCP.

Figure 6.2: Binding affinity and competitive binding of ASCP and ThT to 𝛼-synuclein fibrils. (A) ThT
or ASCP (0 – 50 µM) was incubated with 𝛼-synuclein fibrils (20 µM). The normalized fluorescence intensity
was plotted against the dye concentration and fitted to a one-site specific-binding model. The calculated
apparent binding affinity (Kb) is shown for each dye. (B) ASCP (0 - 20 µM) was added to 𝛼-synuclein fibrils
(20 µM) pre-incubated in the presence of ThT (20 µM). The normalized fluorescence intensity of each dye
was plotted against the concentration of ASCP. The data corresponding to ASCP fluorescence was fitted to a
one-site specific-binding model and ThT fluorescence fitted to a one-phase dissociation model. Data represents
the mean ± standard error of the mean from three independent experiments.

6.3.3

Monitoring the fibrillar and amorphous aggregation of various model proteins in situ

To determine whether ASCP can monitor the aggregation of other proteins into amyloid fibrils,
A1-42 peptide and RCM κ-casein aggregation assays were performed (Figure 6.3). The fluorescence
intensity of both ThT and ASCP (20 µM) were observed to increase over time when incubated with
either A1-42 or RCM κ-casein. Interestingly, the fluorescence intensity profile of ASCP differed
substantially to ThT during the aggregation of A1-42, with ASCP fluorescence increasing early
during the aggregation process (0 – 40 hr) before reaching maximum fluorescence at ~ 40 hr and
decreasing in intensity past 40 hr (Figure 6.3A). Conversely, the fluorescence intensity of ThT only
increased substantially after 40 hr of aggregation and plateaued after ~ 55 hr (Figure 6.3A). Incubation
of A1-42 at 37˚C resulted in an earlier increase and plateau of fluorescence intensity for both ASCP

201

Chapter 6 – Characterization of ASCP as a novel dye to study protein aggregation
and ThT but did not influence the overall fluorescence intensity profile of either dye compared to
when A1-42 was incubated at 30˚C (Figure 6.3B). When used to monitor the aggregation of A1-42
the fluorescence intensity profile of ASCP did not change with increasing concentrations of dye (2 to
20 µM) (Figure 6.3A), suggesting that the dye itself does not significantly influence the kinetics of
A1-42 aggregation. To further examine whether ASCP may influence the aggregation kinetics of
A1-42, ASCP was omitted from the aggregation reaction and the formation of fibrils at various
timepoints was assessed following dilution of the sample into a solution containing ASCP and
measuring the fluorescence (Figure 6.3C). The normalized fluorescence of ASCP in the presence of
A1-42 fibrils formed in the absence of ASCP appeared to be slightly higher at earlier timepoints (i.e.,
0 – 12 hr) compared to ASCP that had been incubated in the presence of A1-42. The normalized
fluorescence of both treatments appeared identical at all remaining timepoints (i.e., > 12 hr), which
together suggests that ASCP does not significantly influence the kinetics of A1-42 aggregation.
Similar as for A1-42, when ASCP and ThT were used to monitor amyloid fibril formation by RCM
κ-casein the increase in ASCP fluorescence occurred much earlier than for ThT (Figure 6.3D), with
the time to half maximum intensity determined to be 8.6 hr for ASCP and 15.6 hr for ThT. These data
again suggest that ASCP may detect species formed earlier during the aggregation of RCM κ-casein
into amyloid fibrils than ThT.

To determine whether ASCP could monitor the amorphous aggregation of proteins, the reductioninduced aggregation of 𝛼-lactalbumin and insulin was monitored in the presence of ThT and ASCP
(Figure 6.3E-F). An initial lag phase of ~ 20 min was observed for both 𝛼-lactalbumin and insulin,
whereby there was no increase in light scatter at 340 nm during this period. After the observed lag
phase, the light scatter at 340 nm was observed to increase for both 𝛼-lactalbumin and insulin,
indicative of the formation of amorphous aggregates. The change in light scatter was observed to
plateau after ~ 120 min and 50 min for 𝛼-lactalbumin and insulin, respectively. Interestingly, the
fluorescence intensity of both ThT and ASCP also increased in these samples in a similar manner to
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that observed for the increase in light scatter at 340 nm. Notably, there was an increase in fluorescence
intensity observed for ASCP, but not ThT, during the early stages (0 – 20 min) of 𝛼-lactalbumin
aggregation, a time-period corresponding to the observed lag phase as determined by light scattering
at 340 nm.
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Figure 6.3: ASCP can be used to monitor the fibrillar and amorphous aggregation of proteins in
situ and ex situ. ThT or ASCP (20 µM) were added to A1-42 (20 µM) and incubated at 30˚C (A) or 37˚C
(B) and the aggregation of protein monitored via the change in fluorescence. When monitoring the
aggregation of A1-42 at 30˚C, various concentrations of ASCP (2 – 20 µM) were present during the
incubation. (C) A1-42 (20 µM) was incubated at 30˚C in the absence (circles) or presence (line) of ASCP
(20 µM) and the aggregation of protein monitored via the change in fluorescence. Aliquots of A 1-42
incubated in the absence of ASCP were taken at various times (t = 0, 6, 12, 24, 36 and 72 hr), diluted into
ASCP (20 µM) to a final A1-42 concentration of 2.5 µM and the fluorescence measured. ThT or ASCP
(20 µM) were added to RCM κ-casein (50 µM, D), 𝛼-lactalbumin (100 µM, E) or insulin (100 µM, F)
and the aggregation of protein was monitored via the change in fluorescence and/or light scatter at 340
nm. RCM κ-casein assays were run in duplicate, while A1-42, 𝛼-lactalbumin and insulin aggregation assays
were run in triplicate. For all experiments, the normalized fluorescence intensity were plotted against time.
Data for panels A - B and D - F are shown as the mean ± standard error of the mean from at least three
independent experiments. Data for panel C comes from an individual experiment.

6.3.4

ASCP and ThT can be used in situ to monitor the aggregation of 𝛼-synuclein in real time

In vitro aggregation assays were used to compare the abilities of ASCP and ThT to monitor
α-synuclein fibril elongation in situ over time. The addition of α-synuclein seeds removes the lag
phase kinetics associated with 𝛼-synuclein aggregation (Buell et al., 2014), and therefore enables
fibril elongation to be examined. When 𝛼-synuclein was incubated in the presence of ThT, there was
an increase in the normalized fluorescence intensity at 490 nm over time that corresponds to the
elongation of 𝛼-synuclein fibrils (Figure 6.4A). At all concentrations of ThT tested, there was a
uniform increase in fluorescence intensity and a plateau observed after ~ 24 hr of incubation.
Similarly, there was an increase in the normalized fluorescence intensity at 610 nm observed when
𝛼-synuclein was incubated in the presence of ASCP (Figure 6.4B). A similar plateau in fluorescence
intensity was also reached following 24 hr of incubation in the presence of up to 5 μM ASCP;
however, at concentrations above 5 μM of ASCP a plateau was not reached after 48 hr of incubation
and the initial rate of elongation was reduced. The total change in ASCP fluorescence intensity at the
endpoint of the assay, which can provide an indication on the total amount of amyloid formed, was
observed to increase in magnitude up to 10 µM of ASCP and decrease at concentrations greater than
10 µM (Figure 6.4C).
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To establish whether the reduced fluorescence intensity and rates of α-synuclein fibril elongation at
higher concentrations of ASCP is due to inhibition of fibril elongation, samples were collected at the
end of the assay and the proportion of soluble (supernatant) and fibrillar (pellet) 𝛼-synuclein was
analyzed via SDS-PAGE (Figure 6.4D). When incubated in the presence of ThT, 𝛼-synuclein
(denoted by a band at ~ 15 kDa) was primarily observed in the insoluble pelleted fraction, indicating
that elongation of α-synuclein seeds into fibrils had occurred in the presence of all concentrations of
ThT tested. Similar to ThT, and in agreement with the elongation assays, 𝛼-synuclein was observed
predominantly in the insoluble pelleted fractions when incubated in the presence of up to 5 µM ASCP.
However, at a concentration of 20 μM ASCP, 𝛼-synuclein was found predominantly in the soluble
(supernatant) fraction. Thus, these data suggest that high concentrations of ASCP inhibits 𝛼-synuclein
fibril elongation.
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Figure 6.4: The in-situ elongation of α-synuclein fibrils measured via ThT or ASCP fluorescence.
Monomeric α-synuclein (50 μM) and α-synuclein seeds (2.5 μM) in 20 mM phosphate buffer (pH 7.4) were
incubated at 37˚C in the presence of varying concentrations of dye (0 – 50 µM). The elongation of the seeds
was monitored by measuring the change in fluorescence over time of ThT (A) or ASCP (B), which were
normalized to allow for easy comparison between the dyes. (C) The change in fluorescence intensity during
the elongation of 𝛼-synuclein seeds in the presence of different concentrations of ASCP (0 – 50 µM). The data
in A - C are representative of three independent repeats. (D) Samples from the microplate assays (from panels
A and B) were centrifuged at 50,000 x g for 20 min to separate soluble monomeric α-synuclein fractions
(denoted as S) from α-synuclein fibrils within the pellet (denoted as P) and subsequently analyzed via SDSPAGE. The concentration of dye is shown on the left of the gels.

6.3.5

Monitoring and visualizing the aggregation of 𝛼-synuclein using ex situ assays and TIRF
microscopy

To determine if ASCP could be used to monitor the seeded aggregation of 𝛼-synuclein ex situ,
𝛼-synuclein was incubated in the absence of dye and aliquots taken at various time intervals and
incubated with ThT or ASCP. The normalized fluorescence of both ThT and ASCP in the presence
of 𝛼-synuclein was observed to increase over time (Figure 6.5A), indicative of the formation of
amyloid fibrils. The increase in fluorescence of both ThT and ASCP over time fitted well to a onephase association curve, which is typical for the seeded aggregation of 𝛼-synuclein (Buell et al.,
2014).
As it was established that ASCP could be used to monitor the elongation of α-synuclein fibrils in situ
and ex situ, we next examined whether the dye could be used to visualize fibrils using TIRF
microscopy. First, as a control, ASCP was incubated in the presence of monomeric 𝛼-synuclein and
imaged via TIRF microscopy. Importantly, ASCP displayed negligible fluorescence in the presence
of monomeric α-synuclein; however, a small number of fluorescent puncta were observed in some
fields of view, typical of insoluble dye molecules (Figure 6.5B). Next, aliquots from a seeded
aggregation reaction were taken at various timepoints, incubated with ASCP, and deposited onto a
Poly-L-lysine coated coverslip for image acquisition (Figure 6.5C). Fibrils could clearly be visualized
via TIRF microscopy following excitation with a 488 nm laser and using an emission window of
> 675 nm. By using ASCP and TIRF microscopy to visualize individual fibrils, the length of the α-
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synuclein fibrils was observed to increase during incubation; short fluorescent fragments
corresponding to α-synuclein seeds were visible at 0 hr and thin filament-like structures, typical of
amyloid fibrils (and with some exceeding lengths of 10 µm) were observed over 24 hr.

Figure 6.5: Monitoring and visualizing the elongation of 𝛼-synuclein fibrils using ex situ fluorometry
and TIRF microscopy. Recombinant 𝛼-synuclein monomer (50 µM) was incubated in the presence of 𝛼synuclein seeds (2.5 µM) in 20 mM phosphate buffer (pH 7.4) to generate mature fibrils. (A) Aliquots were
taken from the elongation reaction at 0, 1, 3, 6, 12 and 24 and 72 hr. The generated 𝛼-synuclein fibrils (20 µM
final concentration) at each time point were incubated in the presence of either ThT or ASCP (20 µM) and the
fluorescence measured. The normalized fluorescence intensity was plotted against time and fitted to a onephase association model. (B) A representative TIRF image of 𝛼-synuclein monomer (50 µM) that was diluted
4,000-fold in 20 mM phosphate-Trolox buffer (pH 7.4) containing ASCP (5 µM). (C) Aliquots were taken
from the elongation reaction at 0, 1, 3, 6, 12 and 24 hr. Samples from each timepoint were diluted 4,000-fold
in 20 mM phosphate-Trolox buffer containing ASCP (5 µM) and imaged using TIRF microscopy.
Representative TIRF microscopy images from each timepoint are shown. Scale bar represents 5 µm.
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After establishing that ASCP can be used to visualize 𝛼-synuclein fibrils using TIRF microscopy, we
sought to further exploit the unique spectral properties of ASCP over ThT, in particular the large
Stokes shift in its emission, by performing single-laser two-color microscopy. As a proof of principle,
the ability of the molecular chaperone 𝛼B-c to bind to 𝛼-synuclein fibrils was investigated. As part
of its chaperone function, αB-c inhibits α-synuclein fibril elongation, in part, through its ability to
interact and form stable complexes with preformed, mature α-synuclein fibrils (Rekas et al., 2007;
Waudby et al., 2010; Bruinsma et al., 2011; Cox et al., 2018). Thus, mature 𝛼-synuclein fibrils were
incubated in the presence of AF488-labelled 𝛼B-c (AF488-𝛼B-c), diluted, and imaged via TIRF
microscopy using a single 488 nm laser (Figure 6.6A). Upon excitation at 488 nm, the fluorescence
emission of 𝛼-synuclein fibrils stained with ASCP was measured at > 675 nm while the fluorescence
emission of AF488-𝛼B-c bound to the fibrils was simultaneously measured at 500 - 550 nm. In the
absence of α-synuclein fibrils, αB-c was found to be randomly dispersed on the coverslip surface and
not co-localized to fluorescent puncta formed by insoluble ASCP, indicating that ASCP does not bind
to αB-c (Figure 6.6B). Additionally, when the non-chaperone control protein AF488-labelled SOD1
was incubated with mature fibrils, it was found to be randomly dispersed in areas surrounding the
α-synuclein fibrils, but not specifically associated with the fibrils (Figure 6.6C). In contrast, when
αB-c was incubated in the presence of α-synuclein fibrils, αB-c was able to be visualized bound along
the surface of the fibrils (Figure 6.6D). Thus, using ASCP and TIRF microscopy we were able to
simultaneously image 𝛼-synuclein fibrils and bound αB-c from the one laser light source.
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Figure 6.6: ASCP can be used in single-laser two-color TIRF microscopy experiments to visualize
binding of the molecular chaperone 𝛼B-c to 𝛼-synuclein fibrils. (A) Schematic of the single-molecule TIRF
microscopy setup used to image 𝛼-synuclein fibrils and AF488-conjugated protein. Illumination of the sample
with a 488 nm laser selectively excites the AF488-labelled protein (in this case AF488-𝛼B-c) and ASCPstained fibrils and the emission from both fluorophores are collected in separate channels. (B) AF488-𝛼B-c
(1 µM) was incubated in 20 mM phosphate-Trolox (pH 7.4) for 30 min at room temperature in the absence of
𝛼-synuclein and diluted 1,000-fold in buffer containing ASCP (5 µM). Fibrillar 𝛼-synuclein (50 μM) was
incubated in 20 mM phosphate-Trolox buffer (pH 7.4) in the presence of (C) AF488-SOD1 or
(D) AF488-𝛼B-c (1 µM) for 30 min at room temperature. Samples were diluted 1,000-fold into buffer
containing ASCP (5 µM) and both 𝛼-synuclein fibrils and AF488-conjugated protein were excited following
illumination at 488 nm. All samples were imaged using TIRF microscopy and representative TIRF images
from each experiment are shown, with the fluorescence emission of AF488-labelled species (left) and ASCP
(middle) collected in separate channels. A merged composite image is also shown for each experiment (right).
A magnified inset of the images from panel D is also shown for clarity. Scale bars represent 5 µm or 2 µm
(magnified inset).
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6.4

Discussion

Thioflavin T (ThT) is the most characterized and widely utilized fluorescent probe for the study and
detection of amyloid fibrils. However, ThT is less able to detect oligomeric or pre-fibrillar species
formed early during aggregation and possesses a small Stokes shift that complicates experiments that
also employ spectrally similar fluorophores. Therefore, there is a need to identify and characterize
other fluorogens with unique spectral properties that can be used to detect and monitor amyloid fibril
formation. The aim of the present study was to characterize a red-emitting aggregation-induced
emission (AIE) fluorogenic dye, ASCP, as a reporter of amyloid fibrils and assess its use for in situ
and ex situ applications. Furthermore, we assessed the ability of ASCP to be used in TIRF
microscopy-based experiments aimed at visualizing and characterizing individual 𝛼-synuclein
amyloid fibrils and their interaction with molecular chaperones. Based on this work, we report that
ASCP serves as an excellent alternative for ThT with regards to detecting and monitoring fibril
formation and possesses the ability to detect species formed early during the aggregation of proteins
into amyloid fibrils. Moreover, ASCP has spectral qualities that make it superior to ThT and can be
used in single-laser TIRF-based investigations of amyloid fibrils.

The absorbance and fluorescence emission spectral properties obtained for both ThT and ASCP were
similar to those previously reported (Groenning, 2010; Yu et al., 2016). Whilst no changes were
observed for the absorbance spectra of ThT in the presence or absence of α-synuclein fibrils, the
absorbance spectra of ASCP increased in magnitude by ~ 60% and was red-shifted 30 nm in the
presence of α-synuclein. These changes in absorbance have been reported for other AIE dyes upon
binding to amyloid structures (Miura et al., 2002; Celej et al., 2008; Rajasekhar et al., 2016), and has
been specifically observed when ASCP is bound to DNA or RNA structures (Yu et al., 2016). The
shift in ASCP absorbance spectra when in the presence of fibrillar α-synuclein is likely due to changes
in local polarity caused by electrostatic solute-solvent interactions (Toutchkine et al., 2003; Voropai
et al., 2003). Binding of the positively charged pyridinium moiety of ASCP to amyloid structures
would result in a change of local polarity between the ground state (i.e., unbound and non-fluorescent)
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and excited state (i.e., bound and fluorescent) of the dye molecule. The resulting changes in polarity
likely lead to the variations in absorbance magnitude and λabs observed for ASCP in the presence of
different α-synuclein species.
Upon excitation at 460 nm (i.e., λex), ASCP displayed a maximum emission (λ em) at 605 nm,
corresponding to a substantial Stokes shift of 145 nm, which is much greater than the Stokes shift
exhibited by ThT (68 nm). Spectral shifts of this type can be attributed to changes in the
intramolecular conformation and electronic structure of the dye as a result of the restriction of carboncarbon bond rotations that occurs when the dye binds to amyloid structures (Wang et al., 2015).
Restriction to a planar conformation results in the expansion of electron-π conjugates, (i.e., the
adjacent donor-π-acceptor electron bridges of C=C bonds) and π-π stacking between benzene groups
of dye molecules, all of which increase electron transfer and reduce the energy of the excited state
(Zhu et al., 2013; Ikkanda et al., 2016; Yang et al., 2016). Thus, the enhanced Stokes shift of ASCP
is attributed to the addition of a methylpyridinium and dimethylamine moieties to the 𝛼-cyanostilbene
core of ASCP that enables an improved capacity to expand electron- conjugates compared to that of
ThT.

As demonstrated by both fluorometry and TIRF microscopy, negligible fluorescence was observed
for ThT and ASCP in the presence of monomeric α-synuclein or solvent alone, whereas there was a
substantial increase in fluorescence intensity in the presence of fibrillar α-synuclein. Both ThT and
ASCP are known as fluorescent molecular rotors, with varying degrees of intramolecular rotation
between C-C bonds. The rotation of C-C bonds quenches the locally excited states generated by
photon excitation, resulting in a dark twisted intramolecular charge-transfer (TICT) state that
produces little to no fluorescence emission (Sasaki et al., 2016). Restricting the rotational
intramolecular motions of the dye, which is predicted to occur upon binding to amyloid fibrils
(Amdursky et al., 2012), prevents energy transfer to the TICT state and preserves the excited state
such that a high quantum yield of fluorescence occurs (Sasaki et al., 2016). There are at least three
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rotation sites within the structure of ASCP; either side adjacent to the C=C bond within its αcyanostilbene backbone (Zhu et al., 2013), and another in the C-C bond between the α-cyanostilbene
backbone and methylpyridinium moiety. We propose that restriction of one or all of the rotational
sites within ASCP results in the observed increase in fluorescence when bound to fibrillar αsynuclein.
The binding affinity of ASCP to α-synuclein fibrils was measured to be nearly twice that of ThT.
This higher affinity is most likely due to additional electrostatic and hydrophobic interactions that
can be made between ASCP and α-synuclein fibrils. Specifically, hydrophobic interactions between
amyloid binding dyes and aromatic residues within fibrils are thought to facilitate high affinity
interactions by enabling π-stacking and presenting large surfaces for dye binding (Biancalana et al.,
2009, 2010; Wu et al., 2009; Zhao et al., 2012). It is possible that the spatial separation and additional
rotational permutations of the aromatic moieties of ASCP allow it to preferentially form hydrophobic
contacts with the aromatic side chains of 𝛼-synuclein fibrils relative to ThT, contributing to the
enhanced affinity of ASCP for amyloid observed in this study.

The simultaneous increase in fluorescence intensity of ASCP and reduction of ThT fluorescence
observed in the binding-competition assay suggests that the binding sites of ASCP to α-synuclein
fibrils are the same or overlap with the binding sites of ThT. Molecular structures obtained through
NMR, crystallography and super-resolution imaging have provided insights into the apparent binding
mechanism of ThT to amyloid structures (Rodríguez-Rodríguez et al., 2010; Ivancic et al., 2016;
Shaban et al., 2017). Since amyloid fibrils are diverse in their underlying amino-acid sequence, it is
generally accepted that ThT recognizes structural features common to all amyloids, in particular, the
continuous cross-β-sheet structures and side-chain arrangements known as cross-strand ladders
(Biancalana et al., 2010). Amyloidogenic dyes, including ThT and Congo Red, have been shown to
bind to the β-sheet surface, orientated within the channel-like motifs formed by the cross-strand
ladders (Krebs et al., 2005). As ASCP is structurally similar to and competitively displaces ThT
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molecules bound to α-synuclein fibrils, it is suggested that ASCP also binds within the cross-strand
ladders of the β-sheet structures of α-synuclein fibrils; however, subsequent NMR and
crystallography experiments would be required to confirm this hypothesis.

The ability to perform in situ assays to monitor the fibrillar aggregation of proteins is particularly
advantageous, as key kinetic and mechanistic processes can be monitored in real time (Buell et al.,
2014; Leung et al., 2015; Cox et al., 2016). Thus, we sought to monitor the real-time aggregation of
RCM κ-casein, a well characterized amyloid-forming protein (Thorn et al., 2005; Ecroyd et al., 2008),
as well as the aggregation of the A1-42 and 𝛼-synuclein proteins, which are associated with the
pathogenesis of Alzheimer’s and Parkinson’s disease, respectively (Murphy et al., 2010; Longhena
et al., 2017; Zhang et al., 2018). Interestingly, our results suggest that ASCP is more sensitive to
oligomeric species formed early during aggregation as there tended to be an earlier and more
pronounced increase in ASCP fluorescence observed when monitoring the aggregation of RCM κcasein and A1-42 compared to ThT. Similar results have been observed previously for another
aggregation-induced emission fluorophore, TPE-TPP, which was shown to be significantly more
sensitive to oligomeric species formed early during the fibrillar aggregation of RCM κ-casein (Kumar
et al., 2017). Similarly, ASCP appears to report on the formation of species, such as small oligomers
and fibril nuclei, present early during the aggregation of A1-42, including the period typically
described as a lag phase when ThT is used in these assays. In contrast, an increase in ThT fluorescence
was not observed until later times, corresponding to the elongation phase of the reaction.

One of the main limitations of ThT is its relative inability to detect oligomeric species formed early
during aggregation (Malmos et al., 2017), which is of particular importance with recent evidence
suggesting that these oligomers are the primary cytotoxic species responsible for the pathogenesis of
numerous aggregation-associated diseases (Choi et al., 2018). The work presented here demonstrates
that ASCP has a superior ability to detect these soluble, pre-fibrillar aggregates compared to ThT and
therefore ASCP may be more suited for the real-time monitoring of protein aggregation. Importantly,
213

Chapter 6 – Characterization of ASCP as a novel dye to study protein aggregation
since lower concentrations of ASCP did not significantly change the fluorescence profile associated
with A1-42 fibril formation, it can be inferred that ASCP does not interfere with the kinetics of
aggregation and that the dye is likely reporting on nucleation events that are not able to be visualized
using ThT. Notably, a decrease in the fluorescence of ASCP, but not ThT, during the later stages of
A1-42 aggregation (> 40 hr) was observed. Such a phenomenon has been observed previously with
the aggregation-induced emission fluorophore, TPE-TPP (Kumar et al., 2017), and may be due to a
reduced fluorescence intensity of ASCP upon changes to the morphology of A1-42 fibrils. Different
fibril polymorphs are suggested to present different binding site distributions for amyloid binding
dyes, which in turn can affect the overall quantum yield of fluorescence (Sidhu et al., 2018).
Consequently, it is possible that the reduced fluorescence of ASCP at later stages of A1-42
aggregation results from a reduced proportion of ASCP-specific binding sites following
morphological changes to the A1-42 fibril structure. It is also possible that ASCP labels nonproductive and reversible aggregates that appear transiently during the incubation time, which may
provide further evidence that ASCP binds to different aggregate conformers compared to ThT (since
the reduction in fluorescence at later time scales during aggregation is not observed for ThT). It was
also noted that the aggregation of A1-42 in the current study occurred at longer timeframes compared
to those observed previously (Hellstrand et al., 2010; Meisl et al., 2014; O’Malley et al., 2016), which
is attributed to the different incubation conditions employed in this work. Crucially, the fluorescence
intensity profile of both ASCP or ThT was not changed when the onset and rate of A1-42 aggregation
was accelerated via incubation at higher temperatures, thus suggesting that the ability of either dye to
report on protein aggregation is not significantly influenced by the rate at which aggregation occurs
since the dye binds to regions in the amyloid structure that have already formed.

Interestingly, it was found that the ability of ASCP to monitor the aggregation of proteins was not
strictly limited to the detection of amyloid fibrils since significant increases in fluorescence were also
observed when it was present during the amorphous aggregation of 𝛼-lactalbumin and insulin.
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Importantly, while both insulin and 𝛼-lactalbumin have been reported to form amyloid fibrils under
certain conditions and chemical modifications (Manno et al., 2006; Kulig et al., 2012), both proteins
have been shown to form strictly amorphous structures upon the addition of a reducing agent as was
performed in this work (Biswas et al., 2008; Ecroyd and Carver, 2008; Kulig et al., 2012; Sanders et
al., 2020). The finding that ThT was also responsive to amorphous aggregation was surprising since
an increase in ThT fluorescence has long been associated with the specific detection of amyloid
aggregates. The increase in fluorescence of both of these dyes in the presence of amorphous
aggregates likely represents their generic mechanism of fluorescence, whereby restriction of
intramolecular rotations is the only pre-requisite for increased fluorescence emission (Malmos et al.,
2017). Both dyes, for instance, have been shown to be fluorescent in the presence of other biological
macromolecular structures that do not contain the -sheet structure characteristic of amyloid fibrils,
such as those formed by DNA and RNA (Biancardi et al., 2014; Xu et al., 2016; Yu et al., 2016; Liu
et al., 2017). Thus, it is likely that both ThT and ASCP can report on amorphous aggregation by
binding to hydrophobic grooves or cavities large enough to accommodate the dyes and restrict their
intramolecular rotations. It is possible that the relatively small size of these dyes facilitates their
binding to amorphous aggregates, since larger AIE fluorogens such as TPE-TPP, which is twice as
large as ThT, do not possess the ability to monitor the amorphous aggregation of proteins (Kumar et
al., 2017). Interestingly, ASCP appears to be able to monitor the early stages of the amorphous
aggregation of 𝛼-lactalbumin in a manner similar to that observed for the fibrillar aggregation of
RCM κ-casein and A1-42, which again suggests that ASCP is able to report on the formation of small,
oligomeric species not large enough to be detected by light scatter or ThT fluorescence. Together, the
results of the competitive binding and aggregation assays suggest that ASCP not only shares a binding
site with ThT but may also possess an additional binding mode(s) compared to ThT that enables
ASCP to detect oligomeric species formed early during both amorphous and fibrillar aggregation.

Data from this study and others have demonstrated that high concentrations of ThT (e.g., 50 µM) do
not significantly affect the kinetics of fibril formation (Xue et al., 2017). Consequently, many real
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time and ex situ fluorometric assays have been developed that utilize ThT to monitor fibril formation
(Ban et al., 2006; Ferkinghoff-Borg et al., 2010; Patil et al., 2011; Wördehoff et al., 2015; Horrocks
et al., 2016). However, caution must still be employed to ensure that the addition of an extrinsic probe
to the fibrillation reaction does not interfere with the aggregation kinetics. In this work we
demonstrate that ASCP can be used to monitor the elongation of 𝛼-synuclein, A1-42 and RCM
κ-casein fibrils in situ via increases in fluorescence intensity over time. However, ASCP may
influence the kinetics of A1-42 aggregation and was found to reduce the elongation rate of 𝛼synuclein fibrils at concentrations greater than 5 µM, and the total fluorescence and amyloid content
at concentrations greater than 10 µM.

This inhibitory effect of ASCP mirrors the in situ inhibition of amyloid fibril elongation observed
with other dyes and amyloidogenic proteins, including a tetraphenylethene (Hong et al., 2012) and
Congo Red (Lorenzo et al., 1994). Certain polyphenols and other stilbene derivatives similar to ASCP
are established inhibitors of amyloid formation, including curcumin (Yang et al., 2005; Ahmad et al.,
2012) and resveratrol (Rivière et al., 2007; Feng et al., 2009). The suggested mechanism of inhibition
is the binding of the fluorogenic dye to an exposed hydrophobic region in partially unfolded protein
monomers (Ge et al., 2012; Hong et al., 2012). This interaction affects the formation of the cross-βsheet motifs and prevents the ‘docking’ or incorporation of the monomers onto the fibril (Porat et al.,
2006; Hong et al., 2012). Therefore, we propose that the additional aromatic structure present in
ASCP, compared to ThT, may enable ASCP to form more favorable hydrophobic interactions with
unfolded monomeric species that prevents their ‘docking’ onto the growing fibril, contributing to the
inhibitory effects of ASCP on 𝛼-synuclein fibril elongation at concentrations above 10 μM.
Regardless, the results of this work have demonstrated that it is possible to use ASCP to monitor the
in situ elongation of fibril elongation, albeit under optimized conditions and lower concentrations of
dye relative to ThT. Moreover, we show ASCP is ideal for ex situ investigations of fibril formation.
Furthermore, ASCP was not found to significantly interfere with the aggregation of other proteins
used in this study and thus the observed amyloid inhibition effect observed for 𝛼-synuclein fibril
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elongation at high concentrations of ASCP may be a protein-specific phenomenon.

Aggregation assays that employ the use of aggregation-sensitive fluorophores, such as ThT, have
been extensively employed to study the kinetics of fibril growth (e.g., lag and elongation rates);
however, the underlying mechanisms of amyloid formation are complex and extremely
heterogeneous. Thus, single-molecule approaches that enable the characterization of individual
amyloid fibrils are becoming increasingly common (Ban et al., 2006; Ferkinghoff-Borg et al., 2010;
Patil et al., 2011; Pinotsi et al., 2014; Yagi et al., 2014; Wördehoff et al., 2015; Horrocks et al., 2016).
The use of AIE fluorophores has a substantial advantage in single-molecule investigations of amyloid
formation since photobleaching is avoided and the protein of interest does not need to be covalently
labelled with a fluorescent probe, which can change the kinetics and overall morphology of the
elongating fibril (Jungbauer et al., 2009; van Ham et al., 2010; Pinotsi et al., 2014; Yagi et al., 2014;
Horrocks et al., 2016; Mučibabić et al., 2016; Wägele et al., 2019). With this in mind, we sought to
investigate if ASCP could serve as a suitable alternative to ThT in single-molecule TIRF microscopy
experiments. The results of this study found that 𝛼-synuclein fibrils stained with relatively low
concentrations of ASCP could easily be visualized using TIRF microscopy and the length of these
fibrils was observed to increase throughout incubation. Furthermore, as a proof of principle, we
demonstrate that the molecular chaperone 𝛼B-c can bind to pre-formed 𝛼-synuclein fibrils and that
both species can be visualized simultaneously when illuminating the sample with a single 488 nm
excitation laser source.

There are several advantages in using ASCP in microscopy experiments compared to ThT. First, the
significant Stokes shift of ASCP allows a single illumination source to simultaneously excite ASCP
and another fluorophore (e.g., Alexa Fluor 488) without the need to worry about fluorescence spectral
overlap, which facilitates the study of more complex biological systems without additional technical
complexity. The spectral separation required for single-laser multi-fluorophore imaging simply
cannot be achieved with probes typically used for biological applications (i.e., ThT, GFP and Alexa
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Fluor dyes) due to their small Stokes shift. Second, dyes that exhibit large Stokes shifts (> 100 nm)
also reduce light scattering and interference between the excitation source and fluorescence emission
detection (Waters, 2009; Escobedo et al., 2010), resulting in significantly improved signal to noise
ratios and enhanced localization of individual fluorophores. Furthermore, the use of dyes such as ThT
and TPE-TPP, which emit in the blue region of the spectrum, is severely restricted in experiments
involving cells or tissues due to interference of the dye signal as a result of autofluorescence. The
significant, red-shifted emission of ASCP overcomes such limitations and, with further development,
could be used for the study of protein aggregates in cells and tissues. Finally, the excitation properties
of ThT (412 nm) are sometimes inaccessible to conventional filter setups of laboratory instruments,
including flow cytometers and fluorescence microscopes, which are typically equipped with 488 nm
lasers as standard. Therefore, ASCP has the advantage of being more compatible with standard optical
configurations (excitation source of 488 nm and ability to monitor emission at ~ 647 nm), that are
most common in fluorescence-based instruments.

6.5

Conclusions

The use of extrinsic dyes, such as ThT, to detect and monitor the growth of amyloid fibrils in vitro
has become commonplace and has greatly contributed to our understanding of the pathology and
progression of aggregation-associated diseases. ThT is the most utilized and characterized dye for the
detection of amyloid; however, there is a growing need to develop alternative dyes that possess an
improved ability to detect soluble or pre-amyloid species formed early during aggregation and have
unique and enhanced spectral qualities compared to ThT. To this end, we investigated the
photophysical and fibril-binding properties of the 𝛼-cyanostilbene derivative ASCP via absorbance
and fluorescence spectroscopy as a potential alternative to ThT. Similar to ThT, ASCP became
fluorogenic in the presence of amyloid fibrils, exhibited a higher binding affinity to 𝛼-synuclein fibrils
compared to ThT and also competitively displaced bound ThT from 𝛼-synuclein fibrils that suggests
a shared binding site. Furthermore, ASCP can be used to monitor amorphous and fibrillar aggregation
when used in situ and has a superior ability to detect soluble oligomers or pre-fibrillar species
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compared to ThT. Interestingly, ASCP also exhibits a pronounced Stokes shift of 145 nm that can be
utilized in TIRF microscopy experiments to simultaneously visualize fluorescently labelled 𝛼B-c
chaperone and ASCP-stained 𝛼-synuclein fibrils using only a single laser. Consequently, we propose
that the red-shifted emission, enhanced Stokes shift and fibril-binding properties makes ASCP a
superior alternative to ThT for the study of amyloid fibrils in TIRF microscopy experiments.
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Protein aggregates are the pathological hallmarks of various neuropathies and aggregation-associated
diseases, such as Alzheimer’s disease, Parkinson’s disease, and cataracts (Sandilands et al., 2002;
Gundersen, 2010; Thal et al., 2015; Choi et al., 2018; Gandhi et al., 2019). Consequently, cells have
evolved a dynamic network of molecular chaperones that are essential for maintaining the function
of the proteome, playing crucial roles in de novo protein folding, the prevention of protein misfolding
and aggregation, and the solubilization of aggregated species (Kim et al., 2013; Balchin et al., 2016).
However, the precise molecular mechanisms by which chaperones perform these multi-faceted roles
remains enigmatic. A significant hurdle for the study of molecular chaperones is that their interactions
with client proteins are heterogeneous, transient, and dynamic, which makes them difficult to study
using traditional ensemble-averaging approaches. Recently, single-molecule approaches have been
increasingly used as a tool to study the fundamental principles underlying both protein aggregation
and molecular chaperone function, since rare and transient sub-populations within an ensemble can
be identified and characterized (Gupta et al., 2014; Kellner et al., 2014; Ratzke et al., 2014;
Wördehoff et al., 2015; Avellaneda et al., 2017; Cox et al., 2018; Kundel et al., 2018; Tsuboyama et
al., 2018; Imamoglu et al., 2020). This work aimed to further develop these single-molecule
approaches to better study the processes that underpin protein aggregation and the mechanisms by
which molecular chaperones assist in the folding of proteins and the prevention of protein aggregation
as part of their role in maintaining protein homeostasis.

7.1

Molecular chaperones actively remodel the conformational landscape of their client
proteins during refolding

A primary goal of this work was to establish a system that would enable the conformation of an
individual client protein to be monitored in real time during its interactions with molecular
chaperones. To achieve this, two well-established model client proteins of molecular chaperones were
exploited, namely Fluc and Rhod. The work described in Chapter 3 and Chapter 4 of this thesis
resulted in the generation of FlucIDS and Avi-RhodIDS as protein-folding sensors that can be (i)
expressed as soluble proteins in bacteria, (ii) biotinylated in vivo to facilitate their site-specific
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immobilization to a coverslip surface, and (iii) used in smFRET TIRF-based experiments to observe
changes in conformation in real time. These protein-folding sensors were then used to investigate the
mechanistic details of how human and bacterial Hsp70 chaperone systems interact with client proteins
to promote their refolding. Based on these results, a proposed model for the refolding of client
proteins by the Hsp70 system is presented in Figure 7.1 (inset 1). First, binding of Hsp40 to a
misfolded client results in partial unfolding and priming of the client protein for capture and further
conformational expansion by Hsp70. While bound by Hsp70, the client protein remains
conformationally dynamic and may form secondary structural elements in regions distinct from the
Hsp70 binding site. Upon dissociation of ADP from Hsp70, which is accelerated by a NEF, the client
protein is released. Following its release from Hsp70, the client protein can refold spontaneously to
the native state or become misfolded and undergo additional rounds of chaperone binding and release.
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Figure 7.1: Using single-molecule approaches to investigate the mechanisms by which molecular
chaperones interact with client proteins. The misfolding of proteins can lead to the formation of diseaseassociated amyloid fibrils or amorphous aggregates. Molecular chaperones play crucial roles in preventing
protein misfolding and aggregation and can also rescue misfolded clients, refolding them to a biologically
active state. (1) The mechanism by which molecular chaperones, specifically the Hsp70 system, can rescue
misfolded clients and refold them to the native state, as determined by smFRET in this work (Chapter 3 and
Chapter 4). This process involves the binding and partial unfolding of the client protein by Hsp40, delivery to
and additional client unfolding by Hsp70, and refolding of the client upon Hsp70 release. (2) The amorphous
aggregation of a novel client protein, CLIC1, can be prevented by sHsp chaperones by sequestering the
aggregation-prone client into high-molecular mass complexes (Chapter 5). (3) The novel dye, ASCP, can be
used in ensemble and single-molecule TIRF-based experiments to study protein aggregation (Chapter 6).
Specifically, ASCP can be used in single-laser two-color TIRF microscopy experiments to simultaneously
visualize amyloid fibrils and the AF488-labelled molecular chaperones.

One of the primary aims of this work was the development of two complementary client proteins,
Fluc and Rhod, that are fluorescently tagged so that they report on chaperone function. Future work
could build on the results described in this thesis and perform more direct and comprehensive
comparisons of these different clients (i.e., FlucIDS and Avi-RhodIDS) during their interactions with
molecular chaperones. Such studies would illuminate how molecular chaperones may differ in their
interactions with client proteins and explain why it is that the Hsp70 system is able to fold some client
proteins (e.g., Fluc) and not others (e.g., Rhod). Furthermore, the FlucIDS construct developed as part
of this work represents an excellent platform to study the mechanisms by which different chaperone
systems or isoforms affect the folding of client proteins. For example, DnaJA2, but not DnaJA1, can
co-operate with HspA8 to refold chemically denatured Fluc (Tzankov et al., 2008; Baaklini et al.,
2012); further single-molecule experiments may enable the precise molecular and functional
mechanisms of these Hsp40 isoforms to be elucidated, so that these differences in their capacity to
refold client proteins can be resolved. Additionally, the developed Avi-RhodIDS sensor could also be
employed in TIRF-based experiments investigating the role of additional chaperone systems, such as
Hsp60 (i.e., GroEL/ES), which are required for efficient Rhod refolding

This work also demonstrated that molecular chaperones remodel the conformational landscape of
their client proteins; however, the direct observation and assignment of specific client conformational
changes to chaperone function remains difficult. Further experiments with fluorescently labelled
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chaperones would represent a significant step forward towards being able to assign specific client
transitions or conformational changes to an aspect of chaperone function (e.g., association or
dissociation, ATP hydrolysis, etc.). Due to the well-established ‘concentration problem’ of singlemolecule experiments, whereby high concentrations of labelled protein prevent the observation of
single immobilized proteins due to background fluorescence (van Oijen, 2011), such experiments
were unable to be performed using the approach exploited in this work. Nano-vesicles that
encapsulate labelled proteins or zero-mode waveguides, which significantly reduce the observation
volume, have both been implemented to overcome this ‘concentration problem’ and used for the study
of molecular chaperones at high concentrations (Levene et al., 2003; Benítez et al., 2008, 2010;
Miyake et al., 2008). The incorporation of such approaches with the developed protein-folding sensor
would represent an exciting avenue for future work in this area, as changes in client conformation
could be monitored concurrently with the association and dissociation of labelled chaperones.

7.2

CLIC1 is a novel sHsp client protein

The work described in Chapter 5 of this thesis aimed to characterize CLIC1 as a novel client protein
for the study of sHsp function. By performing circular dichroism, light scattering assays, sizeexclusion chromatography and SDS-PAGE, it was demonstrated that the sHsp 𝛼B-c, but not Hsp27,
could inhibit the heat-induced aggregation of CLIC1 by sequestering it into soluble high-molecular
mass complexes. As such, it was concluded that CLIC1 represents a novel sHsp client that can be
employed in subsequent work interrogating the function of these molecular chaperones (Figure 7.1,
inset 2). This work also involved attempting to develop CLIC1 into a single-color protein-folding
sensor by taking advantage of the ability of TMR dyes to self-quench when in close proximity to each
other (Zhou et al., 2011). Single-molecule analysis of individual immobilized TMR-labelled CLIC1
proteins revealed that the folded state could not be reliably monitored using TMR fluorescence, since
there was no apparent difference in fluorescence when CLIC1 was incubated in the presence or
absence of denaturant. While further development of CLIC1 into a protein-folding sensor is not
practicable using this approach, there remains a significant need for the development of a single-color
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folding sensor as it could be employed as a chaperone client to enable the simultaneous study of
chaperone systems (via fluorescent labelling of chaperone proteins) at the single-molecule level.
While the use of single-molecule FRET has been exceedingly valuable for characterizing the
structural heterogeneity of both Hsps and their clients, FRET studies are usually restricted to the use
of two fluorophores (and in rare cases three) due to the limited observable wavelength spectrum of
light available. Thus, the number of observables (i.e., proteins) that can be monitored at any one time
is significantly limited. One alternative approach would be to further develop the FlucIDS or AviRhodIDS FRET-based folding sensors described in Chapter 3 and Chapter 4 of this thesis, by replacing
the acceptor fluorophore with a black-hole quencher. Black-hole quenchers act as typical
fluorophores with the exception that they do not fluoresce when excited and instead decay from the
excited state via non-radiative processes (e.g., heat). The utility of black-hole quenchers in smFRETbased approaches has been demonstrated previously (Chen et al., 2012; Le Reste et al., 2012) and
could be implemented without any significant changes to the proteins developed in this work.

7.3

ASCP is a spectrally superior alternative to ThT for the detection and characterization of
pre-fibrillar oligomers and protein aggregates

A key theme of the work outlined in this thesis is the development of single-molecule TIRF-based
approaches to study protein misfolding, aggregation and the action of molecular chaperones.
Thioflavin T (ThT) is the most characterized dye employed for the study and detection of protein
aggregates; however, ThT has a poor ability to detect toxic pre-fibrillar soluble oligomers and suffers
from a small Stokes shift. The work described in Chapter 6 of this thesis aimed to characterize a novel
aggregation-induced emission fluorophore, ASCP, which can be used as an alternative to ThT in
ensemble-based and single-molecule approaches to characterize protein aggregates. By performing
aggregation assays, it was found that ASCP had a higher affinity to and competitively displaced ThT
from mature 𝛼-synuclein fibrils, indicating that ASCP occupies similar binding sites on fibrils
compared to ThT. Furthermore, it was found that ASCP had a similar ability to monitor the fibrillar
(and amorphous) aggregation of various purified model proteins in situ and ex situ compared to ThT;
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however, ASCP exhibited an enhanced ability to detect oligomeric species formed early during the
aggregation of A1-42 that were not detected by ThT. Recent evidence has suggested that the prefibrillar, soluble, oligomeric species are primarily responsible for the pathogenesis of numerous
aggregation-associated diseases, likely owing to their propensity to disrupt the integrity of cellular
membranes (Evangelisti et al., 2016; Fusco et al., 2017; Choi et al., 2018; Zhang et al., 2018).
Consequently, novel dyes such as ASCP that can detect these oligomeric species are becoming
increasingly important as they enable the process of fibril formation to be better understood at the
molecular level and in the context of disease onset and progression.

The results of this work found that ASCP possesses a significantly larger stokes shift (145 nm) when
bound to fibrillar species compared to ThT (68 nm). As a proof-of-principle experiment, the
advantage of this spectral property was exploited by using a single laser to simultaneously illuminate
and visualize the binding of the sHsp 𝛼B-c to ASCP-stained 𝛼-synuclein fibrils using TIRF
microscopy (Figure 7.1, inset 3). Such a result is exciting as the single-laser two-color imaging
approach dramatically simplifies the experimental setup required for such experiments, which
facilitates the more complex interrogation of molecular chaperone function in the context of protein
aggregation. One area of research that could benefit from the imaging approach developed in this
work would be the study of fibril disaggregation by molecular chaperones. For example, future work
could focus on better understanding the mechanism by which the well-characterized human Hsp70
system (e.g., DnaJB1, HspA8 and the NEF, Hsp110) mediates the disaggregation of 𝛼-synuclein
fibrils (Gao et al., 2015; Wentink et al., 2020). One model of how this chaperone system mediates
amyloid disaggregation revolves around the concept that molecular chaperones crowd at the surface
of fibrils and this induces fibril fragmentation (Gao et al., 2015; Nillegoda and Bukau, 2015;
Nachman et al., 2020; Wentink et al., 2020); however, no direct real-time visualization of this
phenomenon has been reported. The TIRF microscopy imaging setup described in this work
represents an experimentally simple approach to directly visualize this disaggregation process with
labelled chaperones and ASCP-stained fibrils.
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7.4

Concluding remarks

The work presented in this thesis describes the development and implementation of various singlemolecule approaches for the study of protein misfolding, aggregation and molecular chaperone
function. Using smFRET and TIRF microscopy, the conformation of two client proteins, FlucIDS and
Avi-RhodIDS, was monitored in real time during the process of chaperone-assisted folding for the first
time. Collectively, the results of this work are consistent with a mechanism by which molecular
chaperones bind to and stabilize expanded conformations of the client protein, thereby resolving
compact misfolded states, and assisting the spontaneous refolding of the client upon chaperone
release. Thus, these results significantly contribute to our understanding of the precise mechanisms
by which molecular chaperones refold misfolded clients to maintain a folded and functional
proteome. Furthermore, this work demonstrates the utility of a novel dye, ASCP, to detect and
characterize oligomeric and aggregated protein species. The enhanced spectral qualities of ASCP
make it a superior alternative to ThT for the study of amyloid fibrils in TIRF microscopy experiments.
Overall, this work illustrates the advantage of single-molecule approaches to study the fundamental
mechanisms by which molecular chaperones act to prevent the misfolding and aggregation of
proteins, a key component of protein homeostasis.
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Appendix I

Table 9.1: Summary of the antibodies or HRP-conjugated proteins employed in this work and their
working concentrations or dilutions.

1˚ antibody

2˚ antibody

(Dilution or final
concentration [µg/mL])

(Dilution or final
concentration [µg/mL])

Figure 4.4 - Refolding of HisRhodIDS from inclusion bodies

Biotinylated anti-6x-His
antibody

Streptavidin-HRP
conjugate

Figure 4.6 – Assessing the
soluble expression of MBP- or
SUMO-tagged RhodIDS

(1 in 5000)

(1.7)

Figure 3.3 – Assessing the
biotinylation of FlucIDS

Streptavidin-HRP conjugate

N/A

Blot

(1.7)
Figure 4.2 – Assessing the
biotinylation of Avi-RhodIDS
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Appendix II

Table 9.2: Summary of the extinction coefficients and molecular mass of each protein used in this work.

Protein

Extinction coefficient
([mg/mL]-1·cm-1)

Molecular mass (Da)

DnaJB1

0.497

38044

HspA8

0.47

70898

𝛼B-c

0.694

20140

CLIC1CysL

0.6

28825

Ulp1

1.092

27394

RhodIDS

1.844

36535

FlucIDS

0.722

64098
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Appendix III

Table 9.3: Summary of the conditions used for restriction-enzyme cloning. The primers, annealing temperatures, cloning vectors and restriction enzymes
used for each cloning reaction are provided.

Final cloned
construct

Primers

His-RhodIDS

Forward primer (5’ NdeI-Rhod)
5’ GTACATATGGTTCATCAGGTGCTC

PCR
annealing
temp (˚C)

Cloning
vector

RE
enzymes

Colony screening primers

55

pET28c

NdeI +
EcoRI

Forward primer (T7-promoter)
5’ TAATACGACTCACTATAGGG

Reverse primer (3’ EcoRI-Rhod)
5’
CTAGAATTCTTAGGCCTTCCCACCCTTCC
MBP- or
SUMO-tagged
Avi-RhodIDS

Forward primer (5’ BamHI-Rhod)
5’ GTAGGATCCATGGTTCATCAGGTGCTC

Forward primer (5’ BamHI-Fluc)
5’ CTAGGATCCATGGAAGACGC
Reverse primer (3’ HindIII-Fluc)
5’ CTAGGATCCATGGAAGACGC

48

Reverse primer (T7-terminator)
3’ GCTAGTTATTGCTCAGCGG

60

pSUMO
or pMBP

Reverse primer (3’ XhoI-Rhod)
5’
CTACTCGAGCTTAATGTTCGTGCCATTCG
SUMO tagged
FlucIDS with Cterminal
AviTag

Colony
screening
annealing
temp (˚C)

BamHI+
XhoI

Forward primer (5’ Rhod)
5’ TCATCAGGTGCTCTACCG

57

Reverse primer (T7-terminator)
3’ GCTAGTTATTGCTCAGCGG

56

pSUMO/
AviTag

BamHI + Forward primer (5’ BamHI-Fluc)
HindIII
5’ CTAGGATCCATGGAAGACGC
Reverse primer (3’ HindIII-Fluc)
5’ CTAGGATCCATGGAAGACGC

59
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Appendix IV

Figure 9.1: Schematic of the protein constructs used in Chapter 3 and Chapter 4

